Cell Scaffold- and Drug-based Strategies for Improving the Integration of Neural Prostheses into Brain Tissue. by Purcell, Erin Kay
CELL SCAFFOLD- AND DRUG-BASED STRATEGIES FOR IMPROVING THE 








A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Biomedical Engineering) 











 Professor Daryl R. Kipke, Chair 
 Professor David C. Martin 
 Associate Professor Jack M. Parent  












                                                                       




                                                                       ii
DEDICATION 
 
To my wonderful loving and supportive family:  my husband Jake, my daughter Scarlett, 









































Daryl Kipke has been an incredibly supportive advisor.  He allowed me to freely design 
and pursue the research studies that I found the most interesting.  He helped me allocate 
the resources needed to complete my work; I am especially thankful for the trip to Dr. 
David Mooney’s lab at Harvard that he arranged for me to gain cell encapsulation 
expertise.  I am very grateful for the support he showed for me through my pregnancies 
and maternity leave while in his lab, and the understanding he has shown for work/family 
life balance.  In addition, my committee has provided wonderful support and feedback to 
me, and I would like to thank Dr. Takayama, Dr. Parent, and Dr. Martin for all of their 
time and effort. 
 
Several individuals worked on the research described in this dissertation.  Aparna Singh 
and Soumya Yandamuri were hard-working and dedicated undergraduate students who 
are co-authors on the research described in chapters 2 and 4.  Jackie Gauthier worked on 
developing initial in vitro methods used for cell encapsulation.  Elizabeth Nunamaker, a 
former graduate student in our lab, initiated the study described in Chapter 3, and is the 
first author on the manuscript published from that work.  John Seymour, a fellow 
graduate student in the lab, fabricated the probes and developed the quantification 
techniques for analyzing tissue response used in Chapters 4 and 5.  He is a co-author on 
the Chapter 4 work.  Dave Thompson is a co-author on the Chapter 5 research; he was 
                                                                       iv
a first year graduate student who assisted with surgeries, recordings, and MatLab coding.  
I was very lucky to work with all of these individuals, who not only made such terrific 
contributions to the projects, but were also so enjoyable to work with. 
 
There are several other people who have likewise added immeasurably to my graduate 
experience.  Members of the Neural Engineering Lab provided valuable feedback, 
insightful discussions, and necessary training on so many occasions, and made for a fun 
and dynamic work environment.  I particularly would like to thank Rachel Miriani, Kip 
Ludwig, Taegyun Moon, Liz Nunamaker, John Seymour, and Jey Subbaroyan.  Jess 
Kemppainen, Elisa Cosgrove, and Alexandra Teuscher have been great friends during my 
time in the program.  Members of my “old lab”, headed by Dr. James Russell, helped me 
learn numerous techniques and have been great friends as well, and I would particularly 
like to acknowledge Dr. Rita Cowell and Dr. Alison Berent-Spillson.  These two women 
also showed me that it is possible to have children and earn a PhD.  Sarah Richardson-
Burns and Jeff Hendricks from Dr. David Martin’s lab have provided many helpful 
discussions.  The wonderful core facilities at the University, including the MIL and 
Organogenesis cores, have been instrumental in the research reported here.  I would like 
to thank Marta Dzaman and Shelley Almburg for their assistance.  Finally, thanks to the 
staff in the Biomedical Engineering offices, especially Maria Steele, Tonya Thompson, 
and Vera Williams for all of their assistance over the years. 
 
My family has supported me throughout my graduate career, and I am especially grateful 
to my husband, Jake.  He made many sacrifices so that I could pursue my goals.  When I 
                                                                       v
was discouraged, he gave me the confidence to keep going.  He supported me in so many 
ways, whether it was through encouraging words, taking care of the household when I 
needed to work or study, or listening to me practice talks or reviewing papers and 
proposals for me.  He has been the best partner I could hope for.  My extended family has 
always been there for me as well; especially my father, brother, grandmother, aunt Jean, 
step-mom and in-laws.  I would finally like to thank my late mother, Jane, for being a 
wonderful mother, teaching me to work hard and be a good student, and to have 
compassion for those who suffer from neurological disease.













LIST OF FIGURES……………………………………………………………………….x 
 
LIST OF TABLES……………………………………………………………………....xvi 
 
LIST OF APPENDICES…………………………………………………………….....xvii 
 
ABSTRACT……………………………………………………………………….......xviii 
CHAPTER 1 ....................................................................................................................... 1 
INTRODUCTION .............................................................................................................. 1 
Neural Prostheses:  Development, Therapeutic Potential, and Performance...................... 1 
The Reactive Tissue Response to Neural Probes................................................................ 6 
Probe Modifications for Improved Tissue Integration...................................................... 10 
Alginate and Cell Encapsulation....................................................................................... 12 
Neural Stem Cell Therapy for Central Nervous System Injury........................................ 16 
Cell Cycle Inhibition as Therapy for Central Nervous System Injury.............................. 20 
Dissertation Organization ................................................................................................. 22 
References......................................................................................................................... 25 
CHAPTER 2 ..................................................................................................................... 34 
IN VITRO DEVELOPMENT AND CHARACTERIZATION OF A CORTICAL 
NEURAL STEM CELL-SEEDED ALGINATE SCAFFOLD ........................................ 34 
Abstract ............................................................................................................................. 34 
                                                                       vii
Introduction....................................................................................................................... 35 
Materials and Methods...................................................................................................... 38 
Materials ....................................................................................................................... 38 
Cortical NSC Culture and Encapsulation in Alginate................................................... 39 
ELISA ........................................................................................................................... 40 
Alginate Mechanical Stability....................................................................................... 40 
NSC Proliferation and Viability in Alginate................................................................. 41 
Immunocytochemistry of Cells in Alginate.................................................................. 41 
Bioactivity of Conditioned Medium from NSC-Seeded Beads.................................... 42 
Statistical Analysis........................................................................................................ 43 
Results............................................................................................................................... 43 
ELISA ........................................................................................................................... 43 
Alginate Mechanical Stability....................................................................................... 45 
Proliferation and Viability in Alginate ......................................................................... 47 
Immunocytochemistry of Cells in Alginate.................................................................. 51 




CHAPTER 3 ..................................................................................................................... 65 
IN VIVO STABILITY AND BIOCOMPATIBILITY OF CALCIUM ALGINATE 
DISKS............................................................................................................................... 65 
Abstract ............................................................................................................................. 65 
Introduction....................................................................................................................... 66 
Materials and Methods...................................................................................................... 71 
Alginate Hydrogel Preparation ..................................................................................... 71 
Surgery.......................................................................................................................... 73 
Disk Weight Change ..................................................................................................... 74 
Rheology: Complex Modulus and Loss Angle............................................................. 74 
Histology....................................................................................................................... 75 
Statistics ........................................................................................................................ 76 
Results............................................................................................................................... 76 
Disk Weight Change ..................................................................................................... 76 
Rheology: Complex Modulus and Loss Angle............................................................. 78 
Histology....................................................................................................................... 79 




CHAPTER 4 ..................................................................................................................... 93 
NEURAL STEM CELL-SEEDING MITIGATES THE EARLY TISSUE RESPONSE 
TO NEURAL PROSTHESES .......................................................................................... 93 
Abstract ............................................................................................................................. 93 
Introduction....................................................................................................................... 94 
Materials and Methods...................................................................................................... 97 
Probe Manufacture........................................................................................................ 97 
Cell Culture and Probe Scaffolding .............................................................................. 98 
Probe Implantation........................................................................................................ 99 
Histology and Quantitative Analysis .......................................................................... 100 
Statistics ...................................................................................................................... 102 
Results and Discussion ................................................................................................... 103 
Probe Design and In Vivo NSC Detection ................................................................. 103 
Scaffold Condition Effects on Neuronal and Non-Neuronal Densities ...................... 105 
Neuronal and Non-Neuronal Densities as a Function of Distance ............................. 111 
The Correlation between Neuronal and Non-Neuronal Densities .............................. 111 




CHAPTER 5 ................................................................................................................... 122 
CELL-CYCLE INHIBITION EFFECTS ON THE RECORDING QUALITY AND 
TISSUE RESPONSE OF CHRONIC NEURAL PROBES............................................ 122 
Abstract ........................................................................................................................... 122 
Introduction..................................................................................................................... 123 
Methods........................................................................................................................... 127 
Probe Implantation and Intracerebroventricular (ICV) Injection ............................... 127 
Neural Recordings ...................................................................................................... 128 
Impedance Spectroscopy ............................................................................................ 129 
                                                                       ix
Immunohistochemistry and Analysis.......................................................................... 129 
Statistical Analysis...................................................................................................... 131 
Results............................................................................................................................. 132 
Impedance Spectroscopy ............................................................................................ 132 
Neural Recording Data ............................................................................................... 133 
Cell Cycle Protein Expression Surrounding Prostheses ............................................. 138 
Neuronal and Non-Neuronal Densities Surrounding Probes ...................................... 139 




CHAPTER 6 ................................................................................................................... 154 
CONCLUSIONS AND FUTURE DIRECTIONS.......................................................... 154 
Conclusions..................................................................................................................... 154 
Future Directions and Preliminary Results ..................................................................... 157 
Establishing the Relationship Between Recording Quality and Tissue Response ..... 157 
Neuronal Dysfunction and Plasticity after Probe Implantation .................................. 161 
Chronic Recordings with Functionalized Neural Stem Cell-Seeded Probes .............. 163 
Concluding Remarks....................................................................................................... 164 
Acknowledgements......................................................................................................... 166 
References....................................................................................................................... 167 
APPENDICES ................................................................................................................ 169 
                                                                       x
LIST OF FIGURES 
 
Figure 1.1. Neural probe designs. The schematic and dimensions of an example of a 
Michigan probe design (a), close-up of a four shank, sixteen site Michigan probe (b), and 
its insertion into the rat cortex (c) (Vetter, Williams et al. 2004).  The Utah 
microelectrode array (d) (Rousche and Normann 1998).  Microwires with a 50 micron 
diameter used by Nicolelis et al. (e) (Nicolelis, Dimitrov et al. 2003). .............................. 2 
Figure 1.2.  The maximum number of days during which neuronal spikes could be 
resolved on any sites of implanted electrode arrays (Liu, McCreery et al. 2006). ............. 5 
Figure 1.3.  The stratification of cellular immunoreactivity at the tissue-electrode 
interface shows the distribution of microglia (ED-1), astrocytes (GFAP), neuronal nuclei 
(NeuN) and processes (NF) surrounding a probe (orange oval, left)  (a, from Biran et al.). 
Microglial (b) and astrocytic (c) responses surrounding probe tracts as a function of time 
(from Szarowski et al.).  The glial sheath is initially diffuse and becomes compacted over 
time.  Images were obtained using Michigan electrodes in a rat model.  Scale = 100 
microns in b,c...................................................................................................................... 1 
Figure 1.4.  Alginate structure (a) and cross-linking mechanism (b-c).  Alginate 
encapsulation is frequently used to protect secretory cells from an immune response 
while allowing the desired factors to freely pass through the membrane (d). .................. 13 
Figure 1.5 (From Reynolds and Weiss, 1996).  The EGF-responsive stem cell generates a 
neurosphere composed of more stem cells (close to 20%, shown in pink) and progenitor 
cells (blue). The secondary stem cells, when replated alone or in populations, generate 
new, clonally derived spheres. Both primary and secondary spheres contain progenitor 
cells that proliferate and differentiate into neurons, astrocytes, and oligodendrocytes. ... 17 
Figure 1.6.  The stages of the cell cycle (a), with X’s marking transitions inhibited by 
flavopiridol.  The structure of flavopiridol is shown in (b). ............................................. 21 
Figure 2.1.  NSC-seeded alginate microcapsules with a G composition have superior 
stability in comparison to all other conditions.  G beads remain intact more frequently 
than M capsules after exposure to 0 mOsm 7 days after seeding (a) (p < 0.001, logistic 
regression).  PLL-coated capsules break more frequently than uncoated capsules (p < 
0.001, logistic regression).  Representative images of G (b), G-PLL (c), M (d), and M-
PLL (e) capsules in solution illustrate the stability of G capsules (intact beads are labeled 
“I”) and breakage (broken beads are denoted “B”) of M and G-PLL beads.  M-PLL beads 
are completely dissolved.  Insets in (b)-(d) highlight representative beads (arrows) to 
improve visualization.  Error bars are not shown due to the nature of the data analysis.  
Scale = 1 mm. ................................................................................................................... 46 
                                                                       xi
Figure 2.2. NSCs survive (a-c) and proliferate (d) in alginate regardless of the 
compositions tested.  Viability of the cells is initially reduced following encapsulation, 
but significantly improves for all conditions after one week (a).  Cells are labeled with 
Hoechst (blue), and propidium iodide (red) stains nuclei of cells with compromised 
membranes indicative of cell death (b-c).  Representative pictures of G-encapsulated cells 
at 21 days illustrate the vulnerability of cells in the center of larger proliferating 
neurospheres to necrosis, presumably due to reduced nutrient and oxygen diffusion (b-c).  
NSCs proliferate irrespective of alginate composition, with significantly increased cell 
numbers detected beginning at 4 days compared to initially low or non-detectable values 
1 day after encapsulation (d).  A further increase occurs at 21 days post-encapsulation.  
M-PLL capsules were too mechanically unstable to assay after the first week. †, ‡ = 
significantly increased versus 1 day, or 1 and 4 days respectively at the 0.05 level 
(ANOVA).  Mean ± s.e.m. is shown.  Scale = 100 microns............................................. 49 
Figure 2.3.   Encapsulated NSCs express nestin (green) on the periphery and GFAP (red) 
in the center of cell masses after entrapment in alginate (a-b). Interestingly, some 
evidence of limited NG-2 expression (green) was observed in one bead, indicating 
oligodendrocyte progenitors (c).  All nuclei were counterstained with Hoechst (blue).  
Images are from (a) G, 14 day, (b) M-PLL, 14 day, and (c) G-PLL, 4 day, scaffolds and 
time points.  Scale = 50 microns....................................................................................... 51 
Figure 2.4.  NSC-conditioned medium from G encapsulated cells protects PC-12 cells 
from serum withdrawal-mediated cell death (a) (p < 0.05, ANOVA).  Representative 
images of live (green) and dead (red) PC-12 cells after a 50% serum withdrawal and 
treatment with medium conditioned by NSC-seeded (b, 75.6% viable) or unseeded (c, 
49.5% viable) alginate microspheres.  Results are reported as a percentage of control PC-
12 cell viability.  Mean ± s.e.m. is shown.  Scale = 100 microns..................................... 52 
Figure 3.1. Diffusion and in situ gelling of liquid alginate.  A.  Diffusion gelling.  
Calcium ions diffuse through the liquid alginate boundary, cross-linking alginate strands 
as the ions move through the volume of alginate.  Cross-links are not uniformly 
distributed throughout the gel.  B.  In situ gelling.  CaCO3 is mixed with alginate to create 
a homogeneous mixture (black circles).  D-Glucono-δ-lactone (GDL, grey circles) is 
added to acidify the solution and release calcium ions, making them available for cross-
linking.  The resultant hydrogel has a uniform distribution of cross-links....................... 68 
Figure 3.2. Differences in hydrogel weight.  A.  On day 0, the alginate’s weights were 
significantly different for each condition.  CaCO3 reacted gels were the heaviest initially 
(p < 0.001).  CaCl2/PLL hydrogel were significantly heavier than CaCl2 reacted gels on 
day 0 (p < 0.001).  B.  Hydrogel weight changes with time.  All of the hydrogels 
decreased in weight on day 1; however, the weights of the CaCl2 and CaCl2/PLL 
hydrogels then increased until day 7.  After day 7, these gels begin to decrease in weight 
for the remainder of the time course.  CaCO3 hydrogels decreased in weight over the 
entire time course.  n = 5................................................................................................... 77 
Figure 3.3. G* and δ changes over time at 10% compression.  A-C: G* changes over time 
at 1 and 5 Hz.  D-F: δ changes over time at 1 and 5 Hz.  A.  Raw data average G* for each 
                                                                       xii
time point at 1 Hz.  Initially, G* for CaCO3 was smaller than G* for either CaCl2 or 
CaCl2/PLL, but increased by day 7 to become significantly greater than both conditions 
(p < 0.01).  After day 14, G* increased for all conditions.  B.  Normalized G* averages for 
each condition over time at 1 Hz.  G* for CaCO3 was greater than CaCl2 and CaCl2/PLL 
for all time points except day 90.  C.  Normalized G* averages for each condition over 
time at 5 Hz.  G* for CaCO3 remained greater than CaCl2 and CaCl2/PLL for all time 
points except day 90.  D.  Raw data average δ for each time point at 1 Hz.  δ for CaCO3 
was lower than CaCl2 and CaCl2/PLL until day 5.  After day 14, δ increased for all 
conditions (p < 0.001).  E.  Normalized δ averages for each condition over time at 1 Hz.  
δ for all conditions decreased until day 3 and then increased to day 90.  F.  Normalized δ 
averages for each condition over time at 5 Hz.  δ changes were smaller at 5 Hz than 1 Hz 
and no significant increase was detected until day 90 for all conditions. n = 5................ 79 
Figure 3.4. Inflammatory response to alginate over time.  Micrographs are at 400x 
magnification of HE stained sections.  The scale bar in C represents 50 μm in all 
micrographs.  A.  CaCl2/PLL samples 7 days post implantation. Fragmentation of the 
alginate (A, not all labeled) has already begun and many macrophages and lymphocytes 
were present in the tissue and around the alginate.  B.  CaCl2 reacted alginate, 14 days 
post implantation.  Fibroblasts had begun secreting collagen around the alginate 
fragments (A, not all labeled).  Macrophages were still present in the tissue (indicated by 
arrows).  C.  CaCO3 reacted alginate, 90 days post implantation.   A thick encapsulation 
layer was detectable around the alginate (A) filled with fibroblasts and new capillaries 
which comprise granulation tissue (**). ........................................................................... 80 
Figure 3.5. Collagen encapsulation thickness around alginate disks over time. 
Encapsulation thickness increased over time for all conditions (p < 0.05).   No difference 
existed between conditions except day 21; CaCO3 reacted alginate had a significantly 
thicker encapsulation layer than CaCl2/PLL or CaCl2 (p < 0.05, *).  n = 6...................... 81 
Figure 3.6: Cellular infiltration of alginate disks over time.  A.  Initially, cell infiltration 
approached moderate levels for all gel conditions (1 ≤ x ≤ 2), but decreased by day 14 
and stabilized at minor infiltration levels (x ≤ 1).  This decrease from day 7 was 
significant for all conditions (p < 0.05) and there was no significant difference between 
conditions at any time point, n = 6.  B.  A representative micrograph (CaCl2, 7 days post 
implant) illustrating the varied nature of the infiltration level in a single condition (A 
indicates alginate fragments).  The scale bar represents 200 μm...................................... 82 
Figure 4.1.  Cross-sectional view of wafer level fabrication. (a) Parylene deposited on 
SiO2 sacrificial layer. SU-8 patterned shank. (b) Parylene encapsulated SU-8 structure. 
(c) 9260 resist patterned to form thick mask over shank. (d) Etched and released final 
structure. Photolithography masks used steps in (a, c). .................................................... 98 
Figure 4.2.   Neuronal (NeuN+ in green, Hoechst+ in blue) and non-neuronal (NeuN-, 
Hoechst+) nuclei counted by a blinded observer (a), and the resulting output (b).  A 
MatLAB interface calculated the counting boundary (closed arrow) based on the user-
defined probe surface boundary (open arrow, shaded area), and a blinded observer 
manually selected neuronal and non-neuronal nuclei within this region (shown in yellow 
                                                                       xiii
and red, respectively).  The algorithm stored the location of each nucleus relative to the 
probe surface, binned counts in 25 micron increments, and normalized counts to cells per 
pixel in each bin (b).  This number was converted to cells per square millimeter for data 
analysis............................................................................................................................ 102 
Figure 4.3.  A neural stem cell-seeded probe (a) and associated dimensions (b).  Cells are 
Hoechst-stained and nuclei appear fluorescent blue (a).  Cross-section views of neural 
stem cell-seeded probes 1 day following implantation from two animals (c-e).  The 
companion brightfield DIC image for (c) is shown in (d) for reference due to 
autofluorescence of the parylene probe.  Graft cells (M2-labeled) were associated with 
nestin (c), GFAP (c),  and doublecortin (DCX, e) expression.  Alginate also 
autofluoresces green.  Scale = 50 microns for (c)-(e)..................................................... 104 
Figure 4.4.  Mean neuronal density (a) and non-neuronal density (b) surrounding implants 
over time as a function of distance from the probe surface (± s.e.m).  Neural stem cell-
seeded probes had a higher neuronal density surrounding them compared to untreated 
probes at one day and both control conditions at one week post-implant (a, p<0.05).  Cell-
seeding reduced non-neuronal encapsulation compared to alginate-only probes at one day 
and untreated probes at one week post implant (p≤0.001).  At six weeks and three months 
post implantation, the neural stem cell-seeded probes had reduced neuronal density and 
increased non-neuronal density surrounding them in comparison to both control 
conditions (p<0.05). ........................................................................................................ 106 
Figure 4.5.  Glial encapsulation of each probe condition over the three month time 
course.  Ox-42 labeled microglia (green) and GFAP labeled astrocytes (red) are shown.  
Images are taken from probes implanted in the same animal at each time point. Appendix 
C contains additional views of selected images.................................................................. 1 
Figure 4.6.  Immunohistochemistry for neuronal markers (NeuN, green; neurofilament, 
red) around probes reveals an initial injury response characterized by decreased neuronal 
density and neurofilament disruption indicative of damaged axons.  A marked 
improvement occurs within the first week, with a significant increase in neuronal density 
(p≤0.006) and improved neurofilament distribution.  Appendix C contains additional 
views of selected images..................................................................................................... 1 
Supplementary Figure 4.1.  Doublecortin staining (DCX, red) was detected in three of 
four animals one week post-implantation (a-c, d-f).  Doublecortin (DCX) is a 
microtubule-associated protein expressed in migrating neuronal precursors, but may also 
be associated with mature astrocytes.  DCX has been observed during glial scar formation 
following traumatic brain injury, with peak expression occurring at 1 week post-injury 
(Francis, Koulakoff et al. 1999; Itoh, Satou et al. 2007).  Tissue was also labeled with 
NeuN (mature neuronal nuclei, green) and Hoechst (nuclear counterstain, blue).  
Expression appeared enhanced in NSC-seeded (a-c) probes compared to controls from 
the same animal (probe only, d-f).  No staining was observed in the remaining animals.  
The origin and function of DCX-expressing cells are yet to be elucidated, could possibly 
indicate a regenerative capacity of the injured brain, the grafted cells, or a combination of 
both.  Scale = 50 microns.  Appendix C contains additional views of selected images. 117 
                                                                       xiv
Figure 5.1.  Administration of the cell-cycle inhibiting drug flavopiridol immediately 
prior to neural prosthetic device insertion reduced impedance at 1 kHz and 10 Hz (mixed 
model ANOVA, p<0.001).  Impedance increased following implantation in the 3 to 7 day 
timeframe, coinciding with a reported period of increased cellular density surrounding 
probes (Purcell, Seymour et al. 2008) (p<0.01).  Mean ± s.e.m. is shown..................... 133 
Figure 5.2.  Analysis of recording quality over the 28 day study period showed no effect 
of flavopiridol administration.  The progression of these values over the duration of the 
study may be explained by the tissue response to the probes.  Recording quality decreases 
in the 0-3 day time period, coinciding with initial insertion trauma (a-c).  Recovery of 
these metrics occurs approximately one week later, when signal and noise are increased 
as cells return to the device during healing (a-e).  Reductions in all metrics except LFP 
amplitude three to four weeks after surgery occurred during glial encapsulation. “Units” 
are given per recording site...................................................................................... 134-137 
Figure 5.3.  Neuroprostheses are associated with an increase in the expression of a cell-
cycle protein (CD-1) in neighboring microglia three days after insertion, which appears 
reduced by flavopiridol administration at the time of surgery.  Analysis was qualitative on 
a sample size of 2-3 animals per group.  Images for each marker are from the same 
control and flavopiridol-treated animals.  Ox-42 (green), GFAP (red), and NeuN (green) 
are shown, and CD-1 is red, green, and red respectively.  Coexpressing cells are yellow.  
Scale = 100 microns.  Appendix C contains additional views of selected images. ........ 138 
Figure 5.4.  Neuronal density (ND), non-neuronal density (NND), and the ratio 
(ND/NND) between them as a function of distance from the probe tract boundary three 
and 28 days after probe implantation.............................................................................. 140 
Figure 5.5.  Representative images of the distribution of neuronal (NeuN, green) and non-
neuronal (Hoechst, blue) nuclei 28 days after implantation (right panels).  Glial 
encapsulation is shown by GFAP-labeled astrocytes (red), but the microglial sheath was 
absent at this time, likely due to remaining attached to explanted probes (left panels).  
Images are from the same control and flavopiridol-treated animals.  Scale = 100 microns.
......................................................................................................................................... 141 
Figure 6.1. Nyquist plots for 20 electrodes immediately after implantation (a) and after 7 
days (b), illustrating an increasingly non-linear relationship between real and imaginary 
components over time (Williams, Hippensteel et al. 2007)............................................ 158 
Figure 6.2.  Comparison of multi-photon and confocal images of the same electrode sites 
implanted in guinea pig tissue.  Multi-photon imaging provides higher resolution at 
deeper focal planes (left panels), enabling cell counting near electrode sites not accessible 
with confocal imaging (right panels).  Neuronal and all cellular nuclei are counterstained 
with NeuN (green) and Hoechst (blue) respectively, and electrode sites are demarcated 
and labeled (Seymour, Purcell et al. 2008).  Also, note the site-by-site variability in 
cellular densities.............................................................................................................. 160 
                                                                       xv
Figure A.1.  An example of M2 staining (green) in an animal at the 6 week time point (a), 
and a control image from a different section in the same animal where the primary 
antibody was omitted (b).  Note the similarity in staining patterns, and the location of 
staining at the graft site.  Images include the DIC channel to facilitate visualization of the 
probe.  Scale = 100 microns............................................................................................ 170 
Figure A.2.  Thy1.2 staining reveals similar positive (brown) patterns in a probe in which 
the primary is included (a) and omitted in the place of buffer (b).  The cells being labeled 
are likely part of the immune response to the implant, and stain vascular elements 
throughout the brain tissue (c).  Scale = 100 microns..................................................... 170 
Figure B.1.  Chronic neural probe assembly................................................................... 173 
Figure B.2.  Probe schematic for devices used in Chapter 5 research.  Single shank, 
sixteen channel probes were used. .................................................................................. 173 
Figure B.3.  Illustration of probe insertion (a four shank model is shown) into the 
craniotomy.  The connector is attached to a stainless steel bone screw with dental acrylic, 
and the ground wire is wrapped around an additional screw.  Following GelFoam and 
silicone closure of the craniotomy, the entire region is encased in dental acrylic, leaving 
only the connector exposed.  From Vetter, Williams et al. 2004.................................... 174 
Figure C.1.  Doublecortin staining.................................................................................. 176 
Figure C.2.  One week neuronal images ......................................................................... 177 
Figure C.3.  Three month neuronal images..................................................................... 178 
Figure C.4.  One week glial images................................................................................ 179 
Figure C.5.  Three month glial images ........................................................................... 180 
                                                                       xvi
LIST OF TABLES 
 
Table 2.1.  Neurotrophic factor release varies with scaffold condition and time.  Values 
are given in pg/million cells/day.  Unencapsulated cells secrete NGF, BDNF, and GDNF 
at various time points throughout the study, whereas all three factors were detected from 
encapsulated cells only when a high G alginate scaffold was used.  BDNF was detected 
from all conditions at the four day time point, and GDNF was detected at the fourteen 
day time point from G encapsulated and unencapsulated cells.  NGF secretion from 
unencapsulated cells at 21 days was significantly greater than 1 day and 4 day values (‡), 
and secretion at 7 days was greater than 4 day values (†) (p < 0.05, ANOVA).  Non-
detectable values are denoted “ND.”  Mean ± s.e.m. is shown. ....................................... 44 
 
Table 3.1. The gelation conditions for all hydrogels to be implanted subcutaneously and 
analyzed via rheology or histology. .................................................................................. 72 
 
Table 5.1.  Correlation coefficients between histology and electrophysiology 
measurements at the 28 day time point reveal several significant relationships between 
these metrics.   “NND” is the density of non-neuronal cells within 50 microns of the 
probe tract boundary.  “ND/NND” is the ratio of neuronal to non-neuronal densities 
within the same region.  * = significant at the 0.05 level, ** = significant at the 0.01 level. 
…………………………………………………………………………………………..141
                                                                       xvii
LIST OF APPENDICES 
 
 
APPENDIX A:  IDENTIFICATION OF GRAFTED NEURAL STEM CELLS IN 
VIVO……………………………………………………………………………………169 
 
APPENDIX B:  NEURAL PROSTHESIS SCHEMATICS……………………………173 
 


















                                                                       xviii
ABSTRACT 
 
Neuroprosthetic devices record extracellular cortical signals which may then be used to 
place exterior devices under a patient’s direct control.  Therefore, these systems have the 
potential to restore function to individuals immobilized by paralysis or neurodegenerative 
disease.  For neuroprosthetics to be useful in clinical and research settings, long-term, 
stable recordings must be achieved.  However, these devices are plagued by recording 
instability, and the reactive tissue response that occurs after insertion into the brain is a 
likely cause.  Specifically, neuronal density is reduced surrounding devices, and glial 
encapsulation (composed of microglia and astrocytes) isolates neuroprostheses from their 
neuronal signal sources. 
 
The research presented describes the development and evaluation of two strategies to 
improve the tissue response to neuroprostheses:  (1) a neural stem cell (NSC)-seeded 
scaffold and (2) a cell cycle-inhibiting drug.  NSCs were hypothesized to secrete factors, 
such as neurotrophins, which would improve device-tissue integration.  The cells were 
encapsulated in an alginate hydrogel and seeded into a well on the neural prostheses.  
Two studies were conducted to develop the cell-seeded device.  In the first study, in vitro 
testing identified the alginate composition which provided optimal scaffold mechanical 
stability as well as support of neurotrophic factor release from encapsulated NSCs.  The 
second study characterized the relationship between alginate composition, degradation, 
and biocompatibility in vivo.  The third study evaluated the effects of the NSC scaffold
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on the tissue response to implanted probes in vivo.  Quantitative histological examination 
revealed that the NSC-seeded alginate scaffold mitigated the early tissue response to an 
implanted prosthesis, but exacerbated it by six weeks post-implantation.  Based on 
research showing a link between central nervous system injury and cell-cycle re-entry by 
neurons, astrocytes, and microglia, the final study of the dissertation investigated the role 
of cell cycle re-entry in the tissue response to neural prostheses.  Specifically, the study 
explored the effects of a cell cycle-inhibiting drug (flavopiridol) on electrophysiology 
and tissue response metrics.  Flavopiridol reduced the appearance of a cell cycle protein 
(cyclin D1) in microglia surrounding probes three days after implantation and decreased 
impedance over the 28 day study period.  Additionally, the data revealed several novel, 
significant correlations between recording quality, impedance, and endpoint histology 
measurements.              
   
In conclusion, the studies demonstrate significant effects of two intervention strategies on 
tissue response and electrophysiology measurements, characterize alginate stability and 
its use as a NSC scaffold, and add insight into the relationship between the tissue-device 
interface and recording quality.   




Neural Prostheses:  Development, Therapeutic Potential, and Performance 
The discovery in 1870 by Fritsch and Hitzig that the cerebral cortex was electrically 
excitable, and that stimulation of defined regions within it produced contralateral 
movement in dogs, provided the basis for decades of neurophysiology studies and 
dismissed the prevailing notion that the cortex was an insignificant “rind” (the Latin 
meaning of “cortex”) (Gross 2007).  Gasser and Erlanger used a cathode ray oscilloscope 
to measure conduction velocities and describe action potential waveforms in the sciatic 
nerve of mammals and frogs beginning in the 1920’s, and were awarded the Nobel Prize 
in 1944 for this work (Perl 1994).  In 1939, Hodgkin and Huxley directly recorded action 
potentials intracellularly from the giant axon of the squid, representing the first time this 
feat was achieved (Hodgkin and Huxley 1939).  Nearly 20 years later, the first long-term 
extracellular recordings from an unrestrained animal were reported using microwires 
(Strumwasser 1958).   
 
Since then, the current designs for cortical prostheses have been developed, namely 
microwires, microelectrode arrays, and the planar Michigan probe (Figure 1.1) (Schwartz 
2004; Polikov, Tresco et al. 2005).  Microwires were the first microelectrodes produced, 
and typically are composed of rows of eight or more 30–50 micron diameter stainless 
steel or tungsten wires spaced 200-300 microns apart.  They are insulated with  
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Figure 1.1. Neural probe designs. The schematic and dimensions of an example of a 
Michigan probe design (a), close-up of a four shank, sixteen site Michigan probe (b), and 
its insertion into the rat cortex (c) (Vetter, Williams et al. 2004).  The Utah 
microelectrode array (d) (Rousche and Normann 1998).  Microwires with a 50 micron 
diameter used by Nicolelis et al. (e) (Nicolelis, Dimitrov et al. 2003).    
 
Teflon or polyimide (Figure 1.1e).  Silicon microelectrode arrays developed at the 
University of Utah have a 10x10 array of microneedles protruding 1.0-1.5 millimeters 
from a 4x4 squared millimeter area (Figure 1.1d).  Platinum or iridium recording sites on 
the tip of each needle are 25-50 microns in length, and the base of each microneedle is 
insulated from its neighbors by a glass coating.  Planar silicon recording electrodes such 
as those developed at the University of Michigan use photolithography techniques to 
create a variety of probe geometries, site sizes and spacings (Figure 1.1a-c).  The devices 
have iridium sites and silicon dioxide/nitride insulation.  Available designs vary from 1-4 
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shanks, 16-32 channels, 2-6 mm shank lengths, and 400-1250 squared micron site sizes 
(NeuroNexus, http://www.neuronexustech.com/).  Unlike microwires and microelectrode 
arrays, the Michigan probe allows for recordings at varying depths within the cortex.  For 
a review of current probe technologies, see (Schwartz, Cui et al. 2006).      
 
Neural probes, in their varied designs, record extracellular signals from a patient’s 
uninjured cortex.  Through oxidation and reduction reactions, charge is transferred from 
ions in the extracellular space produced during neuronal firing to free electrons in the 
electrode, resulting in current crossing the electrode-electrolyte interface (Webster 1998).  
The recordings include low frequency signals (<300 Hz) produced by cell aggregates 
(local field potentials, LFPs) and single and multi-unit activity (“units,” 300 Hz-10 kHz 
filter setting) resulting from neuronal action potentials.  Single and multi-unit signals, and 
possibly LFPs to a lesser extent, may then be used to place an exterior assistive device 
under the patient’s direct control.  Thus, motor function is restored while effectively 
circumventing impaired neural circuits that have been damaged by traumatic injury or 
neurodegenerative disease (Schwartz, Cui et al. 2006). These systems are commonly 
termed “brain-machine interfaces” (BMIs), “brain-controlled interfaces” (BCIs), or, more 
commonly, neural prostheses (Lebedev and Nicolelis 2006; Schwartz, Cui et al. 2006).  
Neural prostheses rely on the property of cortical neurons to change their activity in 
relation to movement parameters (i.e. direction, force, and velocity), as well as the ability 
to operantly condition subjects to voluntarily modulate their cortical firing rates (Evarts 
1968; Fetz 1969; Humphrey, Schmidt et al. 1970; Georgopoulos, Kalaska et al. 1982; 
Georgopoulos, Schwartz et al. 1986).  The feasibility of this strategy was demonstrated in 
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the last decade when monkeys were shown to able to successfully control a cursor on a 
computer screen or a robotic arm using voluntary cortical signals (Taylor, Tillery et al. 
2002; Carmena, Lebedev et al. 2003).  Recent work in tetraplegic humans has shown that 
neural recordings from motor cortex are possible even years after spinal cord injury, and 
those spikes were readily modulated when patients imagined making movements 
(Hochberg, Serruya et al. 2006; Donoghue, Nurmikko et al. 2007).  The ability to use 
these signals to control robotic devices and computer interfaces was confirmed.  Further, 
a recent study has demonstrated cortical control of a complex, multi-jointed robotic arm 
with a gripper by monkeys during a self-feeding task (Velliste, Perel et al. 2008). Thus, 
these technologies have the potential to restore some level of function to the 200,000 
patients currently suffering from full or partial paralysis in the U.S. (Polikov, Tresco et al. 
2005).   
 
While these results are encouraging, these devices are currently plagued by inconsistent 
performance in terms of recording longevity and stability (Rousche and Normann 1998; 
Liu, McCreery et al. 1999; Williams, Rennaker et al. 1999; Nicolelis, Dimitrov et al. 
2003; Polikov, Tresco et al. 2005; Liu, McCreery et al. 2006; Schwartz, Cui et al. 2006).  
Rousche and Normann reported that 60% of microelectrode arrays were functional 
(detected units) after a six month implantation period in cats (Rousche and Normann 
1998).  Nicolelis et al. showed a 58% to 35% drop in the percentage of microwires which 
recorded units from one month to eighteen months after implantation in a monkey 
(Nicolelis, Dimitrov et al. 2003).  Vetter et al. demonstrated that 13/14 implanted 
Michigan probes were functional over a 127 day study period; however, anecdotal 
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evidence suggests variable success with this probe type as well (Vetter, Williams et al. 
2004).  Liu and McCreery et al. have shown that microelectrode array recordings tend to 
be highly variable within the first two months of implantation in cats, and then generally 
stabilize (Liu, McCreery et al. 1999; Liu, McCreery et al. 2006).  However, in some cases 
recordings became increasingly unstable with time, to the point where no neural activity 
could be recorded (Liu, McCreery et al. 1999).  The longevity of individual electrodes 
was widely variable (Figure 1.2) (Liu, McCreery et al. 2006).  In order for neural 
prostheses to be clinically useful, stable, long-term recordings from large populations of 
neurons in multiple brain areas must be reliably and reproducibly achieved (Lebedev and 
Nicolelis 2006).  
 
           
Figure 1.2.  The maximum number of days during which neuronal spikes could be 
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The Reactive Tissue Response to Neural Probes 
Following implantation into the brain, a reactive tissue response occurs to probes which 
is believed to be a major contributing factor to their inconsistent performance.  Glia 
encapsulate the devices, and neuronal density is reduced within the effective recording 
radius of the probe (Edell, Toi et al. 1992; Turner, Shain et al. 1999; Szarowski, 
Andersen et al. 2003; Kim, Hitchcock et al. 2004; Biran, Martin et al. 2005; Polikov, 
Tresco et al. 2005) (Figure 1.3).  Thus, there is a loss of the signal source (neurons) 
surrounding neural prostheses, as well as the formation of a glial sheath which creates a 
barrier to signal transmission.   
 
The glial sheath is composed of a thin inner coating of microglia surrounded by a thicker 
layer of astrocytes.  Microglia constitute 5-10% of the cells in the brain in number, and 
are active surveillants of their surrounding environment, sensing injury and displaying 
immune functions (Polikov, Tresco et al. 2005; Hanisch and Kettenmann 2007).  They 
may be implicated in either the exacerbation or mitigation of central nervous system 
(CNS)  injury depending on the pathology or disease state (Hanisch and Kettenmann 
2007).    These cells have a “ramified” or branched morphology in their surveilling state, 
and take on an amoeboid configuration when shifted into an activated state.  Activated 
microglia phagocytose foreign material, proliferate, and produce lytic enzymes to 
degrade foreign material (Polikov, Tresco et al. 2005).  Astrocytes are the second key 
component of reactive gliosis, and comprise 30-65% of brain cells.  They provide 
structural support for neurons and modulate the environment around them, releasing  
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Figure 1.3.  The stratification of 
cellular immunoreactivity at the 
tissue-electrode interface shows the 
distribution of microglia (ED-1), 
astrocytes (GFAP), neuronal nuclei 
(NeuN) and processes (NF) 
surrounding a probe (orange oval, 
left)  (a, from Biran et al.). Microglial 
(b) and astrocytic (c) responses 
surrounding probe tracts as a function 
of time (from Szarowski et al.).  The 
glial sheath is initially diffuse and 
becomes compacted over time.  
Images were obtained using Michigan 
electrodes in a rat model.  Scale = 
100 microns in b,c.   
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growth factors and buffering neurotransmitters and ions released during neuronal firing 
(Svendsen 2002; Polikov, Tresco et al. 2005). They may also regulate synapse production 
and have a role in neurogenesis (Svendsen 2002).  Reactive astrocytes proliferate, 
migrate, hypertrophy, and upregulate the production of glial fibrillary acidic protein 
(GFAP, an intermediate filament specific to this cell type) following injury (Polikov, 
Tresco et al. 2005).  Together, microglia and astrocytes form an encapsulation layer 
around probes which is initially diffuse one week after implantation and later becomes a 
compact sheath by six weeks in rats (Figure 1.3b-c) (Szarowski, Andersen et al. 2003).  
Long-term glial encapsulation was also demonstrated in rhesus macaques implanted with 
microwires at three month and three year time points; microglial reactivity surrounding 
implants was apparent at the three month time point only, while a robust astrocyte 
response was observed at both time points (Griffith and Humphrey 2006).  
 
Reduced neuronal density surrounding probes is a potential cause of a loss of signal 
quality over time.  Large amplitude, reliably separated neuronal spikes (or “units”) are 
typically found within 50 microns of recording sites, and no extracellular signals are 
recorded from neurons located at distances greater than 140 microns from the probe 
(Henze, Borhegyi et al. 2000).  Therefore, the reported 40% loss of neuronal density 
within 100 microns of the device surface in the first month after implantation is 
particularly concerning (Biran, Martin et al. 2005).  Whether reduced neuronal density 
indicates a “kill zone,” or displacement of neurons by the glial sheath, is debatable (Edell, 
Toi et al. 1992; Biran, Martin et al. 2005).  However, it is clear that this effect is not due 
to initial insertion trauma, but rather prolonged device-tissue interactions (Biran, Martin 
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et al. 2005).  It has also been demonstrated that the neuronal and glial responses are 
intertwined; there is an inverse relationship between neurofilament and microglial 
staining intensity as a function of distance from the probe surface (Biran, Martin et al. 
2005).  The time course of neuronal density reductions has not been fully characterized; 
Biran et al. report similar reductions at the two and four week post-implant time points 
(Biran, Martin et al. 2005).     
 
In addition to the more thoroughly investigated glial and neuronal responses, other 
histological features accompanying probe implantation have been described.   
Vasculature is severed and dragged upon device insertion, and damage extends several 
hundred microns from the implant site (Bjornsson, Oh et al. 2006).  Implanted probes are 
associated with an increase in extracellular matrix molecules such as collagen, 
fibronectin, and laminin around the device (Kim, Hitchcock et al. 2004).  Cells attached 
to explanted probes were shown to secrete detectable quantities of inflammatory 
cytokines (Biran, Martin et al. 2005). Vimentin staining associated with reactive 
astrocytes has been shown to follow a similar pattern and time course to GFAP staining 
(Szarowski, Andersen et al. 2003).  The body of evidence regarding the tissue response to 
implanted neural probes reinforces the conclusion presented by Szarowski et al: “active 
intervention is needed to control the reactive response, heal the vasculature and rescue 
neurons” to improve the tissue-device interface (Szarowski, Andersen et al. 2003). 
 
While a cause-and-effect relationship between tissue response and recording quality is a 
widely held belief in the field of neural engineering, explicit evidence and 
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characterization of this association remains very limited.  The glial scar is known to be  a 
potential diffusion barrier to the transmission of ions, neurotransmitters, and growth 
factors through the extracellular space (Roitbak and Sykova 1999).  This may affect not 
only normal signal transmission, but neural recording by a probe.  Additionally, 
impedance magnitude at 1 kHz (the fundamental frequency of the neuronal action 
potential) is increased at recording sites with “extensive” glial reactivity (Williams, 
Hippensteel et al. 2007).  While it is reasonable to believe that reductions in neuronal 
density would result in a loss of signal quality, this has not yet been proven.  Likewise, 
the relative contributions of gliosis and neuronal loss to recording instability, as well as 
the role of neuronal plasticity and function, have not been explored.  Further 
understanding these issues will result in improved probe modifications to integrate 
devices with surrounding tissue.     
 
Probe Modifications for Improved Tissue Integration 
 
Various strategies have been used to modify the probe surface with the ultimate goal of 
improving the device-tissue interface. These include the use of protein-based coatings 
(Buchko, Kozloff et al. 2001; Cui, Lee et al. 2001; Cui, Wiler et al. 2003; He and 
Bellamkonda 2005; He, McConnell et al. 2006) , conductive polymers (Cui, Lee et al. 
2001; Cui, Wiler et al. 2003; Kim, Abidian et al. 2004; Ludwig, Uram et al. 2006; 
Richardson-Burns, Hendricks et al. 2007; Richardson-Burns, Hendricks et al. 2007; 
Abidian and Martin 2008), and hydrogels (Kim, Abidian et al. 2004).  These strategies 
respectively aim to improve or attract neuronal adhesion to recording sites, reduce 
impedance and increase charge transfer through an effective increase in recording site 
                                                                       11 
surface area, and buffer the mismatch in mechanical properties between the probe and 
surrounding brain tissue.  Relatively few studies have been conducted which implement 
soluble-molecule releasing scaffolds onto the probe to intervene in this response, and no 
available published work describes cell-seeded coatings.  An in vitro study has described 
the use of BDNF-seeded hydrogels to coat microelectrode arrays (Jun, Hynd et al. 2008).  
Multiple groups have reported the use of anti-inflammatory drugs such as dexamethasone 
and minocycline to attenuate the tissue response to neural implants (Shain, Spataro et al. 
2003; Spataro, Dilgen et al. 2005; Kim and Martin 2006; Rennaker, Miller et al. 2007; 
Zhong and Bellamkonda 2007). Dexamethasone released from nanoparticles entrapped in 
alginate hydrogel probe coatings reduced impedance compared to control probes over a 
two week implantation period (Kim and Martin 2006).  Probes treated with a 
nitrocellulose-dexamethasone coating reduced astroglial response and neuronal loss over 
four weeks in vivo (Zhong and Bellamkonda 2007). Probes coated with nitrocellulose 
containing the anti-inflammatory neuropeptide a-melanocyte stimulating hormone (a-
MSH) had reduced impedance at 1 kHz in vitro, although in vivo results were not 
reported (Zhong and Bellamkonda 2005).  Nerve growth factor (NGF)-incorporating 
polypyrrole coatings reduced impedance on microelectrode recording sites and caused 
PC-12 cell differentiation in vitro, indicating retention of NGF bioactivity (Kim 2005).  
Kennedy reports the use of a segment of sciatic nerve placed inside a cone electrode to 
encourage axonal growth into the electrode (Kennedy 1989). In the cone electrode study, 
recordings were taken over 200 days, although the sample size was very small (2 rats). 
Interestingly, the authors believe the effectiveness of this approach may have resulted 
from secretion of nerve growth factor (NGF) and other chemoattractant molecules to the 
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surrounding neurons. A later study in rats and monkeys revealed central myelinated 
axons and dendrites penetrating the cone electrode (Kennedy, Mirra et al. 1992). A 
human ALS patient was implanted with the cone electrode, where NGF-seeded Matrigel 
was used in place of sciatic nerve. The patient was able to modulate his cortical signals to 
control a cursor for typing, and the implant was functional for at least 16 months 
(Kennedy, Bakay et al. 2000). While the approach in these studies showed promise, the 
methods were complex and somewhat unclear (i.e., NGF dosage is not stated), and the 
release characteristics of the neurotrophins in vitro and in vivo are not described.  
Neurotrophic factor-secreting and cell-seeded scaffolds remain largely unexplored as 
probe modification techniques.  Additionally, pharmaceutical interventions have been 
limited to anti-inflammatory drugs.  In this dissertation, we describe the development and 
evaluation of two novel strategies to improve the device-tissue interface:  a neural stem 
cell-seeded alginate scaffold, as well as the administration of a cell-cycle inhibiting drug.   
 
Alginate and Cell Encapsulation  
Alginate is a polysaccharide polymer derived from brown seaweed. It is composed of D-
mannuronic (M) and L-guluronic acid (G) residues in varying proportions (Figure 1.4a). 
Cross-linking and gel formation takes place when divalent cations (usually calcium) 
ionically bind carboxylic acid groups of blocks of guluronic acid residues between 
chains. This is typically illustrated by an eggbox model of binding (Figure 1.4b-c). 
Alginate is a versatile biocompatible polymer used in a wide range of applications, 
including endovascular embolization, wound dressings, nerve regeneration grafts, and 
drug delivery (Thomas 2000; Becker, Kipke et al. 2001; Tonnesen and Karlsen 2002; 
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Hashimoto, Suzuki et al. 2005). Recent work in our laboratory has explored its use as a 
dural sealant (Nunamaker 2006). Alginate is also commonly used to encapsulate cells and 
provide an immuno-isolating barrier between the engrafted cells and the host tissue 
(Figure 1.4d). 
 
Figure 1.4.  Alginate structure (a) and cross-linking mechanism (b-c).  Alginate 
encapsulation is frequently used to protect secretory cells from an immune response 
while allowing the desired factors to freely pass through the membrane (d).   
 
Pancreatic islets and insulin-secreting cells are the most well characterized alginate-
encapsulated cells, where treatment of diabetic patients is the ultimate goal. The literature 
surrounding this subject is extensive, with ground-breaking work published by Lim and 
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Sun in 1980.  Here, reversal of diabetes in rats implanted with alginate-encapsulated 
islets was demonstrated for a period of 2-3 weeks (Lim and Sun 1980). Numerous groups 
have pursued alginate-encapsulated cells for the treatment of a variety of disease states 
since then (de Vos, Faas et al. 2006).  
 
A relationship between alginate composition and the function of the graft has been 
demonstrated in numerous studies.  Alginate cross-linking ion and concentration, weight 
percentage, polycation coating, molecular weight, and proportion of G and M residues 
have been reported to affect cell viability, scaffold stability, diffusion through the gel, and 
biocompatibility in vitro and in vivo. Cross-linking ion choice and concentration, as well 
as alginate molecular weight, may affect a variety of scaffold variables, but these are 
typically negligible factors in scaffold function at the values used for cell encapsulation 
studies.  Specifically, divalent cations have varying affinities for alginate, and those with 
higher affinities than calcium (such as lead, cadmium, barium, and strontium) are less 
sensitive to chelating compounds which may break cross-links and reduce gel mechanical 
integrity (Strand, Morch et al. 2000).  However, these heavy metals are cytotoxic and 
generally not useful for cell encapsulation.  Increasing calcium chloride concentration up 
to 0.02M during cross-linking increases gel strength, but gel strength is constant with 
additional increases in CaCl2 concentration and is usually used at a 0.1 M concentration 
for cell encapsulation (Martinsen, Skjak-Baek et al. 1989).  Greater calcium chloride 
concentration also contributes to increased gel porosity and diffusion (Strand, Morch et 
al. 2000). Gels with a higher weight percentage of alginate have improved stability, but 
this may coincide with reduced cell proliferation and viability (Martinsen, Skjak-Baek et 
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al. 1989; Stabler, Wilks et al. 2001).  Increasing molecular weight reduces diffusion 
through the gel and contributes to increased stability; however, this is a factor only when 
comparing relatively low molecular weight alginates (Martinsen, Skjak-Baek et al. 1989; 
Stabler, Wilks et al. 2001).  Above a molecular weight of approximately 240,000, 
alginate stability is determined primarily by G/M content alone (Martinsen, Skjak-Baek 
et al. 1989; Strand, Morch et al. 2000).   
 
There are reported tradeoffs in the effects of G/M content and the use of polycation 
coatings in graft stability, function, and biocompatibility, and these metrics must be 
investigated for new applications and cell types on an individual basis.  Poly-L-lysine 
(PLL), as well as other less common polycation coatings, are often used to stabilize the 
alginate bead and provide a barrier to immune system components such as IgG (Kulseng, 
Thu et al. 1997; Gugerli, Cantana et al. 2002). However, the PLL coating layer may itself 
incite inflammation and toxicity to encapsulated cells (King, Sandler et al. 2001; Strand, 
Ryan et al. 2001; Rokstad, Holtan et al. 2002; King, Lau et al. 2003).  Alginates with 
high G content are more mechanically stable and permissive to diffusion of proteins than 
those with a high M content (Martinsen, Skjak-Baek et al. 1989; Martinsen, Storro et al. 
1992; Strand, Morch et al. 2000). However, high G alginate has been shown to initially 
inhibit the metabolic and secretory activity of cells due to growth inhibition, theoretically 
because a higher strength gel is more difficult for proliferating cells to displace 
(Constantinidis, Rask et al. 1999; Stabler, Wilks et al. 2001).  Therefore, the effects of 
G/M content and PLL coating should be investigated for new alginate cell encapsulation 
applications, such as the entrapment of neural stem cells.   
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Neural Stem Cell Therapy for Central Nervous System Injury 
 
 
Neural stem cells are self-renewing, multipotent cells capable of producing neurons, 
astrocytes, and oligodendrocytes (Kornblum 2007).  In 1992, Reynolds and Weiss 
reported the culture of “neurospheres” (heterogenous masses of stem and progenitor 
cells) derived from single mouse CNS cells and propagated with epidermal growth factor 
(EGF) (Reynolds and Weiss 1992) (Figure 1.5). The stem cell characteristics of these 
cells, which were defined as the ability to proliferate, retain multi-lineage potential over 
time, and generate a large number of progeny, were reported in a later publication 
(Reynolds and Weiss 1996).  In addition to this groundbreaking work, neural stem cells 
have been discovered and described from a variety of sources: both endogenous and 
exogenous; adult, fetal, and embryonic; and from CNS regions including the cortex, 
striatum, cerebellum, hippocampus, subventricular zone, and spinal cord (Ryder, Snyder 
et al. 1990; Reynolds and Weiss 1992; Weiss, Dunne et al. 1996; Lindvall, Kokaia et al. 
2004; Martino and Pluchino 2006; Gaillard, Prestoz et al. 2007; Kornblum 2007; Singec, 
Jandial et al. 2007; Zhao, Deng et al. 2008).  Importantly, neural stem cells have been 
researched extensively as a source of regeneration or repair for CNS tissue damaged by 
injury or degenerative disease.      
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Figure 1.5 (From Reynolds and Weiss, 1996).  The EGF-responsive stem cell generates a 
neurosphere composed of more stem cells (close to 20%, shown in pink) and progenitor 
cells (blue). The secondary stem cells, when replated alone or in populations, generate 
new, clonally derived spheres. Both primary and secondary spheres contain progenitor 
cells that proliferate and differentiate into neurons, astrocytes, and oligodendrocytes.  
 
Administration of exogenous stem and progenitor cells to sites of CNS injury may be 
used as a means of replacing lost tissue, where the focus is on directing the 
differentiation of implanted cells into neurons and reinnervation of the appropriate 
targets.  This strategy has its roots in fetal tissue grafting for Parkinson’s Disease (PD) 
patients, which showed evidence of amelioration of symptoms in early clinical trials and 
generated much excitement in the medical community (Lindvall, Brundin et al. 1990; 
Freed, Greene et al. 2001). However, several issues subsequently arose with the 
procedure, including availability of tissue, variability in functional outcome, evidence of 
dyskinesia in transplant patients, ethical considerations in using cells derived from 
aborted fetuses and, very recently, reports of PD pathology in long-term grafted neurons 
(Lindvall, Kokaia et al. 2004; Miller 2008).  Additionally, allodynia associated with 
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aberrant graft-induced sprouting has been reported in rats receiving NSCs to treat spinal 
cord injury (Hofstetter, Holmstrom et al. 2005).  Nonetheless, tissue replacement with 
stem and progenitor cell grafts has been used to intervene in numerous sources of CNS 
pathology, and positive outcomes also have been reported in animal models of stroke, 
ALS, Huntington’s Disease, spinal cord injury, traumatic brain injury, and multiple 
sclerosis (Lindvall, Kokaia et al. 2004; Martino and Pluchino 2006). Lending further 
support to this approach, Gaillard et al. recently reported reestablishment of cortical 
circuitry by grafted embryonic cortical neurons into damaged mouse cortex, where 
transplanted tissue developed efferent projections to the thalamus and spinal cord 
(Gaillard, Prestoz et al. 2007).   
 
Separate from a cell replacement mechanism, several studies suggest that neural stem 
cells have an innate ability to promote healing and axonal regeneration of host neurons as 
well as reduction in glial scar formation.  These effects may explain the numerous reports 
of restoration of functional recovery in the absence of effective replacement of damaged 
neurons or reinnervation by transplanted tissue (Ourednik, Ourednik et al. 2002; Teng, 
Lavik et al. 2002; Lu, Jones et al. 2003; Pluchino, Quattrini et al. 2003; Heine, Conant et 
al. 2004; Lindvall, Kokaia et al. 2004; Llado, Haenggeli et al. 2004; Pluchino, Zanotti et 
al. 2005; Richardson, Broaddus et al. 2005; Martino and Pluchino 2006; Lee, Jeyakumar 
et al. 2007). Additionally, in vitro studies have shown a neuroprotective effect of NSC-
conditioned medium in models of Huntington’s disease, PD, and serum withdrawal-
induced PC-12 cell death (Yasuhara, Matsukawa et al. 2006; Li, Liu et al. 2007; Lim, Lee 
et al. 2008). This “bystander” or “chaperone” effect is believed to be due to the 
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constitutive secretion of multiple neurotrophic factors, as well as factors that degrade 
molecules which are inhibitory to axonal growth.  Specifically, NSCs have been found to 
elute or express nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), 
glial derived neurotrophic factor (GDNF), neurotrophin-3 (NT3), stem cell factor (SCF), 
and matrix metalloprotease-2 (MMP-2), which degrades chondroitin sulfate proteoglycan 
(a molecule inhibitory to axonal growth) (Ourednik, Ourednik et al. 2002; Lu, Jones et al. 
2003; Heine, Conant et al. 2004; Llado, Haenggeli et al. 2004; Ryu, Kim et al. 2004; 
Yasuhara, Matsukawa et al. 2006; Redmond, Bjugstad et al. 2007).  Importantly, these 
neurotrophic factors are known to support neuronal survival and plasticity in various 
models of axonopathy and neuropathy (Kolb, Gorny et al. 1997; Han and Holtzman 
2000; Nicole, Ali et al. 2001; Lu, Pang et al. 2005; Wilkins and Compston 2005).   While 
the mechanism is unclear, studies have also reported reduced gliosis in injured CNS 
tissue associated with NSC transplantation (Teng, Lavik et al. 2002; Lee, Jeyakumar et 
al. 2007).  Studies by Pluchino et al. have highlighted the ability of exogenous 
neurosphere-derived neural precursor cells to display immune functions that result in 
neuroprotection in a model of multiple sclerosis, providing evidence for another potential 
mechanism underlying the bystander effect (Pluchino, Quattrini et al. 2003; Pluchino, 
Zanotti et al. 2005).  Thus, implanted neural stem cells may rescue compromised host 
neurons and reduce glial scar formation through a variety of potential mechanisms, both 
known and yet to be elucidated.  These cells may exert similar effects on the tissue 
response to implanted neural probes.  This dissertation explores this possibility, as well as 
the efficacy of using a cell cycle inhibiting drug to improve the integration of the probe 
with brain tissue.  
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Cell Cycle Inhibition as Therapy for Central Nervous System Injury 
 
The cell cycle is a complex process involved in the growth and proliferation of cells, and 
is regulated by numerous proteins.  Cells are most often in a quiescent or resting phase 
termed G0, but may become mitotic after successfully passing through the necessary 
phases and checkpoints of the cycle:  a growth phase during which RNA synthesis and 
protein production take place (G1), a DNA synthesis step (S), and a final preparatory 
stage (G2) prior to cellular division (M) (Figure 1.6a).  To complete this process, the cells 
must pass two important checkpoints that are regulated by cyclin-dependent kinases 
(CDKs), which occur during G1 and G2.  Cyclins are regulatory subunits of CDKs, and 
control these transitions.  Binding to cyclins is necessary for CDKs to achieve the 
appropriate phosphorylation state and become activated (Schafer 1998).  The G1 to S 
phase transition is regulated by CDK4,6 binding to cyclin D, which in turn results in the 
transcription of genes necessary for cell cycle progression (Schafer 1998).     
 
Following central nervous system injury, cell cycle proteins are upregulated in mitotic 
cells (namely, astrocytes and microglia) and non-mitotic cells (differentiated neurons).  
Mitotic cells proliferate upon re-entry into the cell cycle, while non-mitotic cells undergo 
caspase-mediated apoptosis (Cernak, Stoica et al. 2005).  Cell cycle inhibitors prevent 
cellular re-entry into the cell cycle, and have been shown to prevent glial proliferation 
and neuronal death in models of brain injury in vitro and in vivo. 
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Figure 1.6.  The stages of the cell cycle (a), with X’s marking transitions inhibited by 
flavopiridol.  The structure of flavopiridol is shown in (b). 
 
Specifically, flavopiridol (Figure 1.6b) is a flavonoid cell cycle inhibiting drug which has 
shown efficacy in attenuating CNS damage in several injury models, and has completed 
Phase II trials for cancer treatment (Morris, Bramwell et al. 2006).  Flavopiridol is a 
broad CDK inhibitor, reduces cyclin D1 transcription, and arrests the cell cycle in G1 or 
at the G2/M interface (Swanton 2004).  Di Giovanni et al. showed that a one-time 
intracerebroventricular injection of flavopiridol reduced cyclin D1 expression, decreased 
neuronal cell death, reduced glial activation, and improved motor and cognitive recovery 
following traumatic brain injury in rats (Di Giovanni, Movsesyan et al. 2005).  
Flavopiridol administration to rats with spinal cord injury reduced cell cycle protein 
expression, improved functional recovery, reduced lesion volume, decreased astrocyte 
activation, and reduced neuronal apoptosis (Byrnes, Stoica et al. 2007).  Flavopiridol 
attenuated excitotoxic cell death and reduced the expression of cell cycle proteins in 
kainic acid-treated neurons in vitro (Verdaguer, Jimenez et al. 2004).  It is also 
neuroprotective in neurons exposed to the parkinsonian neurotoxin 1-methyl-4-
phenylpyridinium in vitro (Alvira, Tajes et al. 2007).  In an in vitro model of apoptotic 
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motoneurons, flavopiridol administration reduced cell death associated with cell cycle 
(cyclin D1 and E) expression following neurotrophic factor withdrawal (Appert-Collin, 
Hugel et al. 2006).  A combination of flavopiridol and minocycline was neuroprotective 
in an ischemic rat model for the ten week study period (Iyirhiaro, Brust et al. 2008).  
Thus, there are several lines of evidence that flavopiridol administration reduces the 
effects of CNS injury.  As such, flavopiridol is a candidate for mitigation of the tissue 
response to neural prostheses. 
 
Dissertation Organization 
This dissertation includes four research studies which are either in press, revision, 
submission, or preparation for submission to peer-reviewed journals.  Chapters two 
through five describe this work.  The first chapter of the dissertation is an introduction, 
which familiarizes the reader with general background information.  The last chapter of 
the dissertation reviews the significance of the conclusions of the described research, and 
discusses future directions for the work. 
 
Chapter 2 investigates the effects of alginate composition on the neurotrophic factor 
secretion of encapsulated neural stem cells, as well as the stability of the scaffold itself.  
The results indicate that alginate with a high guluronic acid content, and no poly-L-lysine 
coating layer, provided superior stability and support of neurotrophic factor release 
amongst the conditions tested.  Further, medium conditioned by neural stem cells 
encapsulated in this material increased PC-12 survival in an in vitro model of cell death.  
This chapter is in revision in the journal Tissue Engineering.     
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Chapter 3 examines the stability and biocompatibility of alginate disks of various 
compositions (CaCl2-crosslinked, CaCl2-crosslinked with poly-L-lysine coating, and 
CaCO3-crosslinked) implanted subcutaneously in rats for a period of three months.  We 
hypothesized that CaCO3-crosslinking and poly-L-lysine coating may improve the in vivo 
mechanical stability of alginate, and that poly-L-lysine may enhance the inflammatory 
response to implanted gels.  The results indicated no clear differences in biocompatibility 
between the conditions, and little evidence for improved mechanical stability with poly-
L-lysine coating.  Chapter 3 is in press in The Journal of Biomedical Materials Research 
– Part A.    
 
Chapter 4 studies the impact of neural stem cell-seeding a non-functional parylene neural 
prosthesis on the tissue response to the devices over a three month time period.  Cell-
seeding improved the tissue response within the first week of implantation, and had a 
negative impact on device-tissue integration by six weeks.  The time course of altered 
neuronal and non-neuronal densities surrounding the implants is also described.  Chapter 
4 has been submitted to Experimental Neurology. 
 
Chapter 5 explores the role of cell cycle re-entry in the tissue response to neural probes.  
The use of a cell cycle-inhibiting drug, flavopiridol, decreased electrode impedance over 
the four week study period, and reduced expression of a cell cycle protein (cyclin D1) in 
activated microglia at the three day time point.  No effects on recording metrics were 
observed, although the time course of these measurements corresponded well with the 
evolving tissue reaction to the devices.  Significant correlations between endpoint 
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histology, impedance, and recording quality were demonstrated.  Chapter 5 is in 
preparation for submission to the Journal of Neural Engineering.     
 
Chapter 6 summarizes the conclusions of the previous chapters, as well as their impacts 
to the field of neural engineering.  Additionally, several opportunities for future work are 
discussed, including quantitative immunohistochemistry with in situ probes, 
functionalization of neural stem cell-seeded prostheses, and investigating neuronal 
function around the devices.   
 
The dissertation provides several novel results characterizing the device-tissue interface, 
as well as the development and evaluation of two new intervention strategies to improve 
upon it.  This work impacts the fields of neural engineering, biomaterials, and 
neuroscience, and provides a foundation for future discovery in these areas.     
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CHAPTER 2 
IN VITRO DEVELOPMENT AND CHARACTERIZATION OF A CORTICAL 




The purpose of this study was to evaluate the effects of alginate composition on the 
neurotrophic factor release, viability, and proliferation of encapsulated NSCs, as well as 
on the mechanical stability of the scaffold itself.  Four compositions were tested:  a high 
guluronic acid (68%) and a high mannuronic acid (54%) content alginate, with or without 
a poly-L-lysine (PLL) coating layer.  Enzyme-linked immunosorbent assay (ELISA) was 
used to quantify the release of brain derived neurotrophic factor (BDNF), glial derived 
neurotrophic factor (GDNF) and nerve growth factor (NGF) from the encapsulated cells.   
All three factors were detected from encapsulated cells only when a high G alginate 
without PLL was used.  Additionally, capsules with this composition remained intact 
more frequently when exposed to solutions of low osmolarity, potentially indicating 
superior mechanical stability.  NSCs survived and proliferated in all alginate matrices 
similarly over the 21 day study course irrespective of scaffold condition.  NSC-seeded 
alginate beads with a high G, non-PLL coated composition may be useful in the repair of 
injured nervous tissue, where the mechanism is the secretion of neuroprotective factors.  
We verify the neuroprotective effects of medium conditioned by NSC-seeded alginate 
beads on the serum-withdrawal mediated death of PC-12 cells here.   
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Introduction 
Alginate is a biocompatible hydrogel that has been used to encapsulate many types of 
cells with the purpose of immuno-isolation from the host (Lim and Sun 1980; Joki, 
Machluf et al. 2001; Borlongan, Skinner et al. 2004; Wikstrom, Elomaa et al. 2008).  
Encapsulation protects graft cells from potential damage caused by an immune response 
while allowing the secretion of therapeutic agents from the cells into the surrounding host 
tissue.  Small molecules such as glucose, oxygen and waste products freely pass through 
the gel matrix.  Recent studies have investigated the use of alginate as a neural stem cell 
(NSC) scaffold (Li, Liu et al. 2006; Ashton, Banerjee et al. 2007; Li, Liu et al. 2007).  
However, the effect of alginate composition on NSC function has not been investigated.   
 
Administration of stem cells to sites of central nervous system (CNS) injury may be used 
as a means of replacing damaged or diseased tissue, where the focus is on directing the 
differentiation of implanted cells into neurons and subsequent reinnervation of host 
tissue. This strategy has been used to intervene in numerous models of CNS injury, 
including Parkinson’s Disease, stroke, ALS, spinal cord injury, traumatic brain injury, 
and Huntington’s Disease (Lindvall, Kokaia et al. 2004; Martino and Pluchino 2006; 
Gaillard, Prestoz et al. 2007). However, in many studies the degree of functional recovery 
following NSC transplantation is not explained by the quantity of differentiated graft 
cells alone, lending credence to a “bystander” or supporting role of NSCs (Ourednik, 
Ourednik et al. 2002; Pluchino, Zanotti et al. 2005; Martino and Pluchino 2006).  Several 
studies suggest that NSCs have an innate ability to promote neuroprotection and axonal 
regeneration of host tissue (Ourednik, Ourednik et al. 2002; Teng, Lavik et al. 2002; Lu, 
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Jones et al. 2003; Heine, Conant et al. 2004; Llado, Haenggeli et al. 2004). Potential 
mechanisms include constitutive secretion of multiple neurotrophic factors (Ourednik, 
Ourednik et al. 2002; Teng, Lavik et al. 2002; Lu, Jones et al. 2003; Llado, Haenggeli et 
al. 2004), as well as degrading molecules which are inhibitory to axonal growth (Heine, 
Conant et al. 2004). NSCs derived from various sources have been found to elute nerve 
growth factor (NGF), brain derived neurotrophic factor (BDNF),  glial derived 
neurotrophic factor (GDNF), and matrix metalloprotease-2 (MMP-2), which degrades 
chondroitin sulfate proteoglycan (a molecule inhibitory to axonal growth)(Lu, Jones et al. 
2003; Heine, Conant et al. 2004; Llado, Haenggeli et al. 2004; Li, Liu et al. 2007). Thus, 
neural stem and progenitor cells may be exploited as a sort of miniature drug factory, 
releasing factors which result in the desired healing response in injured nervous tissue.  
Encapsulation of these cells in alginate may further enhance their therapeutic utility by 
localizing the cells to the site of injury and isolating them from a host immune response. 
 
Alginate is a biocompatible polysaccharide polymer composed of D-mannuronic (M) and 
L-guluronic acid (G) residues in varying proportions. Cross-linking and gel formation 
takes place when divalent cations, such as calcium, ionically bind carboxylic acid groups 
of blocks of guluronic residues between chains. Alginate has been used widely to 
encapsulate cells following ground-breaking work published by Lim and Sun in 1980, 
which demonstrated reversal of diabetes in rats implanted with alginate-encapsulated 
pancreatic islets for a period of 2-3 weeks (Lim and Sun 1980).  Several studies have 
sought to understand the relationship between alginate composition and the function of 
the graft (Soon-Shiong, Otterlie et al. 1991; De Vos, De Haan et al. 1997; Constantinidis, 
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Rask et al. 1999; King, Sandler et al. 2001; Stabler, Wilks et al. 2001; Strand, Ryan et al. 
2001; Rokstad, Holtan et al. 2002; King, Lau et al. 2003; Wikstrom, Elomaa et al. 2008). 
Two common themes emerge in the literature regarding alginate composition and graft 
performance: the effect of the M/G content of the alginate and the importance of a 
polycation coating layer. These two variables have been related to gel mechanical 
stability, viability of encapsulated cells, in vivo biocompatibility, and diffusion through 
the alginate gel. In terms of mechanical stability, alginates with a high G content are 
more mechanically stable than those with a high M content (Strand, Morch et al. 2000). 
However, high G alginate has been shown to initially inhibit the metabolic and secretory 
activity of cells due to growth inhibition, theoretically because a higher strength gel is 
more difficult for proliferating cells to displace (Constantinidis, Rask et al. 1999; Stabler, 
Wilks et al. 2001). Beads composed of high G alginate are also known to be more porous 
than high M alginate, thus enhancing diffusion of molecules into and out of the matrix 
(Martinsen, Storro et al. 1992). Poly-L-lysine (PLL) coating is commonly employed as a 
means of strengthening the alginate bead and providing a barrier to immune system 
components such as IgG (Kulseng, Thu et al. 1997; Gugerli, Cantana et al. 2002). 
However, the PLL coating layer may itself cause an unfavorable foreign body response 
and slight toxicity to encapsulated cells, and its use remains controversial (King, Sandler 
et al. 2001; Strand, Ryan et al. 2001; Rokstad, Holtan et al. 2002; van Raamsdonk, 
Cornelius et al. 2002; King, Lau et al. 2003; Orive, Hernandez et al. 2003; Orive, Tam et 
al. 2006).  
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In light of the extensive research indicating a relationship between alginate composition 
and encapsulated cell function, as well as the limited amount of data on NSC 
encapsulation in alginate, the effects of M/G content and PLL coating on entrapped 
cortical NSCs were investigated.  We show that neurotrophic factor release and 
mechanical stability in response to an osmotic challenge were optimal in a high G 
scaffold without a PLL coating layer.  NSCs survived and proliferated in alginate 
regardless of the compositions tested. Neurotrophic factor release and bioactivity assay 
data substantiated the use of NSCs encapsulated in alginate to heal injured nervous tissue 
via a bystander mechanism.  These scaffolded cells have therapeutic potential in treating 
nervous system injuries in future studies, and current work in our lab is investigating their 
ability to repair a cortical lesion in the adult rat brain (Purcell, Seymour et al. 2007).    
 
Materials and Methods 
Materials 
Cortical NSCs, nestin antibody, neuronal class III β-tubulin (TUJ-1) antibody, and all 
NSC cell culture reagents were purchased from StemCell Technologies (Vancouver, BC).  
MTS assay and ELISA kits were obtained from Promega Corporation (Madison, WI).  
Alginate was from NovaMatrix (Drammen, Norway).  Live/Dead Assay and PC-12 
medium reagents were from Invitrogen Corporation (Carlsbad, CA).  BD Biocoat 
collagen-coated plates were from BD Biosciences (San Jose, CA).  Centricon filters and 
NG-2 antibody were from Millipore Corporation (Billerica, MA). Secondary antibodies 
were from Molecular Probes (Eugene, OR).  PC-12 cells were obtained from the 
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American Type Culture Collection (ATCC) (Manassas, VA).  All other reagents were 
from Sigma-Aldrich (St. Louis, MO).         
 
Cortical NSC Culture and Encapsulation in Alginate 
E14 murine cortical neural stem cells were cultured and expanded with 20 ng/mL 
epidermal growth factor (EGF) according to the supplier’s protocol with a 
penicillin/streptomycin antibiotic supplement.  The culture and stem cell characteristics 
of these cells have been described (Reynolds and Weiss 1992; Reynolds and Weiss 
1996).  Cell encapsulation was achieved by mixing a cell slurry with alginate 50:50 and 
dropping into a 0.1 M calcium chloride solution for 10 minutes.  The encapsulation 
yielded beads with a final concentration of 500,000 cells/mL in 1% w/v alginate 
(approximately 200 cells per bead).  The weight percentage was chosen based on a 
recommendation reported in the literature (Stabler, Wilks et al. 2001).  Cells were 
approximately 90% viable as assessed by trypan blue staining prior to encapsulation.  
Bead size was approximately 1 mm in diameter and controlled by parallel air flow 
through a glass atomizer. Four different conditions were employed to optimize the 
encapsulation procedure: a high guluronic (G) alginate (68% G content, molecular weight 
= 219,000 g/mol) or a high mannuronic (M) alginate (54% M content, molecular weight 
= 222,000 g/mol), with or without a PLL coating layer.  The conditions chosen have been 
shown to have differing mechanical strengths based on M/G content, and molecular 
weights were closely matched to eliminate this factor as an experimental variable 
(Martinsen, Skjak-Baek et al. 1989; Strand, Morch et al. 2000).  These conditions are 
abbreviated as G, M, G-PLL, and M-PLL.   All alginates were highly purified and sterile.   
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PLL coating was achieved as previously described (Strand, Gaserod et al. 2002). Briefly, 
beads were rinsed in physiological saline prior to a ten minute incubation in 0.1% PLL-
HCl (15,000-30,000 MW) in saline. Following additional saline rinsing, beads were 
incubated for 10 minutes in 0.1% alginate in saline. Beads received a final rinse prior to 
being returned to medium. Beads were cultured in static transwell dishes containing 
500,000 cells (encapsulated or unencapsulated) which were allowed to proliferate in the 
presence of EGF over time. 
 
ELISA 
At 1, 4, 7, 14, and 21 day time points, media samples were collected for quantification of 
growth factor release with enzyme linked immunosorbent assay (ELISA) (n=5 per 
condition).  Untreated media and supernatant from non-encapsulated cells were used as 
controls. Supernatant was concentrated with YM-3 Centricon filters at 4°C.  Promega 
Emax ELISA kits for NGF, BDNF, and GDNF were used according to the 
manufacturer’s protocol.  Average values below the lowest dilution above zero of the 
standard curve for each kit were considered to be non-detectable (ND).   
 
Alginate Mechanical Stability 
The mechanical stability of the alginate beads was assessed using a semi-quantitative 
osmotic pressure test (Van Raamsdonk and Chang 2001). Testing was conducted at 1, 7, 
14 and 21 day time points.  Alginate beads were exposed to solutions of low osmolarity 
(0, 2.8, and 11.1 mOsm saline with media used as a control) for a period of 3 hours, as 
previously described (Van Raamsdonk and Chang 2001). Thirty beads per condition were 
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assessed visually for breakage at each time point. The number of intact capsules was 
compared between conditions by an observer blinded to the experimental condition. 
 
NSC Proliferation and Viability in Alginate 
Beads were collected for quantification of proliferation with an MTS assay and viability 
with propidium iodide staining at the same time points as ELISA.  In the MTS assay, a 
tetrazolium compound is bioreduced by metabolically active cells into a formazan 
product which is quantified by a plate reader.  Twenty beads per well (n=4 wells per 
condition per day) were assayed for each condition in accordance with previously 
published methods and sample sizes in similar studies (Bunger, Jahnke et al. 2002).  
 
To assess the viability of the cells in the alginate, beads were exposed to propidium 
iodide for 1.5 hours and counterstained with Hoechst for the final 10 minutes (n=4 per 
condition). Results were assessed by obtaining the percentage of propidium iodide 
positive nuclei by counting under a Zeiss Axioplan microscope. Slides were evaluated by 
an observer blinded to the experimental condition. 
 
Immunocytochemistry of Cells in Alginate 
Beads were collected at the same time points as ELISA for histology (n=4 per condition). 
For all staining applications, beads were briefly fixed in PBS-buffered 4% 
paraformaldehyde for 10 minutes followed by dehydration in graded washes of ethanol 
up to 70%. The samples were embedded in paraffin and sectioned on a microtome at a 5 
μm thickness. Sections were de-paraffinized, rehydrated, blocked with 10% normal goat 
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serum and stained with markers of differentiation. Specifically, immunocytochemistry for  
TUJ-I (neuronal precursors), GFAP (astrocytes), NG-2 (oligodendrocyte precursors), and 
nestin (undifferentiated NSCs) were performed based on a previously described method 
at 1:500, 1:80, 1:500, and 1:80 concentrations respectively (Cowell, Plane et al. 2003).  
Tris buffered saline (TBS) was used in place of phosphate buffered saline (PBS) to 
improve bead stability during staining by avoiding phosphate binding of calcium cross-
links.  Nuclei were counterstained with Hoechst.  As a negative control, TBS was used in 
place of primary antibody. Analysis of results was a qualitative assessment of histology. 
 
Bioactivity of Conditioned Medium from NSC-Seeded Beads 
To verify the potential ability of cortical NSCs to exert neuroprotective effects via a 
bystander mechanism when encapsulated in alginate, a serum-withdrawal model of 
apoptosis in PC-12 cells was used (Li, Liu et al. 2007). PC-12 cells were cultured in 
RPMI-1640 medium supplemented with 10% heat-inactivated horse serum and 5% fetal 
bovine serum on type IV collagen-coated 96-well plates, based on methods previously 
described (Greene and Tischler 1976).  To obtain conditioned medium, NSCs were 
encapsulated in 1% high G alginate, and medium was collected 48 hours later.  The high 
G alginate scaffold was chosen for this experiment based on its improved mechanical 
stability and support of neurotrophic factor release as demonstrated in this study.  Non-
seeded alginate beads conditioned the control medium.  Fifty percent of serum-containing 
medium was removed and replaced with either NSC-conditioned or control medium 
(from empty capsules). Control cells were given a media change only.  Twenty-four and 
forty-eight hours later, PC-12s were evaluated for viability with a Live/Dead kit.  The 
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center of each well was imaged with the 20X objective of a Leica inverted microscope, 
and live and dead cells were counted by an observer blinded to the experimental 
condition with ImageJ software (U. S. National Institutes of Health, Bethesda, MD).  The 
experiment was repeated, and a univariate ANOVA model which factored in time and 
trial was used to evaluate the combined data. Cell viability was evaluated as a percent of 
control.     
 
Statistical Analysis 
Differences between controls and experimental conditions for ELISA, MTS values, NSC 
and PC-12 viability were analyzed with standard ANOVA techniques, and a Tukey post-
hoc test where significance was noted.  Osmotic pressure test data was analyzed with 
logistic regression due to the binary response variable (1 = intact bead, 0 = broken bead).   
Histology was evaluated on a qualitative basis.  Statistical significance was defined at the 




The amount of NGF secreted from the unencapsulated cells (roughly between 10 and 90 
pg/million cells/day depending on time point, Table 2.1) was similar to that previously 
reported from the C17.2 NSC line derived from cerebellum (approximately 10 pg/million 
cells/day), and NGF secreted from cells in G capsules also fell within this range (Lu, 
Jones et al. 2003).  GDNF secretion from unencapsulated and G encapsulated cells on 
day fourteen was somewhat higher than the value reported for the C17.2 clone (70 
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pg/million cells/day) (Table 2.1) (Lu, Jones et al. 2003).  No secretion of NGF or GDNF 
was detected at any time point from cells encapsulated in other scaffold conditions.  NGF 
was detected on fewer days from G encapsulated cells compared to unencapsulated cells 
(Table 2.1).  BDNF was detected from all conditions, both encapsulated and 
unencapsulated, at the four day time point, and values were generally higher than that 
reported for C17.2 cells (10 pg/million cells/day) (Table 2.1) (Lu, Jones et al. 2003).  The 
four day time point is also when cell viability tended to be at its lowest levels for scaffold 
conditions; it is unknown if the two phenomena are related (Figure 2.2a).  NGF 
 
Table 2.1.  Neurotrophic factor release varies with scaffold condition and time.  Values 
are given in pg/million cells/day.  Unencapsulated cells secrete NGF, BDNF, and GDNF 
at various time points throughout the study, whereas all three factors were detected from 
encapsulated cells only when a high G alginate scaffold was used.  BDNF was detected 
from all conditions at the four day time point, and GDNF was detected at the fourteen 
day time point from G encapsulated and unencapsulated cells.  NGF secretion from 
unencapsulated cells at 21 days was significantly greater than 1 day and 4 day values (‡), 
and secretion at 7 days was greater than 4 day values (†) (p < 0.05, ANOVA).  Non-
detectable values are denoted “ND.”  Mean ± s.e.m. is shown. 
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levels for unencapsulated cells were higher at 7 and 21 days compared to initial time 
points; no other significant differences were found.     
 
Alginate Mechanical Stability  
G beads were significantly more stable than all other conditions when exposed to 
solutions of low osmolarity (Figure 2.1a, p < 0.001).  The odds of beads remaining intact 
was increased by at least 18-fold in comparison to other conditions when a high G 
composition was used.   Representative images of beads exposed to 0 mOsm solutions 
after 7 days in vitro further highlight the improved stability of high G beads compared to 
other alginate compositions during this test (Figure 2.1b-e).     High M beads were more 
stable than PLL-coated beads (Figure 2.1a, p < 0.001).  The data shows that PLL coating 
resulted in increased incidence of bead breakage, with no significant difference between 
G-PLL and M-PLL beads.  The presence of a PLL coating layer was visually confirmed 
in a separate investigation using the same coating protocol with FITC-labeled PLL and 
fluorescence microscopy (data not shown).  There was a significant reduction of alginate 
stability after 24 hours; the odds of beads being intact decreased 9-fold after this time 
point (Figure 2.1a, p < 0.001).  No further significant changes in stability over time were 
observed.    Similar results were found when beads were exposed to solutions of 2.8 and 
11.1 mOsm saline (data not shown). 
                                                                       46 
 
Figure 2.1.  NSC-seeded alginate microcapsules with a G composition have superior 
stability in comparison to all other conditions.  G beads remain intact more frequently 
than M capsules after exposure to 0 mOsm 7 days after seeding (a) (p < 0.001, logistic 
regression).  PLL-coated capsules break more frequently than uncoated capsules (p < 
0.001, logistic regression).  Representative images of G (b), G-PLL (c), M (d), and M-
PLL (e) capsules in solution illustrate the stability of G capsules (intact beads are labeled 
“I”) and breakage (broken beads are denoted “B”) of M and G-PLL beads.  M-PLL beads 
are completely dissolved.  Insets in (b)-(d) highlight representative beads (arrows) to 
improve visualization.  Error bars are not shown due to the nature of the data analysis.  
Scale = 1 mm.     
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Proliferation and Viability in Alginate  
NSCs survive and proliferate in all alginate matrices regardless of composition (Figure 
2.2a-d).  M-PLL capsules were too mechanically unstable to assay after the first week. 
After an initial drop in viability at 4 days to the 20-40% range, cell viability rebounds to 
over 70% thereafter regardless of encapsulation condition (Figure 2.2a, p < 0.05).  Cell 
death levels were high immediately following encapsulation, mainly due to necrosis with 
many cells appearing to be lysed by the procedure. Representative pictures of healthy and 
propidium iodide positive cells from the same sample of high G-encapsulated 
neurospheres are shown in Figure 2.2b-c.  Cells at the interior of larger encapsulated 
neurospheres are particularly vulnerable to necrosis, presumably due to reduced nutrient 
and oxygen diffusion (Figure 2.2c).  At later time points, chromatin clumping possibly 
indicating apoptosis was seen in a few cells, and much lower levels of necrosis occurred.  
There were no significant differences in viability between alginate conditions.  An MTS 
assay revealed cell proliferation in all alginate matrices irrespective of composition, and 
cell number was significantly increased over initially low or non-detectable values 
beginning at 4 days (Figure 2.2d, p < 0.05).  Previous experiments visually validated the 
MTS assay of alginate beads with toluidene blue staining of paraffin sections (data not 
shown).  The data indicate that NSCs survive and proliferate within alginate matrices 
following an initial drop in viability regardless of composition, likely due to the 
physiological challenge the encapsulation procedure presents to the cells. 
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Figure 2.2. NSCs survive (a-c) and proliferate (d) in alginate regardless of the 
compositions tested.  Viability of the cells is initially reduced following encapsulation, 
but significantly improves for all conditions after one week (a).  Cells are labeled with 
Hoechst (blue), and propidium iodide (red) stains nuclei of cells with compromised 
membranes indicative of cell death (b-c).  Representative pictures of G-encapsulated cells 
at 21 days illustrate the vulnerability of cells in the center of larger proliferating 
neurospheres to necrosis, presumably due to reduced nutrient and oxygen diffusion (b-c).  
NSCs proliferate irrespective of alginate composition, with significantly increased cell 
numbers detected beginning at 4 days compared to initially low or non-detectable values 
1 day after encapsulation (d).  A further increase occurs at 21 days post-encapsulation.  
M-PLL capsules were too mechanically unstable to assay after the first week. †, ‡ = 
significantly increased versus 1 day, or 1 and 4 days respectively at the 0.05 level 
(ANOVA).  Mean ± s.e.m. is shown.  Scale = 100 microns.  
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Immunocytochemistry of Cells in Alginate 
Results of immunocytochemistry were limited due to bead instability during staining, and 
dehydration and processing seemed to affect tissue appearance.  However, preliminary 
results revealed that encapsulated NSCs express nestin on the periphery and GFAP in the 
center of larger proliferating cell masses after entrapment in alginate (Figure 2.3a-b). 
Smaller neurospheres were often nestin positive and largely GFAP negative (data not 
shown).   This profile of expression is typical for that observed with similar neurosphere-
derived cells in culture (Campos, Leone et al. 2004).  No expression of TUJ-1 was 
observed.  Interestingly, some evidence of limited NG-2 expression was observed in one 
bead, indicating oligodendrocyte precursors (Figure 2.3c).    
 
Figure 2.3.   Encapsulated NSCs express nestin (green) on the periphery and GFAP (red) 
in the center of cell masses after entrapment in alginate (a-b). Interestingly, some 
evidence of limited NG-2 expression (green) was observed in one bead, indicating 
oligodendrocyte progenitors (c).  All nuclei were counterstained with Hoechst (blue).  
Images are from (a) G, 14 day, (b) M-PLL, 14 day, and (c) G-PLL, 4 day, scaffolds and 
time points.  Scale = 50 microns. 
 
Bioactivity of Conditioned Medium from NSC-Seeded Beads 
Results of a viability assay revealed a significant protective effect of conditioned medium 
collected from NSCs encapsulated in G beads against serum withdrawal-mediated PC-12 
cell death over 48 hours (Figure 2.4a, p < 0.05).  These results are novel for cortical 
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NSCs, and corroborate a similar study done with hippocampal NSCs (Li, Liu et al. 2007).  
Representative images of live and dead PC-12 cells are shown for NSC-conditioned and 
control medium treatments in Figure 2.4b and c, respectively.   
 
Figure 2.4.  NSC-conditioned medium from G encapsulated cells protects PC-12 cells 
from serum withdrawal-mediated cell death (a) (p < 0.05, ANOVA).  Representative 
images of live (green) and dead (red) PC-12 cells after a 50% serum withdrawal and 
treatment with medium conditioned by NSC-seeded (b, 75.6% viable) or unseeded (c, 
49.5% viable) alginate microspheres.  Results are reported as a percentage of control PC-
12 cell viability.  Mean ± s.e.m. is shown.  Scale = 100 microns. 
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Discussion 
Alginate composition has been shown to affect encapsulated cell proliferation and 
secretion of therapeutic proteins, as well as the mechanical stability of the scaffold 
(Constantinidis, Rask et al. 1999; Strand, Morch et al. 2000; Stabler, Wilks et al. 2001).  
We sought to characterize the effects composition may have on NSCs, as alginate is 
largely unstudied as a carrier for these cells.  NSCs survive and proliferate in alginate 
irrespective of the scaffold compositions tested in this study.  Among the conditions 
tested, a high G content alginate without a PLL coating layer was the optimal 
composition based on its mechanical stability during the osmotic pressure test and 
support of neurotrophic factor release.      
 
Our data reveal that cortical NSCs, even when encapsulated in alginate, secrete NGF, 
BDNF and GDNF into the surrounding media. Importantly, these neurotrophic factors are 
known to support neuronal survival and plasticity in various models of axonopathy and 
neuropathy (Kolb, Gorny et al. 1997; Han and Holtzman 2000; Nicole, Ali et al. 2001; 
Lu, Pang et al. 2005; Wilkins and Compston 2005).  Quantitative analysis of constitutive 
neurotrophic factor release from NSCs is relatively rarely reported in the literature, 
despite the popular theory that release of these proteins and their effects on compromised 
host tissue is a potential mechanism behind the cells’ restorative capacity (Ourednik, 
Ourednik et al. 2002; Teng, Lavik et al. 2002; Lindvall, Kokaia et al. 2004; Llado, 
Haenggeli et al. 2004; Martino and Pluchino 2006).   Time courses of release are 
generally lacking, as are release profiles from scaffolded cells.  Lu et al. reported 
detection of NGF, BDNF, and GDNF in medium collected from C17.2 neural stem cells 
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after a 24 hour time point, with levels in the 10-70 pg/million cells/day range (Lu, Jones 
et al. 2003).  GDNF and NGF, but not BDNF, secretion was detected from these cells in a 
separate report (Llado, Haenggeli et al. 2004).  GDNF release from alginate encapsulated 
and unencapsulated hippocampal NSCs tended to be approximately 500-1,000 pg/million 
cells after 72 hours, as reported by Li et al. (Li, Liu et al. 2007).  Our results are 
consistent with these ranges.   
 
This study revealed that the detection of released neurotrophic factors is influenced by 
alginate composition and time.  BDNF and GDNF are detected at single time points (4 
and 14 days, respectively), while NGF release is observed throughout the study by 
unencapsulated and encapsulated cells.  NGF is detected on fewer days (occurring only in 
the first week post-encapsulation) from encapsulated cells in comparison to 
unencapsulated cells, possibly due to the initial reduction in viability of the cells by 
encapsulation, degradation of the NGF protein, or interactions of NGF with the alginate 
matrix.  GDNF and NGF are only detected from encapsulated cells when a high G, non-
PLL coated capsule is used.  Meanwhile, BDNF is released from cells in all conditions 
tested.  Why the high G alginate capsules seem more permissive to neurotrophic factor 
release is unclear, given that previous literature for insulin-secreting cells has suggested 
reduced proliferation and less secretion at early time points for cells encapsulated in high 
G alginate (Stabler, Wilks et al. 2001).  No significant effect of alginate composition on 
NSC proliferation was demonstrated here, which may be due to the relatively low 
alginate weight percentage (1%) used, as well as differences in the cell types studied.   
Additionally, the increased gel porosity of high G alginate (which could be further 
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enhanced by swelling) and the potential for stabilization of trophic factors by interaction 
with the alginate matrix are possible explanations (Martinsen, Storro et al. 1992; Peters, 
Isenberg et al. 1998).  Since neurotrophic factors are larger than insulin (approximately 
20-30 kDa versus 5 kDa), the increased porosity of high G alginate may be necessary to 
allow for adequate release.  It has been suggested that interaction with alginate may 
stabilize growth factors (Peters, Isenberg et al. 1998). The release timing of individual 
neurotrophic factors may be explained by cellular events and their relationship to 
evolving environmental cues, and the quantities and timing of neurotrophic factor release 
is likely to vary with culture conditions.  BDNF release coincided with low cell viability, 
while GDNF detection occurred at a time of increased viability and cell number.  It is 
important to note that the initial drop in viability following encapsulation could affect the 
types and quantities of trophic factors released from the cells.  However, elucidating the 
mechanisms behind the release profile of neurotrophic factors by the NSCs is beyond the 
scope of the current work. 
 
The mechanical stability of alginate in vivo over time remains an important challenge 
(Orive, Hernandez et al. 2003; Nunamaker, Purcell et al. 2007).  In a cell encapsulation 
application, alginate localizes graft cells to the transplant site and isolates them from the 
immune response, and loss of mechanical strength may compromise these functions. 
Alginates with a high G content are known to be more mechanically stable than those 
with higher M contents, due to stabilization by additional cross-links (Strand, Morch et 
al. 2000). That result was verified here, where the stability of alginate capsules of varying 
compositions was semi-quantitatively compared by an osmotic pressure test. High G 
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capsules remained intact far more frequently when exposed to solutions of low 
osmolarities compared to M beads and PLL-coated conditions, and no evidence of 
decreased proliferation and therapeutic factor secretion was observed.  A tradeoff 
between cellular function and scaffold mechanical strength has been reported previously 
with insulin-secreting cells (Stabler, Wilks et al. 2001).  However, this tradeoff was more 
pronounced for higher weight percentage (2%) alginates than the weight percentage (1%) 
used here. Additionally, this phenomenon was reported for a markedly different cell type 
than the one studied here, with presumably substantial impacts on proliferation and 
secretion characteristics.    
 
It was somewhat surprising that the PLL-coated capsules were more prone to breakage 
than uncoated beads during the osmotic pressure test, given that PLL has been credited 
with improving mechanical stability (Benson, Papas et al. 1997; Rokstad, Holtan et al. 
2002).  This data requires careful interpretation, with consideration for the consequences 
of saline washing, the potential effects of polycation coating on swelling behavior, the 
impact of alginate concentration, and the definition of mechanical stability.  The results 
may be affected by the multiple saline washes used in the coating protocol. Monovalent 
sodium ions may compete with divalent calcium ions for binding sites between G 
residues, and ultimately break the cross-links and weaken the gel (Wang and Spencer 
1998).  We have previously reported a study in which uncoated and PLL-coated alginate 
disks were washed identically in saline, implanted subcutaneously in rats, and monitored 
over a three month time period for mechanical stability, weight changes related to 
swelling behavior, and biocompatibility (Nunamaker, Purcell et al. 2007).  PLL-coating 
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resulted in a slight but significant increase in complex modulus seven days after 
implantation in comparison to non-coated gels; no other significant differences in 
stability between the two conditions were noted.  Therefore, PLL coating may confer a 
slight advantage, or at least have a non-detrimental role, on gel stability when results are 
not affected by saline washing.  However, saline washing is a prototypic part of PLL 
coating protocols; thus if coating is pursued, the current results indicate that the 
potentially destabilizing effects of saline washing should be considered.   
 
In the same study, both PLL and non-coated gels initially dropped in weight following 
implantation, followed by similar trends in increasing weight (interpreted as swelling) for 
a period of two weeks.  The weight gains were greater for non-coated than PLL-coated 
samples, potentially indicating greater swelling.  Previous research has indicated that 
osmotic swelling of the bead core against a less elastic polycation membrane may 
eventually cause capsules to burst (Thu, Bruheim et al. 1996). Therefore, although the G 
capsules may not burst, they may swell during exposure to an osmotic challenge, likely 
changing diffusion properties (which may, in turn, be related to their permissiveness to 
neurotrophic factor release) (Gugerli, Cantana et al. 2002).  The capsules in this study 
may be particularly vulnerable to swelling and saline effects due to the relatively low 
weight percentage used (1%); increased alginate concentration improves resistance to 
swelling (Thu, Bruheim et al. 1996).  Finally, the way in which mechanical stability is 
measured (i.e. rheology in the in vivo study, osmotic pressure in the in vitro study) is 
likely to affect results.  De Castro et al. reported PLL-coating to confer superior 
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resistance to compression, but the lowest resistance to osmotic pressure, in a mechanical 
stability test of three different polycation coatings (De Castro, Orive et al. 2005).   
 
The authors in the current study hypothesize that alginate beads were initially weakened 
by saline washes prior to PLL coating, and swelled in response to solutions of low 
osmolarity against the PLL coating, causing them to burst.  Thus, the mechanical stability 
of uncoated beads was improved compared to coated beads in the current experiment, but 
consideration for the effects of saline washing, swelling behavior and changes in 
diffusion characteristics is required.  Importantly, PLL coating has been credited with 
isolating alginate from IgG and complement diffusion into the gel. The coating protocol 
used in the experiments reported here was recommended to achieve this property 
(Kulseng, Thu et al. 1997). However, polycation coatings are still controversial after over 
25 years of research due to the fact that they may directly elicit a tissue response (King, 
Sandler et al. 2001; Strand, Ryan et al. 2001; van Raamsdonk, Cornelius et al. 2002; 
King, Lau et al. 2003; Orive, Hernandez et al. 2003; Orive, Tam et al. 2006).  In addition 
to the questionable effect on in vivo biocompatibility, our data demonstrate bead 
breakage during an osmotic challenge and reduced neurotrophic factor detection 
associated with PLL coating.       
 
Our results indicate that a high G alginate without PLL coating was the optimal 
composition for NSC encapsulation amongst the conditions tested based on superior 
mechanical stability during the osmotic pressure test and support of neurotrophic factor 
release.  However, several opportunities for further development remain. Alternative 
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polycations or a different polycation coating procedure may allow for tailoring diffusivity 
properties without a loss in mechanical stability or neurotrophic factor detection (Orive, 
Hernandez et al. 2003).   Alginate weight percentage variation, bead size reduction, and 
incorporation of interpenetrating networks are additional examples of methods which 
may improve results (Desai, Sojomihardjo et al. 2000; Stabler, Wilks et al. 2001; 
Canaple, Rehor et al. 2002; Wang, Childs et al. 2005).  We are currently evaluating the 
ability of a high G, non-PLL coated alginate scaffold seeded with NSCs to repair a 
cortical lesion in vivo, and early results are promising (Purcell, Seymour et al. 2007).        
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CHAPTER 3 




Alginate is a commonly used biomedical hydrogel whose in vivo degradation behavior is 
only beginning to be understood.  The use of alginate in the central nervous system is 
gaining popularity as an electrode coating, cell encapsulation matrix, and for duraplasty.  
However, it is necessary to understand how the hydrogel will behave in vivo to aid in the 
development of alginate for use as a neural interface material.  The goal of the current 
study was to compare the rheological behavior of explanted alginate disks and the 
inflammatory response to subcutaneously implanted alginate hydrogels over a 3 month 
period.  Specifically, the effects due to (1) in situ gelling, (2) diffusion gelling and (3) use 
of a poly-L-lysine coating were investigated.  While all samples’ complex moduli 
decreased 80% in the first day, in situ gelled alginate was more stable for the first week 
of implantation.  The poly-L-lysine coating offered some stability increases for diffusion 
gelled alginate, but the stability in both conditions remained significantly lower than in 
situ gelled alginate.  There were no differences in biocompatibility that clearly suggested 
one gelation method over another.  These results indicate that in situ gelation is the 
preferred method in neural interface applications where stability is the primary concern. 
Keywords:  Hydrogel, Alginate, Degradation, Biocompatibility 
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Introduction 
Recently, there have been several reports utilizing alginate in advanced neural interface 
technologies.  These include microelectrode coatings, cell scaffolds, neural stem cell 
encapsulation, and development of an artificial dura mater (Becker and Kipke 2003; 
Vetter, Becker et al. 2003; Kim, Abidian et al. 2004; Kajiwara, Ogata et al. 2005; Purcell 
and Kipke 2006; Purcell, Seymour et al. 2006; Nunamaker, Otto et al. in submission; 
Nunamaker, Otto et al. in submission).  Alginate shows promise and utility as a material 
in the development of advanced neural interfaces.  Its long-term biocompatibility, mild 
reaction conditions that allow hydrogel cross-linking while in direct contact with neural 
tissues, and minimal risk of seizure activity in rats are especially important considering 
the imminent and prolonged contact of the hydrogel components with neural tissues 
(Draget, SkjakBraek et al. 1997; Le Tallec, Korwin-Zmijowska et al. 1997; Aydelotte, 
Thonar et al. 1998; Becker, Kipke et al. 2001; Becker, Kipke et al. 2002; Becker and 
Kipke 2003; Nguyen, Qian et al. 2003; Becker, Preul et al. 2005).  Unfortunately, little is 
known about the long-term stability of alginate, which may be important to the lifetime 
of advanced neural prosthetic devices incorporating this material.   
Alginate is a naturally occurring polysaccharide copolymer that can be used to create 
hydrogels with a broad range of material properties.  Derived from brown algae, alginate 
is composed of blocks of both β-D-mannuronic acid (M) and α-L-guluronic acid (G) 
linked together by 1,4-bonds (Haug 1964; Lahaye 2001).  Alginate is water soluble and 
can be ionically cross-linked by various divalent ions (Haug and Smidsrod 1965).  
Currently Ca2+ is preferred to cross-link alginate for biomedical applications due to the 
mild reaction conditions compared to the cellular toxicity of both Ba2+ and Sr2+ (Haug 
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and Smidsrod 1965; Smidsrod and Haug 1965; Draget, SkjakBraek et al. 1997; Wideroe 
and Danielsen 2001).  In the process of cross-linking, the calcium ions interact with the 
carboxyl groups of the G blocks of two neighboring alginate chains forming an “egg box” 
orientation (Grant, Morris et al. 1973).  Because of the large variety of alginate sources 
and G and M block ratios, the properties of the resulting cross-linked gels can be highly 
variable.  Alginate with a higher G content typically results in stronger gels; while 
alginate with a higher M content yields more flexible gels (Amsden and Turner 1999). 
 
Two methods of gelation have been extensively described and used to create alginate 
hydrogels: diffusion gelling and in situ gelling (Figure 3.1) (Haug and Smidsrod 1965; 
Smidsrod and Haug 1965; Smidsrod and Haug 1972; Wang, Zhang et al. 1993; Wang, 
Zhang et al. 1994; Yamagiwa, Kozawa et al. 1995; Ishikawa, Ueyama et al. 1999; 
Becker, Kipke et al. 2001; Kuo and Ma 2001; Shchipunov, Koneva et al. 2002; Liu, Qian 
et al. 2003; Mammarella and Rubiolo 2003).  CaCl2 is a commonly used calcium source 
that relies on diffusion to cross-link alginate.  Ca2+ can readily dissociate from the Cl- to 
cross-link the first carboxyl groups with which it comes into contact.  This rapid reaction 
creates a skin around the volume of liquid alginate.  Subsequently, the calcium ions 
diffuse inward (i.e. diffusion gelling), increasing the skin’s thickness as the alginate bolus 
is cross-linked (Blandino, Macias et al. 1999; Bienaime, Barbotin et al. 2003).  Although 
this results in rapid gel formation, the resulting hydrogel structure is highly variable 
(Aydelotte, Thonar et al. 1998; Bienaime, Barbotin et al. 2003).  Despite this, diffusion 
gelling remains an ideal approach that is widely used for rapidly encapsulating cells in 
microspheres of alginate (Li, Altreuter et al. 1996; Kulseng, Thu et al. 1997; Strand, 
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Figure 3.1. Diffusion and in situ gelling of liquid alginate.  A.  Diffusion gelling.  
Calcium ions diffuse through the liquid alginate boundary, cross-linking alginate strands 
as the ions move through the volume of alginate.  Cross-links are not uniformly 
distributed throughout the gel.  B.  In situ gelling.  CaCO3 is mixed with alginate to create 
a homogeneous mixture (black circles).  D-Glucono-δ-lactone (GDL, grey circles) is 
added to acidify the solution and release calcium ions, making them available for cross-
linking.  The resultant hydrogel has a uniform distribution of cross-links.  
 
CaCO3 and CaSO4 are commonly used Ca2+ sources that rely on internal gelling through 
the release of calcium ions in situ.  In the case of CaCO3, poorly soluble calcium ions in 
the form of CaCO3 are homogeneously mixed with alginate and then the Ca2+ is 
solubilized by the addition of catalyst, such as D-glucono-δ-lactone (GDL).  GDL slowly 
acidifies the alginate:CaCO3 solution, driving the release of Ca2+ (Draget, Ostgaard et al. 
1991; Shchipunov, Koneva et al. 2002).  Calcium ions bind to the nearest available 
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carboxyl groups on the alginate molecules, cross-linking the hydrogel in a spatially 
uniform manner.  This method can be time intensive due to the time required for the 
hydrolysis of GDL and subsequent calcium release; however, the resultant hydrogel has a 
more uniform and reproducible structure (Draget, Ostgaard et al. 1991; Kuo and Ma 
2001; Shchipunov, Koneva et al. 2002). 
 
Diffusion gelled alginate has previously been shown to destabilize both in vitro and in 
vivo (LeRoux, Guilak et al. 1999; King, Sandler et al. 2001; Kong, Alsberg et al. 2004).  
Prolonged exposure to sodium ions decreases both compressive and shear stiffness of 
alginate, suggesting that physiological conditions will soften the gel over a time period of 
up to 7 days after gelation (LeRoux, Guilak et al. 1999).  Further, LeRoux et al. showed 
that high M alginate hydrogels exhibited a significant decrease in complex modulus but 
retained solid-like behavior after 7 days of exposure to 0.15M NaCl and 1.8mM CaCl2 
(LeRoux, Guilak et al. 1999).  Kong et al., however, demonstrated the superior retention 
of elastic modulus of high G alginate over high M alginate implanted up to 35 days 
(Kong, Alsberg et al. 2004).  This effect is due to calcium’s higher affinity for G sites 
than M sites, resulting in a more dense distribution of cross-links in a high G 
concentration hydrogels.  This dense distribution of cross-links enhances the stability of 
high G alginate hydrogels after prolonged exposure to the inert electrolytes found in vivo, 
thereby decreasing the effect of ion exchange at the cross-link site (Kong, Alsberg et al. 
2004).  While these previous studies support our current investigations of high G alginate 
stability in vivo, there are currently no studies that investigate stability differences based 
on gelation method. 
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Poly-L-lysine (PLL) coatings are commonly used to stabilize alginate capsules and 
provide a barrier to immune system components such as IgG in cell encapsulation 
applications (Kulseng, Thu et al. 1997; Gugerli, Cantana et al. 2002).  Unfortunately, 
there is evidence that the PLL coating itself may be toxic to encapsulated cells and cause 
an unfavorable foreign body response (King, Sandler et al. 2001; Strand, Ryan et al. 
2001; Rokstad, Holtan et al. 2002; King, Lau et al. 2003).  Additionally, claims that PLL 
coatings improve alginate mechanical stability have been based on in vitro findings.  
PLL-coated alginate capsules seeded with proliferative cells remained intact for longer 
periods of time compared to non-coated capsules in culture (Benson, Papas et al. 1997; 
Rokstad, Holtan et al. 2002).  Given the potential toxicity of PLL on encapsulated cells, 
these results may be confounded by a slight reduction in cell proliferation, which could in 
turn result in more stable capsules. While quantitative testing has revealed that increased 
PLL membrane thickness corresponds with more mechanically stable non-seeded 
capsules in vitro, quantitative in vivo mechanical testing has not been reported in the 
literature (Gugerli, Cantana et al. 2002).  Given that polycation coatings remain 
controversial after 25 years of research due to questionable biocompatibility, and that 
quantitative in vivo material testing data is lacking, there is a clear need to explore the in 
vivo biocompatibility and stability of PLL-coated alginate in comparison to uncoated 
alginate (Orive, Hernandez et al. 2003). 
 
In the current study, we investigated alginate disks cross-linked with CaCl2 or CaCO3 and 
measured each of the following parameters over time: (1) weight changes, (2) complex 
modulus, (3) loss angle, and (4) biological response to the subcutaneously implanted 
                                                                       71
disks.  Additionally, we investigated the effects of PLL coatings on CaCl2 cross-linked 
alginate disks on these same four parameters.  The goal of this paper was to identify 
stability and biocompatibility differences in diffusion gelled and in situ gelled alginate 
samples and evaluate the necessity of PLL coatings for enhanced stability.  Specifically, 
we wanted to identify any advantages (biocompatibility or stability) of the specific 
gelation methods and hydrogel coating to guide future development of advanced neural 
interface technologies. 
Materials and Methods 
Alginate Hydrogel Preparation 
High G content sodium alginate (66% G acid) was acquired from Novamatrix (Pronova 
UP LVG, Drammen, Norway).  Non-coated hydrogels were prepared as previously 
described but with sterilized chemical components (Nunamaker, Otto et al. in 
submission; Nunamaker, Otto et al. in submission).  Briefly, 1.95 wt% 43 mPas alginate 
was cross-linked following one of the reaction schemes outlined in Figure 3.1.  The 
gelation method and volume of the resulting hydrogels for each specific experiment is 
outlined in Table 3.1.  Rheology hydrogels were created in a sterile 10 ml beaker: 2 ml 
alginate was reacted with (1) 100 mM CaCO3 (Sigma, St. Louis, MO) and 80 mM GDL 
(Sigma, St. Louis, MO) (final concentrations), or (2) 2 ml 200 mM CaCl2 (Sigma, St. 
Louis, MO) (Table 3.1).  Histology hydrogels were created in a single well of a sterile 24 
well tissue culture plate: 500 μl of alginate was reacted with (1) 100 mM CaCO3 and 80 
mM GDL (final concentrations), or (2) 500 μl 200 mM CaCl2 (Table 3.1).  Hydrogels 
created via in situ gelling (CaCO3) were well mixed before addition of GDL to ensure 
homogeneous distribution of cross-links throughout the gel.  Hydrogels created via 
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diffusion gelling (CaCl2) were cross-linked by slowly pipetting the CaCl2 solution onto 
the bolus of alginate.  All gels were allowed to fully cross-link under sterile conditions 










n per Time 
Point 
Histology 0.5 5 mg 7.1 No 6 CaCO3 
Rheology 2 20 mg 28.4 No 5 
Histology 0.5 0.5 mL; 200 
mM 
0 No 6 CaCl2 
Rheology 2 2 mL; 200 mM 0 No 5 
Histology 0.5 0.5 mL; 200 
mM 
0 Yes 6 CaCl2/PLL 
Rheology 2 2 mL; 200 mM 0 Yes 5  
Table 3.1. The gelation conditions for all hydrogels to be implanted subcutaneously and 
analyzed via rheology or histology. 
 
To test the effect of a PLL coating, CaCl2 hydrogels made for rheology and histology 
were additionally coated with poly-L-lysine (CaCl2/PLL) as described by Strand et al. 
(Table 3.1)(Strand, Gaserod et al. 2002).  Briefly, alginate disks were rinsed in 
physiological saline and incubated for 10 minutes in 0.1% PLL in saline.  PLL-HCl 
(15,000-30,000 MW) was obtained from Sigma (St. Louis, MO).  Disks were rinsed 
again in saline and incubated for 10 minutes in 0.1% alginate in saline.  Disks were rinsed 
a final time in saline prior to implantation.  To maintain similarity to PLL coated 
hydrogels, CaCl2 gels were also rinsed in saline several times prior to implantation. 
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Surgery 
Alginate hydrogel stability and biocompatibility were tested in 300 g Sprague Dawley 
rats (Charles River Laboratories, Wilmington, MA).  All procedures were approved by 
the University of Michigan Committee on Use and Care of Animals.  Anesthesia was 
administered using an intra-peritoneal injection of an anesthetic cocktail (comprised of 
Ketamine, Xylazine, and Acepromazine, each at concentrations of 100 mg/ml and a 
respective mixing ratio of 5:0.5:1) administered at 0.15 ml/100 g body weight.  Rats were 
indicated for rheology or histology before surgical implantation due to the size difference 
in the gels.  All hydrogels were implanted in separate subcutaneous pouches created on 
the abdomen and the skin was securely closed with surgical staples.   
 
Forty-eight rats were utilized in the rheology study, each receiving four hydrogels.  The 
hydrogel conditions (CaCO3, CaCl2, or CaCl2/PLL) were chosen at random for each 
animal, but no animal received more than 2 gels of the same condition.  At the time of 
hydrogel recovery, the rats were deeply anesthetized with anesthetic cocktail (0.3 ml/100 
g body weight) and then euthanized with a cardiac injection of 1 ml Fatal-Plus® 
(Pentobarbital 390 mg/ml, Vortech Pharmaceutical, Dearborn, MI).  Five hydrogels per 
condition were recovered at each time point (1, 3, 5, 7, 14, 21, and 90 days) by removing 
the hydrogel from the subcutaneous pouch.  All hydrogels were weighed and rheological 
measurements taken immediately following explantation. 
 
Twelve rats were utilized in the histology study.  Each rat was implanted with 2 gels per 
condition for all conditions (CaCO3, CaCl2, and CaCl2/PLL), resulting in a total of 6 
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implants per animal.  At each predetermined time point (7, 14, 21, and 90 days), the 
hydrogels were recovered from 3 rats per time point to evaluate the biological response to 
the implants.  Rats were euthanized in the same manner as described for the rheology 
study.  The tissue and alginate disk were explanted en bloc and treated with Bouin’s 
Fixative for 24 hours. 
Disk Weight Change 
To determine the swelling/shrinking behavior of the hydrogels, all gels indicated for 
rheology were weighed prior to implantation.  Immediately upon explantation, all gels 
were weighed again to determine an increase or decrease in disk weight.  The average 
weight difference and standard error were calculated for each hydrogel condition 
(CaCO3, CaCl2, and CaCl2/PLL) and time point (1, 3, 5, 7, 14, 21, and 90 days). 
Rheology: Complex Modulus and Loss Angle 
The viscoelastic behavior of the hydrogels was tested with a parallel plate rheometer (AR 
550, TA Instruments, New Castle, DE) using a 25 mm plate at 37 ˚C.  The alginate 
samples were compressed to 10% and subjected to a 1% strain across a frequency sweep 
of 1 to 100 rad/s at each level.  Sandpaper (150-grit) was placed on the plate surfaces to 
minimize the occurrence of slip at the plate/sample interface.  The storage (G') and loss 
moduli (G") were calculated by the rheometer and recorded for further analysis. 
The complex modulus (G*), which represents the frequency-dependent stiffness of the 
hydrogel, and loss angle, δ, which provides a relative measure of viscous effects to elastic 
effects in a material, were calculated as previously described (Nunamaker, Otto et al. in 
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submission).  Low values of δ indicate minimal internal damping, a result of energy 
dissipation and internal friction in deformation cycles due to internal entanglements and 
cross-link density (δ = 0˚, elastic solid; δ = 90˚, Newtonian viscous fluid) (LeRoux, 
Guilak et al. 1999).  The response of alginate to shear is a good indicator of the fatigue 
resistance and how it will perform in vivo.  Brain tissue typically exhibits a complex 
modulus ranging from 1 to 24 kPa and alginate is expected to remain in this range 
(Donnelly and Medige 1997).  For application in or on the brain, the frequency range of 1 
Hz – 5 Hz was chosen, as this represents the heart rate frequency range of humans and 
rats and therefore the highest oscillation rate the gels would be exposed to in vivo.  
Average G* and δ and the respective standard errors at 1 Hz and 5 Hz were calculated. 
Histology 
Tissue samples were dehydrated in a graded series of ethanol washes (10-70 %), 
embedded in paraffin, and sectioned with a microtome.  Two 8 µm-thick sections per 
implant were each stained with hematoxylin and eosin (H&E) or Masson's trichrome 
(MT) based on previous reports (Kyriakides, Leach et al. 1999; Kang, Kang et al. 2005).  
H&E-stained sections were used to detect the presence of inflammatory response cells.   
 
MT-stained sections were used to assess the degree of cell infiltration surrounding the 
implant on a qualitative scale (0-4), and to quantitatively evaluate the thickness of the 
encapsulating collagen layer as described (King, Sandler et al. 2001; Bos, Hennink et al. 
2005; Kang, Kang et al. 2005).  The scoring levels indicated increasing levels of 
infiltration: (0) no cells present on the surface of the alginate; (1) less than 50% of the 
surface area of alginate covered by cellular attachment indicating minor infiltration; (2) 
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greater than 50% of the surface area of alginate covered by cellular attachment indicating 
moderate infiltration; (3) 100% of the surface area of alginate covered by cellular 
attachment indicated severe infiltration.  Due to the amount of variation seen in both of 
these measurements, infiltration scores were taken from 10 separate hydrogel fragments 
in different regions of the same tissue section.  Similarly, collagen thickness was 
measured around 10 separate hydrogel fragments by taking 8 equally spaced 
measurements around each fragment.  The repeated measures for each parameter (cell 
infiltration and encapsulation thickness) for a given tissue section were averaged, 
resulting in one infiltration score and one encapsulation thickness per section.  For each 
parameter the results for a condition then were combined to calculate the average and 
standard error for each condition (7, 14, 21 and 90 days for CaCO3, CaCl2, and 
CaCl2/PLL). 
Statistics 
All results were analyzed for normality and subsequently analyzed by the appropriate 
ANOVA (parametric or non-parametric).  When indicated, the appropriate post-hoc test 
was utilized to determine significant differences in the data.  The statistical test used in 
each situation is reported with the results for each section of the study. 
Results 
Disk Weight Change 
Due to the nature of gelation and coating of the hydrogels, the gels had significantly 
different initial weights (Dunn’s comparison test).  CaCO3 reacted alginate was 
significantly heavier than CaCl2 or CaCl2/PLL reacted alginate (p < 0.001, Figure 3.2A).  
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CaCl2/PLL hydrogels were also significantly heavier than CaCl2 reacted alginate (p < 
0.001, Figure 3.2A) due to the PLL coating of the hydrogel.   
 
Hydrogel weights varied with duration of implant (Figure 3.2B).  CaCO3 reacted 
hydrogels trended towards a continual decrease in weight over the entire time course (p < 
0.001, Kruskal-Wallis ANOVA).  CaCl2 and CaCl2/PLL gels both decreased in weight on 
day 1, but subsequently demonstrated a significant weight gain up to day 7 before 
significantly decreasing in weight for the remainder of the implant duration (p < 0.005, 
Kruskal-Wallis ANOVA).  Both CaCO3 and CaCl2/PLL hydrogels decreased 
approximately 30% in weight by day 90, but CaCl2 only decreased 17%. 
 
Figure 3.2. Differences in hydrogel weight.  A.  On day 0, the alginate’s weights were 
significantly different for each condition.  CaCO3 reacted gels were the heaviest initially 
(p < 0.001).  CaCl2/PLL hydrogel were significantly heavier than CaCl2 reacted gels on 
day 0 (p < 0.001).  B.  Hydrogel weight changes with time.  All of the hydrogels 
decreased in weight on day 1; however, the weights of the CaCl2 and CaCl2/PLL 
hydrogels then increased until day 7.  After day 7, these gels begin to decrease in weight 
for the remainder of the time course.  CaCO3 hydrogels decreased in weight over the 
entire time course.  n = 5. 
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Rheology: Complex Modulus and Loss Angle 
G* varied with both experimental condition and time.  No significant difference in G* 
existed between experimental conditions initially (p = 0.099, ANOVA).  A large decrease 
(> 80%) in G* was determined for all experimental conditions for 1 day post implant (p < 
0.001, Figure 3.3A).  By day 3, G* was significantly greater for CaCO3 reacted alginate 
than CaCl2 or CaCl2/PLL.  This phenomena continued until day 7 (p < 0.01, Figure 
3.3A), after which no significant differences in G* existed between the hydrogels.  
CaCl2/PLL was significantly greater than CaCl2 on day 7 (p < 0.01).  When the G* data 
for the hydrogels were normalized to their initial (day 0) measurements, G* for CaCO3 
was significantly greater than CaCl2 or CaCl2/PLL for days 1-7 for both 1 Hz and 5 Hz (p 
< 0.01, Figure 3.3B and C) and CaCl2/PLL was significantly greater than CaCl2 on day 7 
(p < 0.01).  At day 14 and above, there was no significant difference in G* between the 3 
different conditions, but G* increased significantly for all experimental conditions (p < 
0.05). 
 
δ varied with experimental condition and time.  CaCO3 had a significantly lower δ than 
CaCl2 or CaCl2/PLL on days 0 and 1 (p < 0.001, ANOVA, Figure 3.3D).  All three 
conditions varied significantly with time (p < 0.001).  δ significantly decreased for all 
conditions up to 3 days post implant (p < 0.01) and then slowly increased up to day 90, 
significantly exceeding initial δ measurements by 2.5 times (p < 0.001).  When δ was 
normalized to the initial measurements for each condition, no difference was detected 
until day 3 (Figure 3.3E and F).  On day 3, CaCO3 was significantly greater than CaCl2 (p 
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< 0.01), and on day 5, CaCO3 was significantly greater than CaCl2 and CaCl2/PLL (p < 
0.01) at both 1 and 5 Hz.  There was no significant difference at any other time point. 
 
Figure 3.3. G* and δ changes over time at 10% compression.  A-C: G* changes over time 
at 1 and 5 Hz.  D-F: δ changes over time at 1 and 5 Hz.  A.  Raw data average G* for each 
time point at 1 Hz.  Initially, G* for CaCO3 was smaller than G* for either CaCl2 or 
CaCl2/PLL, but increased by day 7 to become significantly greater than both conditions 
(p < 0.01).  After day 14, G* increased for all conditions.  B.  Normalized G* averages for 
each condition over time at 1 Hz.  G* for CaCO3 was greater than CaCl2 and CaCl2/PLL 
for all time points except day 90.  C.  Normalized G* averages for each condition over 
time at 5 Hz.  G* for CaCO3 remained greater than CaCl2 and CaCl2/PLL for all time 
points except day 90.  D.  Raw data average δ for each time point at 1 Hz.  δ for CaCO3 
was lower than CaCl2 and CaCl2/PLL until day 5.  After day 14, δ increased for all 
conditions (p < 0.001).  E.  Normalized δ averages for each condition over time at 1 Hz.  
δ for all conditions decreased until day 3 and then increased to day 90.  F.  Normalized δ 
averages for each condition over time at 5 Hz.  δ changes were smaller at 5 Hz than 1 Hz 
and no significant increase was detected until day 90 for all conditions. n = 5.  
 
Histology 
In general, CaCO3 and PLL-coated implants were more intact than uncoated CaCl2 
implants at 7 days.  After day 14, all disks displayed increasing levels of hydrogel 
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fragmentation with collagen around each fragment, increasing the separation of the 
fragment from the main disk.  Macrophages were seen in the tissue around all disks at all 
of the time points (Figure 3.4).  After 21 and 90 days, fibrosis and granulation tissue were 





Figure 3.4. Inflammatory response to alginate over time.  Micrographs are at 400x 
magnification of HE stained sections.  The scale bar in C represents 50 μm in all 
micrographs.  A.  CaCl2/PLL samples 7 days post implantation. Fragmentation of the 
alginate (A, not all labeled) has already begun and many macrophages and lymphocytes 
were present in the tissue and around the alginate.  B.  CaCl2 reacted alginate, 14 days 
post implantation.  Fibroblasts had begun secreting collagen around the alginate 
fragments (A, not all labeled).  Macrophages were still present in the tissue (indicated by 
arrows).  C.  CaCO3 reacted alginate, 90 days post implantation.   A thick encapsulation 
layer was detectable around the alginate (A) filled with fibroblasts and new capillaries 




The encapsulation layer thickness varied with time (Figure 3.5).  Collagen encapsulation 
was low initially, then increased significantly at day 14 for CaCl2 and CaCl2/PLL 
implants and 21 days for CaCO3 hydrogels (p < 0.05, ANOVA).  Encapsulation thickness 
was in the range of 15-35 μm for all conditions at 14, 21, and 90 days post-implantation.  
CaCO3 gels had significantly thicker encapsulation than other conditions on day 21 (p < 
0.05) but no other significant differences were detected.   
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Figure 3.5. Collagen encapsulation thickness around alginate disks over time. 
Encapsulation thickness increased over time for all conditions (p < 0.05).   No difference 
existed between conditions except day 21; CaCO3 reacted alginate had a significantly 
thicker encapsulation layer than CaCl2/PLL or CaCl2 (p < 0.05, *).  n = 6.  
 
Cell infiltration of the alginate disks varied with time (Figure 3.6).  Cell infiltration was 
initially high (scores ranged from 0.9 - 1.5 on day 7), and then significantly decreased for 
all conditions (p < 0.05, ANOVA).  No significant differences in cell infiltration were 
detected between the conditions at any time point. 
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Figure 3.6: Cellular infiltration of alginate disks over time.  A.  Initially, cell infiltration 
approached moderate levels for all gel conditions (1 ≤ x ≤ 2), but decreased by day 14 
and stabilized at minor infiltration levels (x ≤ 1).  This decrease from day 7 was 
significant for all conditions (p < 0.05) and there was no significant difference between 
conditions at any time point, n = 6.  B.  A representative micrograph (CaCl2, 7 days post 
implant) illustrating the varied nature of the infiltration level in a single condition (A 
indicates alginate fragments).  The scale bar represents 200 μm. 
 
Discussion 
To gain insight into the destabilization of alginate for the development of advanced 
neural interface technologies, we investigated the stability and biological response to 
alginate in the rat subcutaneous implantation model.  The responses demonstrated in this 
experimental paradigm were expected to be representative of alginate degradation in 
neural interface applications, albeit a more rigorous test environment.  The effects due to 
in situ gelling versus diffusion gelling and use of a PLL coating were investigated.  While 
all samples’ complex moduli decreased 80% in the first day, the in situ gelled alginate 
was more stable for the first week of implant.  More significantly, the in situ gelled 
alginate was the only condition that remained within the biologically relevant G* range 
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over the entire 3 month period.  This indicates that there is an increased potential of 
mechanical failure for diffusion gelled alginate during the first week of implant, even in 
the presence of a PLL coating.  However, there were no differences in the histology that 
would clearly suggest the use of one gelation method over another.  Additionally, there 
appears to be no significant differences between the mechanical stability of the different 
hydrogels after the first week.  Based on these results, the use of in situ gelled alginate is 
more desirable than diffusion gelled alginate in neural interface applications that require 
high stability during the first week of implantation. 
 
In situ gelled alginate disks exhibited significantly different weight changes compared to 
diffusion gelled alginate disks.  Although all of the hydrogels exhibited a decrease in 
weight on the first day, indicating an exudation of liquid, CaCO3 continued to decrease in 
weight over all time points, indicative of hydrogel degradation over time (Bajpai and 
Sharma 2004).  Conversely, CaCl2 and CaCl2/PLL hydrogels increased in weight for the 
first week indicating swelling but then decreased in weight, exhibiting similar hydrogel 
degradation behavior as CaCO3 (Bajpai and Sharma 2004).   A larger weight change for 
CaCl2/PLL hydrogels than CaCl2 hydrogels after 3 months was also detected but is likely 
due to the loss of the PLL coating, which accounted for initial weight differences 
between the two experimental conditions.  The initial exudation of liquid explanation is 
supported by the measured decrease in δ for all of the conditions on day 1.  An exudation 
of liquid without hydrogel degradation would cause an increase in internal entanglements 
detected as a decrease in δ (LeRoux, Guilak et al. 1999).  This may also be responsible 
for the significant decrease in G* seen on day 1.  The movement of water out of the 
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hydrogel could have changed the underlying structure of the hydrogel enough to cause 
the observed decrease in G*.  Based on these observations, the authors hypothesize that 
the exudation of liquid from the alginate matrix initially causes the hydrogel to lose 
stability due to a loss of hydrogen bonding within the matrix and a loss of surface tension 
on the surfaces of the hydrogel.   
 
Alginate degradation over time was not evident in all of the experimental outcomes.  The 
weight change stabilized for all of the experimental conditions between days 21 and 90.  
Over these same time points, G* increased, indicating increasing hydrogel stiffness with 
time.  However, this weight stabilization and increase in G* was accompanied by a 
significant increase in δ indicating degradation of the hydrogel structure.  The lack of 
agreement between the data can be explained by the replacement of the degrading 
alginate with fibroblasts and collagen.  The formation of granulation tissue amid the 
remaining degrading alginate fragments between these two time points contributed to the 
observed weight stabilization, increased G*, and decreased δ for all hydrogel conditions. 
 
Alginate disk fragmentation was an unexpected phenomenon demonstrated by all of the 
experimental conditions.  The fractionation of the implants increased with sequential time 
points, making mechanical testing increasingly more difficult.  All of the alginate pieces 
collected for a given disk sample were used together for these studies.  The authors 
hypothesize that the fragmentation was due to the combination of destabilization of 
calcium cross-links by phosphates in the extracellular fluid and phagocytosis of alginate 
fibers by macrophages.   
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Due to the pulsation of the brain with heart rate and respiratory rate, the alginate will be 
subject to oscillatory strain in vivo.  The response of alginate to shear is a good indicator 
of the fatigue resistance and how it will perform in vivo.  Brain tissue typically exhibits a 
complex modulus ranging from 1 to 24 kPa (Donnelly and Medige 1997).  It is necessary 
for alginate to remain in this range to avoid fatigue when used in the central nervous 
system.  CaCO3 reacted alginate disks all remained in this range for all time points, 
indicating sufficient long-term stability.  CaCl2 hydrogels fell below this range on days 3, 
5, 7 and CaCl2/PLL hydrogels on days 3 and 5 indicating material fatigue.  This is can be 
attributed to the swelling demonstrated by the hydrogels over this timeframe, which 
disrupted the hydrogels’ underlying chemical interactions and structure (Wang and 
Spencer 1998; Kong, Alsberg et al. 2004).  Previously, Strand et al. determined that PLL 
coated alginate caused a fibrotic reaction more quickly than alginate alone (Strand, Ryan 
et al. 2001).  Although a similar effect was not detected in the current study, it is possible 
that low level fibrosis was responsible for the increase in G* over uncoated CaCl2 gels on 
day 7.  Based on these results, diffusion gelled alginate hydrogels have potential to 
mechanically fail during the first week of implant when used as a neural interface 
material.   
 
Cellular infiltration for the alginate disks was due to the large pore size and phagocytosis 
of the surface alginate fragments.  Although alginate is inherently non-sticky and cells are 
not likely to adhere to the alginate, they are able to treat it as a foreign body.  The pore 
size of gelled, high guluronic acid content alginate is relatively large, 200 – 400 nm 
(Veluraja and Atkins 1989).  This is sufficient to allow phosphate molecules to diffuse 
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into the matrix, thereby destabilizing the ionic interactions that hold the hydrogel 
together.  Additionally, the individual strands of alginate have been measured at 13-26 
nm (Veluraja and Atkins 1989), small enough for macrophages to begin sequestering 
portions of the destabilized strands.  This combination of destabilization and 
phagocytosis is responsible for the early cellular infiltration detected histologically.   
 
The results indicate that in situ gelled alginate is more stable in vivo than diffusion gelled 
alginate during the first week of implantation.  Based on initial hydrogel weights alone, 
diffusion gelled hydrogels would have been hypothesized to have a higher cross-link 
density and improved stability.  The significantly lower weight of CaCl2 reacted 
hydrogels compared to CaCO3 reacted hydrogels potentially indicated a lower level of 
water retention in the hydrogel matrix.  This was hypothesized to contribute to improved 
long term stability of the hydrogels but this is not what was found in the current study.  
CaCO3 reacted alginate hydrogels had a significantly higher G* and a significantly 
smaller decrease in G* over the first 7 days (p < 0.01).  CaCO3 reacted gels additionally 
exhibited significantly lower δ measurements initially, indicating a denser distribution of 
cross-links and entanglements which possibly contributed to the improved stability in 
vivo.  Previously, Kong et al. indicated that high G alginate was more stable than high M 
alginate due to the cross-link density of the high G alginate (Kong, Alsberg et al. 2004).  
The high cross-link density allowed the hydrogel to maintain a small pore size and resist 
tissue growth and replacement of the alginate scaffold used in that study (Kong, Alsberg 
et al. 2004).  This explanation of cross-link density contributing to stability is applicable 
to the enhanced stability seen with CaCO3 gels over CaCl2 gels in the current study.  
                                                                       87
Additionally, in situ gelled alginate did not swell like diffusion gelled alginate, thereby 
minimizing the influx of chemical species that disrupt the ionic interaction of Ca2+ with 
the alginate carboxylic acid residues (Kong, Alsberg et al. 2004).  These mechanisms 
worked together, maintaining the G* of in situ gelled alginate hydrogels within the 
biologically relevant range for advanced neural interface technologies (1 – 24 kPa).  
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CHAPTER 4 
NEURAL STEM CELL-SEEDING MITIGATES THE EARLY TISSUE 
RESPONSE TO NEURAL PROSTHESES 
 
Abstract 
Neural prosthetics capable of recording or stimulating neuronal activity may restore 
function for patients with motor and sensory deficits resulting from injury or degenerative 
disease.  However, inconsistent recording quality and stability in chronic applications 
remains a significant challenge.  A likely reason for this is the reactive tissue response to 
the devices following implantation into the brain, which is characterized by neuronal loss 
and glial encapsulation.  We have developed a neural stem cell-seeded probe to facilitate 
integration of a synthetic prosthesis with the surrounding brain tissue.  We fabricated 
parylene devices that include an open well seeded with neural stem cells encapsulated in 
an alginate hydrogel scaffold.  Quantitative and qualitative data showing the distribution 
of neuronal, glial, and progenitor cells surrounding seeded and control devices is reported 
over four time points spanning three months.  Neuronal loss and glial encapsulation were 
mitigated by cell seeding during the initial week of implantation, and exacerbated after 
six weeks post-insertion.  We hypothesize that graft cells secrete neuroprotective and 
neurotrophic factors that effect the desired healing response early in the study, with 
subsequent cell death and scaffold degradation accounting for a reversal of these results 
later.   Applications of this biohybrid technology include neural recording and sensing 
studies in research settings, and relevance in a clinical setting is a future possibility.
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Introduction 
Neuroprosthetic devices have the capacity to record signals from a patient’s uninjured 
cortex.  These signals may then be used to place an exterior assistive device under the 
patient’s control, thus restoring function while circumventing nervous tissue that has been 
damaged by injury or disease (Schwartz, Cui et al. 2006; Donoghue, Nurmikko et al. 
2007; Fitzsimmons, Drake et al. 2007).  In the last decade, monkeys were shown to be 
able to successfully control a cursor on a computer screen or a robotic arm using 
voluntary cortical signals (Taylor, Tillery et al. 2002; Carmena, Lebedev et al. 2003).  
Recent work has demonstrated these feats by tetraplegic humans implanted years after 
injury (Hochberg, Serruya et al. 2006; Donoghue, Nurmikko et al. 2007).  Further, a 
recent study has demonstrated cortical control of a complex, multi-jointed robotic arm 
with a “hand” gripper by monkeys during a self-feeding task (Velliste, Perel et al. 2008). 
Thus, neuroprostheses have the potential to restore some level of function to the 200,000 
patients currently suffering from full or partial paralysis in the U.S. (Polikov, Tresco et al. 
2005).   
 
While such results are encouraging, these devices are currently plagued by inconsistent 
performance in terms of recording longevity and stability (Rousche and Normann 1998; 
Liu, McCreery et al. 1999; Williams, Rennaker et al. 1999; Nicolelis, Dimitrov et al. 
2003; Polikov, Tresco et al. 2005; Liu, McCreery et al. 2006; Schwartz, Cui et al. 2006).  
In order for neuroprostheses to be useful in research and clinical settings, stable, long-
term recordings from large populations of neurons in multiple brain areas must be 
reliably and reproducibly achieved (Lebedev and Nicolelis 2006).   Following 
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implantation into the brain, a reactive tissue response occurs to the prostheses, which is 
believed to be a major contributing factor to their inconsistent performance.  An 
encapsulation layer composed of microglia and astrocytes isolates the device from the 
surrounding tissue, and neuronal density within the effective recording radius of the 
probe is reduced (Edell, Toi et al. 1992; Turner, Shain et al. 1999; Szarowski, Andersen 
et al. 2003; Kim, Hitchcock et al. 2004; Biran, Martin et al. 2005; Polikov, Tresco et al. 
2005).  The glial sheath creates a diffusion barrier to the transmission of ions through the 
extracellular space which may affect recording quality (Roitbak and Sykova 1999).  
Additionally, impedance magnitude at 1 kHz (the fundamental frequency of the neuronal 
action potential) increases at recording sites with “extensive” glial reactivity (Williams, 
Hippensteel et al. 2007).  While the relationship between recording quality and neuronal 
density has yet to be defined, it is reasonable to believe that neuronal loss would result in 
a reduction of signal quality.  The reported 40% loss of neuronal density within 100 
microns of the device surface in the first month after implantation is particularly 
concerning, given that this region produces the large amplitude, reliably separated spikes 
useful for neural prostheses (Henze, Borhegyi et al. 2000; Biran, Martin et al. 2005).     
 
The tissue response to implanted prostheses is a characteristic reaction to central nervous 
system (CNS) damage (Silver and Miller 2004).  Stem and progenitor cell therapy have 
shown promise as one approach to repair CNS injury, where mechanisms may include 
cell replacement and reinnervation, or a bystander effect, where the transplanted cells 
support host tissue by secreting therapeutic factors, correcting a biochemical deficit or 
inhibiting cytotoxic injury processes (Teng, Lavik et al. 2002; Lindvall, Kokaia et al. 
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2004; Pluchino, Zanotti et al. 2005; Gaillard, Prestoz et al. 2007).  In support of the 
“bystander” or “chaperone” effect, several studies suggest that undifferentiated neural 
stem cells have an innate ability to promote healing and axonal regeneration of host 
neurons as well as a reduction in glial scar formation (Ourednik, Ourednik et al. 2002; 
Teng, Lavik et al. 2002; Lu, Jones et al. 2003; Heine, Conant et al. 2004; Llado, 
Haenggeli et al. 2004; Pluchino, Zanotti et al. 2005). This is believed to be due to 
constitutive secretion of multiple neurotrophic factors (Ourednik, Ourednik et al. 2002; 
Teng, Lavik et al. 2002; Lu, Jones et al. 2003; Llado, Haenggeli et al. 2004), as well as 
the degrading of molecules which are inhibitory to axonal growth (Heine, Conant et al. 
2004).  Additionally, the ability of undifferentiated neural precursor cells to protect 
injured CNS tissue by displaying neuroprotective immune functions has been reported 
(Pluchino, Zanotti et al. 2005).   
 
We have developed a neural stem cell (NSC)-seeded biohybrid probe hypothesized to 
improve device integration with brain tissue, and the tissue response to the probes in vivo 
in rats was evaluated over a three month time period.  The parylene devices contain a 
hollow well containing an NSC-seeded alginate hydrogel scaffold.  Alginate is a 
biocompatible polysaccharide polymer which forms a hydrogel following cross-linking 
with divalent cations such as calcium.  This material is commonly used to encapsulate 
secretory cells, localize them to an implant site, and provide an immuno-isolating barrier 
between the engrafted cells and the host tissue (Orive, Hernandez et al. 2003).  We have 
previously demonstrated the release of neurotrophic and neuroprotective factors from 
NSCs encapsulated in alginate (Purcell, Singh et al. 2008).   Here, we show that 
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combining a cortical prosthesis with this scaffold diminishes the early tissue response and 
facilitates initial integration of the device with the surrounding brain tissue. Cell-seeding 
increases neuronal loss and glial encapsulation after six weeks, presumably due to a loss 
of graft cell viability and scaffold integrity.   
 




The probes were microfabricated in the Lurie Nanofabrication Facility using methods 
previously described, and the process is illustrated in Figure 4.1 (Seymour and Kipke 
2007). Briefly, a sacrificial release layer of SiO2 was grown on a Si wafer. Parylene-C 
(Specialty Coating, Indianapolis, IN) was deposited (5-microns thick) via chemical vapor 
deposition. SU-8 2025 (Microchem, Newton, MA) was spincoated and patterned to create 
the core of each tine.  Parylene was etched using oxygen plasma RIE. Probes were 
released using hydrofluoric acid and then thoroughly rinsed in acetone, ethanol and DI 
water.  Final dimensions of the probe were 2.6 mm long, 200 microns wide and 40 
microns thick.  An opening through the thickness of the device measuring 100 microns 
across and 2.1 mm in length was designed to carry scaffold material (Figures 4.1, 4.3a).  
Support arms to this feature had square cross-sections measuring 40 microns on each 
side.   
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Figure 4.1.  Cross-sectional view of wafer level fabrication. (a) Parylene deposited on 
SiO2 sacrificial layer. SU-8 patterned shank. (b) Parylene encapsulated SU-8 structure. 
(c) 9260 resist patterned to form thick mask over shank. (d) Etched and released final 




Cell Culture and Probe Scaffolding 
 
E14 murine cortical neural stem cells (NSCs) were obtained from StemCell Technologies 
(Vancouver, BC), cultured as neurospheres and expanded with 20 ng/mL epidermal 
growth factor (EGF) according to the supplier’s protocol.  The culture and stem cell 
characteristics of these cells have been described (Reynolds and Weiss 1992; Reynolds 
and Weiss 1996).  The cells are a heterogeneous mixture of stem and progenitor cells 
(Reynolds and Weiss 1996).  Probe scaffolding was achieved by mixing a cell slurry with 
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alginate 50:50, rapidly dip-coating the probe in the mixture, and cross-linking with a 0.1 
M calcium chloride solution.  The alginate was highly purified with 68% guluronic acid 
content and MW = 219,0000 g/mol from NovaMatrix (Drammen, Norway).  This 
composition was chosen based on a previous study (Purcell, Singh et al. 2008).  Probes 
had a final concentration of 10,000,000 cells/mL in 1% w/v alginate, resulting in 
approximately 100 cells in the microscale probe well.  Non-seeded probes were treated 
identically to NSC-seeded probes, with the exceptions that cells and/or alginate were 
omitted from the coating procedure.  
 
Probe Implantation 
Sixteen male Sprague Dawley rats (300–350 g) were each implanted with four untethered 
probes (two containing NSC-seeded alginate, one with alginate only, and one untreated 
probe) using a surgical procedure similar to those previously reported (Vetter, Williams 
et al. 2004; Seymour and Kipke 2007). Anesthesia was achieved via a ketamine cocktail.  
A 3x3 mm craniotomy was centered over the somatosensory cortex (-2.0 mm AP, +/- 4.0 
mm ML from Bregma) in each hemisphere.  Dura was resected and two probes (one 
seeded, one unseeded) were manually inserted in each craniotomy with an approximate 2 
mm span between them.  Calcium alginate was used for duraplasty followed by surgical 
closure with silicone and dental acrylic.  No immunosuppressive treatments were used.  
All procedures strictly complied with the United States Department of Agriculture 
guidelines for the care and use of laboratory animals and were approved by the 
University of Michigan Animal Care and Use Committee. 
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Histology and Quantitative Analysis 
After implantation, animals were deeply anesthetized and transcardially perfused with 
4% paraformaldehyde at the appropriate time point (1 day, 1 week, 6 weeks, or 3 months, 
n=4 animals per time point).  Brain tissue was explanted, postfixed overnight in 4% 
paraformaldehyde, and cryoembedded following sucrose protection.  Probes were left in 
situ for histology.  Serial 12 micron thick sections along the shank of the probes were 
collected, and eight tissue sections between cortical layers II and V were randomly 
selected and immunostained for NeuN (1:100, Millipore Corporation, Billerica, MA) and 
Neurofilament (1:1000, Novus Biologicals, Littleton,CO) and counterstained with 
Hoechst (1 µg/mL, Invitrogen Corporation, Carlsbad, CA) for quantitative analysis of 
tissue response.  Six sections were stained with Ox-42 (1:100, Serotec, Oxford, UK), glial 
fibrillary acidic protein (GFAP, 1:100), and Hoechst (1 µg/mL) to assess glial 
encapsulation qualitatively.  Six sections per probe were stained for nestin (1:100, 
StemCell Technologies, Vancouver, BC), GFAP (1:100, Sigma, St. Louis, MO), and M2 
(1:10, Iowa Hybridoma Bank, Iowa City, Iowa) for identification of murine-derived 
NSCs and possible differentiation status.  Six additional sections were stained with 
neuronal class III β-tubulin (TUJ-1) antibody (1:500, StemCell Technologies, Vancouver, 
BC), NG-2 (1:500, Millipore Corporation, Billerica, MA)  and M2 (1:10, Iowa 
Hybridoma Bank, Iowa City, Iowa) to identify neuronal and oligodendrocyte precursors 
respectively.  Six sections per probe were stained for doublecortin (1:1000, Abcam, 
Cambridge, UK) and M2, and counterstained with Hoechst.  Where positive M2 staining 
was observed, a total of twelve sections were stained with nestin and GFAP and analyzed 
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for a quantification of the expression of these markers as an indication of differentiation 
status; approximately 60 cells in each of two animals were counted.  
 
The immunohistochemistry procedure has been described (Cowell, Plane et al. 2003).  
Briefly, sections were hydrated in buffer (PBS or TBS), blocked with 10% normal goat 
serum, and incubated overnight with primary antibodies at 4˚C.  Sections were then 
rinsed, incubated in the appropriate secondary antibodies (1:200 Alexa-350, 488, and/or 
568, Invitrogen), counterstained with Hoechst, and coverslipped with ProLong Gold 
(Invitrogen).  Antibody solutions included 0.3% triton X-100 and 5% normal goat serum.  
Buffer was used in place of primary antibody for controls.  Confocal images were 
collected with an Olympus FV500 microscope with a 20X or 40X objective.   
 
A MatLAB graphical user interface was developed in-house to facilitate cell counting, 
and this method has been described previously (Seymour and Kipke 2007). An outline of 
the exterior edge of the probe cross-section was delineated using a differential 
interference contrast (DIC) and UV fluorescence image.  A blinded technician selected 
all nuclei as either neuronal (NeuN+, Hoechst+) or nonneuronal (Hoechst+ only) within a 
software-defined 175 micron radius of the probe surface. A representative image after 
cell counting and the resulting histograms are illustrated in Figure 4.2.  Four optical 
images (3 mm step size) in each of eight physical sections per probe were analyzed.  The 
software algorithm used the coordinates of the user-selected nuclei to calculate the 
shortest distance to the probe surface, bin the counts by distance, and calculate the 
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sampling area of each bin to result in neuronal and non-neuronal densities as a function 
of distance from the probe. 
 
Figure 4.2.   Neuronal (NeuN+ in green, Hoechst+ in blue) and non-neuronal (NeuN-, 
Hoechst+) nuclei counted by a blinded observer (a), and the resulting output (b).  A 
MatLAB interface calculated the counting boundary (closed arrow) based on the user-
defined probe surface boundary (open arrow, shaded area), and a blinded observer 
manually selected neuronal and non-neuronal nuclei within this region (shown in yellow 
and red, respectively).  The algorithm stored the location of each nucleus relative to the 
probe surface, binned counts in 25 micron increments, and normalized counts to cells per 
pixel in each bin (b).  This number was converted to cells per square millimeter for data 




For neuronal and non-neuronal density, eight sections were analyzed for each of four 
probes per animal, with four animals evaluated for each of four time points.  Data was 
binned into seven 25-micron distance bins from the probe surface; a total of 2,688 
individual data points for both neuronal and non-neuronal densities were used to generate 
the statistical models. 
 
A linear mixed effects model was used to evaluate the responses of neuronal density and 
nonneuronal density due the clustering of multiple probe evaluations within each animal.  
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The fixed effects were the probe condition, distance, and time. The random effect was the 
animal subject.  Analysis was performed using the statistical package SPSS (Chicago, 
IL).  Results were assessed by Fisher’s Least Significant Difference method and termed 
statistically significant at the p=0.05 level.   
 
A univariate general linear model was used to assess the correlative relationship between 
neuronal density and non-neuronal density.  Common correlation methods (such as 
Pearson’s correlation) were not used as these techniques do not take in to account the 
fixed and random effects of the data, and may yield an inflated correlation coefficient.  
The fixed effects were the probe condition, distance, and time. The random effect was the 
animal subject.  Non-neuronal density was defined as a covariate in order to assess it as a 
predictor of neuronal density.     
 
Results and Discussion 
Probe Design and In Vivo NSC Detection  
Parylene devices were successfully designed and fabricated containing a hollow well for 
scaffold retention (Arrow, Figure 4.3a-b).  Immunohistochemistry for the murine-specific 
marker M2 allowed for the in vivo detection of cortical neural stem cells derived from 
embryonic mice based on a previous report (Teng, Lavik et al. 2002).  Alginate and 
parylene autofluoresced in green and blue respectively, enabling visualization of these 
structures (Figure 4.3c-e).  Neural stem cells were detected at the 1 day time point in 
vivo, and mainly expressed a combination of nestin and GFAP, with limited doublecortin 
(DCX, typically indicative of neuronal precursors) expression also observed (Figure 4.3c-
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e).  Approximately 44% of M2-positive cells were associated with nestin, 5.5% expressed 
GFAP, and 36% displayed both of these markers, indicating undifferentiated cells, 
astrocytes, and glial progenitors (or, reactive astrocytes) respectively (Messam, Hou et al. 
2000).  There was no evidence of TUJ-1 or NG-2 positivity.   The markers observed were 
similar to those reported in the literature, where the majority of neural stem and 
progenitor cells express nestin and GFAP, and neuronal and oligodendrocyte markers are 
observed far less frequently (Reynolds and Weiss 1996; Ourednik, Ourednik et al. 2002; 
Teng, Lavik et al. 2002).  The somewhat limited detection of NSCs and identification of 
 
Figure 4.3.  A neural stem cell-seeded probe (a) and associated dimensions (b).  Cells are 
Hoechst-stained and nuclei appear fluorescent blue (a).  Cross-section views of neural 
stem cell-seeded probes 1 day following implantation from two animals (c-e).  The 
companion brightfield DIC image for (c) is shown in (d) for reference due to 
autofluorescence of the parylene probe.  Graft cells (M2-labeled) were associated with 
nestin (c), GFAP (c),  and doublecortin (DCX, e) expression.  Alginate also 
autofluoresces green.  Scale = 50 microns for (c)-(e). 
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their differentiation status in vivo is likely due to the relatively small number of cells 
initially present in the microscale device and the reportedly large loss (>90%) in 
progenitor graft cell viability within the initial days following implantation (Sortwell, 
Pitzer et al. 2000; Bakshi, Keck et al. 2005).   
 
Scaffold Condition Effects on Neuronal and Non-Neuronal Densities  
Quantitative and qualitative analysis of neuronal and non-neuronal densities within the 
first 175 microns of the probes revealed the degree of injury around the implants as a 
function of scaffold condition, time, and distance from the probe surface (Figures 4.4-6).   
Neural stem cell-seeded probes had a higher surrounding neuronal density compared to 
untreated probes at one day post-implantation (Figure 4.4a, p=0.023; mean NSC 
ND=585, mean probe ND=555 cells/mm2).  Neuronal density was increased around NSC 
probes compared to both control conditions at the one week time point (Figure 4.4a, 
p≤0.002; mean NSC ND=911, mean alginate ND=813, mean probe ND=819 cells/mm2).  
The experimental probes had reduced non-neuronal encapsulation compared to alginate-
only probes at one day and untreated probes at one week after insertion (Figure 4.4b, 
p≤0.001; 1 day means:  NSC NND=925, alginate NND=1047; 1 week means:  NSC 
NND=1612, probe NND=1778 cells/mm2).  The mitigation of the early tissue response is 
likely due to an initial bystander effect of the NSCs.  The increased neuronal density 
surrounding seeded probes may result from the secretion of multiple neuroprotective 
factors by the grafted cells, both known and yet to be elucidated.  We have previously 
demonstrated the release of brain derived neurotrophic factor (BDNF), glial derived  
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Figure 4.4.  Mean neuronal density (a) and non-neuronal density (b) surrounding implants 
over time as a function of distance from the probe surface (± s.e.m).  Neural stem cell-
seeded probes had a higher neuronal density surrounding them compared to untreated 
probes at one day and both control conditions at one week post-implant (a, p<0.05).  
Cell-seeding reduced non-neuronal encapsulation compared to alginate-only probes at 
one day and untreated probes at one week post implant (p≤0.001).  At six weeks and 
three months post implantation, the neural stem cell-seeded probes had reduced neuronal 
density and increased non-neuronal density surrounding them in comparison to both 
control conditions (p<0.05).   
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neurotrophic factor (GDNF) and nerve growth factor (NGF) from alginate-encapsulated 
NSCs over a three week time period in vitro (Purcell, Singh et al. 2008).   These 
neurotrophic factors are known to support neuronal survival and plasticity in various 
models of axonopathy and neuropathy (Kolb, Gorny et al. 1997; Han and Holtzman 
2000; Nicole, Ali et al. 2001; Lu, Jones et al. 2003; Wilkins and Compston 2005).  The 
neuroprotective effect of medium conditioned by NSC-seeded alginate beads was further 
verified using a serum-withdrawal mediated cell death model in PC-12 cells (Purcell, 
Singh et al. 2008).  Alternatively, the increase in neuronal density could be due, in part, 
to the neuronal differentiation and integration of graft cells into the surrounding brain 
tissue.  However, no direct evidence of this phenomenon was seen in the 
immunohistochemistry results, and the degree of neuronal density increase is unlikely to 
be largely explained by the number of cells seeded onto the microscale implant.  The 
production of new neurons by endogenous stem cells originating in the host is an 
additional, and unexplored, possibility.  This also seems improbable as a primary cause of 
results, as neural stem cells originating in the subventricular zone have been shown to 
contribute primarily to astrogliosis, with neuronal differentiation rarely observed 
following migration to the site of cortical trauma (Salman, Ghosh et al. 2004).  However, 
it is worth noting that evidence of doublecortin positivity was observed in one graft 
(Figure 4.3e), as well as in host tissue one week after implantation (Supplementary 
Figure 4.1).  Doublecortin (DCX) is a microtubule-associated protein expressed primarily 
in migrating neuronal precursors, and reportedly may also be associated with mature 
astrocytes according to Verwer et al. (Francis, Koulakoff et al. 1999; Verwer, Sluiter et 
al. 2007).    Expression of DCX around neural implants has not been previously reported 
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in the literature, and may represent an additional target for future strategies to improve 
device-tissue integration if its presence indicates a regenerative capacity of the injured 
brain, the grafted cells, or a combination of both.   
 
At six weeks and three months post implantation, the neural stem cell-seeded probes had 
reduced neuronal density and increased non-neuronal encapsulation surrounding them in 
comparison to both control conditions (Figure 4.4, p≤0.049 for neuronal density at six 
weeks, p≤0.001 at three months, p<0.001 for non-neuronal density at both time points; 6 
week means (cells/mm2):   NSC ND=877, alginate ND=916, probe ND=978, NSC 
NND=1400, alginate NND=1141, probe NND=1247; 3 month means (cells/mm2):  NSC 
ND=843, alginate ND=953, probe ND=978, NSC NND=1185, alginate NND=1140, 
probe NND=1058).  This effect may be due to reduced NSC viability over time, which 
has been reported previously and may be aggravated by degradation of the alginate 
scaffold (Sortwell, Pitzer et al. 2000; Bakshi, Keck et al. 2005). Alginate stability drops 
markedly during the first 24 hours in vivo, and is prone to fragmentation over the 
following three months (Nunamaker, Purcell et al. 2007).  This may leave the grafted 
cells vulnerable to an immune reaction, and such a response may account for the 
exacerbation of the tissue response after six weeks.          
 
Alginate coating (without cell seeding) had no effect on neuronal density surrounding 
probes over the course of the study (Figure 4.4a).  However, alginate coating yielded 
mixed effects on non-neuronal density (Figure 4.4b).  One day after implantation, 
alginate coated probes had a significantly higher non-neuronal density than NSC-seeded 
and control probes (Figure 4.4b, p≤0.001).  This effect was especially pronounced within 
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the first fifty microns of the probe surface.  Interestingly, microglia appeared to have a 
ramified, or “surveilling”, morphology surrounding a neural stem cell-alginate probe 
initially, whereas activated cells with an amoeboid structure were found near an alginate 
probe in the same hemisphere of one animal (Figure 4.5).  An initial loss of calcium ions 
to the surrounding tissue, resulting in a potentially injurious hypertonic environment and 
activation of glia, could explain this.  Alginate with varying compositions has been 
shown to experience a dramatic loss in mechanical stability after one day of implantation, 
indicating a loss of calcium cross-links (Nunamaker, Purcell et al. 2007).  Interestingly, 
cell-seeded alginate does not exhibit this initial glial activation; the encapsulated cells 
may buffer the surrounding tissue from this effect (Figure 4.5).  Additionally, the total 
volume of alginate contained on the probe may be less in the cell-seeded condition.  One 
week after implantation, alginate probes reduce non-neuronal density in comparison to 
untreated probes, likely due to the non-adhesive nature of the gel (p<0.001) (Rowley, 
Madlambayan et al. 1999).  Alternatively, alginate may buffer the mechanical mismatch 
between the probe and surrounding brain tissue, and reduce glial encapsulation as a 
consequence.  By six weeks post-implantation, alginate and untreated probes have 
equivalent non-neuronal densities surrounding them.  The alginate scaffold is likely to 





























































































































































































                                                                       111
Neuronal and Non-Neuronal Densities as a Function of Distance  
Neuronal density increased as a function of distance from the probe, and non-neuronal 
density decreased reciprocally. Neuronal density was minimal in the first 25 microns of 
the probe, with significant incremental increases in the 25-50, 50-75, and 75-100 micron 
bins (Figure 4.4a, p<0.001).  Neuronal density stabilized thereafter, with similar 
neurofilament staining patterns across conditions.  The loss of neuronal soma within the 
first 100 microns of the probe is particularly concerning, considering that reliably sorted, 
large amplitude spikes are recorded when neurons are within 50 microns of recording 
sites, and no discernable signals are detected from cells greater than 140 microns from 
probes (Henze, Borhegyi et al. 2000).  There was a significant decrease in non-neuronal 
density as a function of distance from the probe surface (Figure 4.4b).  Non-neuronal 
density was highest in the 0-25 micron bin, and significantly decreased in the 25-50 
micron bin, followed by a further decrease in the 50-75 micron bin (p<0.001).  Non-
neuronal density stabilized thereafter.  Again, the greatest glial encapsulation of the 
device occurred in the region yielding the highest quality signals.  The observation that 
the tissue response is the most severe in the recordable region surrounding the probe 
indicates that this phenomenon may result in recording instability, and corroborates 
previous reports (Szarowski, Andersen et al. 2003; Kim, Hitchcock et al. 2004; Biran, 
Martin et al. 2005).  
 
The Correlation between Neuronal and Non-Neuronal Densities 
There was a significant negative correlation between neuronal and non-neuronal densities 
(Figure 4.4a-b, p<0.001).  This result expands upon previous work, which has 
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demonstrated an inverse relationship between microglial and neurofilament staining as a 
function of distance from implanted probes (Biran, Martin et al. 2005).  The most likely 
reason for this is the deleterious effects on neuronal viability and axonal outgrowth by the 
glial scar.  Reactive microglia involved in the injury response to probes are known to 
elute potentially neurotoxic inflammatory cytokines, and reactive astrocytes may produce 
proteoglycans inhibitory to axonal regeneration (Silver and Miller 2004; Biran, Martin et 
al. 2005).  Simple displacement of the neurons is unlikely to be the reason for the 
negative correlation between neuronal and non-neuronal densities, as neuronal density 
increased and then reached a plateau as a function of distance from the probe surface.  If 
there had been displacement, we would have expected a clustering of neurons (indicated 
by an increase in neuronal density) in the region adjacent to the glial sheath. 
 
Neuronal and Non-Neuronal Densities as a Function of Time  
There are general trends in the distribution of neurons and glial elements surrounding the 
devices as a function of time.  Neurofilament disruption indicative of axonal damage was 
evident immediately after implantation for all conditions and accompanied the dramatic 
loss of neuronal density within the first 100 microns of the probe surface (Figure 4.6; 
Figure 4.4a, p≤0.036) (Chen, Meaney et al. 1999).  This injury response appeared 
considerably improved one week after surgery, and neuronal density was significantly 
increased at this time (Figure 4.6; Figure 4.4a, p<0.01). Values stabilized thereafter.  
Non-neuronal density is lowest one day after transplantation, followed by a peak value of 
this metric one week after implantation (Figure 4.5; Figure 4.4b, p<0.05).  By six weeks, 
a thin glial sheath surrounded all probes, with non-neuronal densities progressively 
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decreasing through the three month time point (Figure 4.5; Figure 4.4b, p<0.001).  These 
results corroborate a qualitative study of the glial encapsulation of silicon probes 
(Szarowski, Andersen et al. 2003). Sustained glial activation and neuronal density loss 
within the first 100 microns surrounding the insertion site of silicon probes was reported 
in a study which quantified these responses after two and four weeks in vivo (Biran, 
Martin et al. 2005).  In these studies, the use of silicon probes necessitated the removal of 
the devices prior to tissue processing, potentially disrupting the interface.  Our results are 
in general agreement with these reports in the literature, and expand upon them as a 
quantitative data set studying an intact device-tissue interface over multiple time points 
spanning three months. 
 
Changes in neuronal density surrounding neural prostheses as a function of time have not 
been demonstrated previously in the literature.  The initially severe injury seen following 
insertion, followed by a return of neuronal soma near the probe at one week, corresponds 
well with the variation in recording quality observed with silicon probes; there is 
typically a loss and recovery of unit recordings generally corresponding to this time 
course (Ludwig, Uram et al. 2005).  However, recording quality often diminishes over 
subsequent weeks and months, which is not predicted by the general improvements in six 
week and three month neuronal and non-neuronal density data.  It may be that slight 
increases in neuronal density are negated by the compact glial sheath formed at later time 
points, which may impede ionic transfer to recording sites (Roitbak and Sykova 1999)  
Alternatively, the data raises the possibility of neuronal plasticity and the formation of  
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silent synapses as additional explanations for recording instability.  Henze et al. have 
reported detecting approximately six units per tetrode, despite estimations that 60-100 
neurons should have sufficient amplitude to be discernible above noise (Henze, Borhegyi 
et al. 2000).  Whether or not the neurons located within a recordable distance from 
electrodes are functionally normal or not is unknown.  Understanding not only changes in 
the structure, but also the function, of tissue surrounding the probes may enable 
additional intervention strategies to improve recording stability.              
 
Conclusions 
Our data show that neural stem cell-seeding attenuates the initial tissue response 
associated with the introduction of a foreign body into the brain.  Given the physical 
isolation of the graft cells from the surrounding tissue, in vitro data demonstrating the 
secretion of neuroprotective factors by the scaffold (Purcell, Singh et al. 2008), and 
evidence that the majority of cells express nestin initially in vivo, a bystander effect is the 
likely mechanism. Doublecortin-positive immature neurons were associated primarily 
with seeded probes one week after implantation, possibly indicating a regenerative 
capacity of the injured brain, graft cells, or both (Supplementary Figure 4.1).  Reduced 
graft cell viability and function over time, followed by a secondary inflammatory reaction 
to cellular debris, may explain the deleterious effect of cell-seeding at later time points.  
Degradation of the alginate scaffold may leave transplanted cells vulnerable to immune 
rejection.  It is also possible that an early reduction of glial activation by neural stem cells 
intensifies neuronal injury later (Hanisch and Kettenmann 2007).  Future studies of this 
biohybrid device will include investigating these mechanisms further, improving cell 
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Supplementary Figure 4.1.  Doublecortin staining (DCX, red) was detected in three of 
four animals one week post-implantation (a-c, d-f).  Doublecortin (DCX) is a 
microtubule-associated protein expressed in migrating neuronal precursors, but may also 
be associated with mature astrocytes.  DCX has been observed during glial scar formation 
following traumatic brain injury, with peak expression occurring at 1 week post-injury 
(Francis, Koulakoff et al. 1999; Itoh, Satou et al. 2007).  Tissue was also labeled with 
NeuN (mature neuronal nuclei, green) and Hoechst (nuclear counterstain, blue).  
Expression appeared enhanced in NSC-seeded (a-c) probes compared to controls from 
the same animal (probe only, d-f).  No staining was observed in the remaining animals.  
The origin and function of DCX-expressing cells are yet to be elucidated, could possibly 
indicate a regenerative capacity of the injured brain, the grafted cells, or a combination of 
both.  Scale = 50 microns.  Appendix C contains additional views of selected images.      
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CHAPTER 5 
CELL-CYCLE INHIBITION EFFECTS ON THE RECORDING QUALITY AND 
TISSUE RESPONSE OF CHRONIC NEURAL PROBES 
 
Abstract 
Neural prostheses are currently plagued by recording instability, which limits their utility 
in research and clinical settings.  The tissue response which occurs to these devices in 
vivo is likely a key contributing factor to this issue.  After implantation, probes are 
encapsulated by glia and neuronal density in the surrounding tissue is reduced.  We 
hypothesized that re-entry into the cell cycle may be associated with the reactive gliosis 
surrounding probes, and that administration of a cell cycle inhibitor (flavopiridol) at the 
time of surgery would reduce this effect.  We investigated the effects of flavopiridol on 
recording quality and impedance over a 28 day time period, and conducted histology at 3 
and 28 days post-implantation.  Flavopiridol reduced the expression of a cell cycle 
protein (cyclin D1) in microglia surrounding probes at the 3 day time point.  Impedance 
at 1 kHz was reduced by drug administration across the study period compared to vehicle 
controls.  Correlations between recording (SNR, units) and impedance metrics revealed a 
significant, but small, inverse relationship between these variables.  However, the 
relationship between impedance and recording quality was not strong enough for 
flavopiridol to result in an improvement in SNR or the number of units.  Additionally, the 
effects of the drug were not reflected in the variable endpoint histology data collected 
from tissue in which the interface with the device was damaged upon probe 
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explantation.  Our data indicate that flavopiridol is an effective treatment for reducing 
impedance in vivo, likely through inhibiting microglial encapsulation of recording 
devices.  However, this did not translate to improvements in recording quality, and 
combination of flavopiridol with a second strategy which enhances neuronal signal may 
further improve results.  Finally, the correlation between endpoint histology and 
electrophysiology metrics across all animals provides quantitative evidence for a direct 
relationship between recording quality and the tissue response to neural prostheses.   
 
Introduction 
Neural prostheses record action potentials from a patient’s cortex which may then be 
used to control external assistive devices (Taylor, Tillery et al. 2002; Carmena, Lebedev 
et al. 2003; Hochberg, Serruya et al. 2006; Schwartz, Cui et al. 2006; Donoghue, 
Nurmikko et al. 2007; Fitzsimmons, Drake et al. 2007; Velliste, Perel et al. 2008).  
Therefore, these systems have the potential to restore some level of function to the 
200,000 individuals currently suffering from full or partial paralysis in the U.S., as well 
as patients immobilized by neurodegenerative disease (Polikov, Tresco et al. 2005)  For 
neural prostheses to be useful in clinical and research settings, stable recordings from 
large populations of neurons in multiple brain areas should be reliably and reproducibly 
achieved over a period of several years (Lebedev and Nicolelis 2006).   However, 
recording longevity and stability is highly variable according to numerous reports, and 
the reactive tissue response that occurs to devices following implantation into the brain is 
likely to be a key contributing factor (Rousche and Normann 1998; Liu, McCreery et al. 
1999; Williams, Rennaker et al. 1999; Nicolelis, Dimitrov et al. 2003; Polikov, Tresco et 
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al. 2005; Liu, McCreery et al. 2006; Schwartz, Cui et al. 2006).  Neuronal density is 
reduced surrounding probes following insertion, and an encapsulating sheath of microglia 
and astrocytes further isolates the devices from their neuronal signal sources (Edell, Toi 
et al. 1992; Turner, Shain et al. 1999; Szarowski, Andersen et al. 2003; Kim, Hitchcock 
et al. 2004; Biran, Martin et al. 2005; Polikov, Tresco et al. 2005).  However, evidence of 
a direct cause-effect relationship between recording quality and histology metrics remains 
limited.  Williams et al. report recording sites with extensive glial reactivity to have 
increased impedance magnitude at 1 kHz (the fundamental frequency of the neuronal 
action potential), as well as a non-linear relationship between the real and imaginary 
components of impedance (Williams, Hippensteel et al. 2007).  Additionally, neuronal 
density within the first 100 microns of the device surface is reduced, and this region 
produces the large amplitude, reliably separated spikes useful for neural prostheses 
(Henze, Borhegyi et al. 2000; Biran, Martin et al. 2005; Purcell, Seymour et al. 2008).       
 
While neuronal loss and glial encapsulation surrounding neural prostheses are well 
documented phenomena, the mechanisms underlying these changes in the device-tissue 
interface remain largely unexplored.  Certainly, inflammation plays a role; the release of 
inflammatory cytokines from cells attached to explanted probes has been demonstrated, 
and anti-inflammatory drugs such as dexamethasone have reduced impedance and 
astrogliosis associated with probes in vivo (Shain, Spataro et al. 2003; Spataro, Dilgen et 
al. 2005; Bjornsson, Oh et al. 2006; Kim and Martin 2006; Zhong and Bellamkonda 
2007).  Another contributing factor is the rupture of vasculature during insertion, which 
has been observed up to 300 microns from the probe surface (Bjornsson, Oh et al. 2006). 
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If neuronal density surrounding probes is reduced due to cell death, then understanding 
the underlying mechanisms (i.e. apoptosis, necrosis, excitoxicity, inflammation, etc.), and 
their relative contributions, would allow for the development of appropriately targeted 
pharmacological intervention strategies.  The functionality of the remaining neurons also 
needs to be explored.  Likewise, understanding the signals resulting in the activation or 
quiescence of glia surrounding probes could enable improved methods of promoting 
device-tissue integration. 
 
In recent years, a contribution of cell-cycle re-entry to the activation of glia, as well as 
neuronal apoptosis, has been demonstrated in models of central nervous system (CNS) 
injury (Verdaguer, Jimenez et al. 2004; Di Giovanni, Movsesyan et al. 2005; Appert-
Collin, Hugel et al. 2006; Alvira, Tajes et al. 2007; Byrnes, Stoica et al. 2007).  The cell 
cycle is a complex process through which cells progress from a quiescent to a 
proliferative state, and cellular advancement through this cycle is controlled by cyclin 
dependent kinases (CDKs) and associated cyclins (Schafer 1998).  Following CNS injury 
and an associated upregulation of these cell-cycle proteins, mitotic cells (namely, 
microglia and astrocytes) proliferate, while non-mitotic cells (differentiated neurons) 
undergo caspase-mediated apoptosis (Cernak, Stoica et al. 2005).  Flavopiridol is a 
flavonoid drug which is a broad CDK inhibitor and arrests progression through the cell 
cycle (Swanton 2004).  Di Giovanni et al. showed a single injection of flavopiridol 
intracerebroventricularly reduced expression of the cell cycle protein cyclin D1, 
decreased neuronal cell death, reduced glial activation, and improved motor and 
cognitive recovery following traumatic brain injury in rats (Di Giovanni, Movsesyan et 
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al. 2005).  Flavopiridol has resulted in improved functional and histological outcomes in 
in vitro and in vivo models of spinal cord injury, Parkinson’s disease, motorneuron 
apoptosis, and excitotoxic injury (Verdaguer, Jimenez et al. 2004; Appert-Collin, Hugel 
et al. 2006; Alvira, Tajes et al. 2007; Byrnes, Stoica et al. 2007).   
 
We hypothesized that the implantation of neural prostheses may result in an upregulation 
of cell cycle proteins in the adjacent tissue, which is associated with neuronal apoptosis 
and the activation and proliferation of glia.  Therefore, cell cycle re-entry could be 
involved in the prototypic glial encapsulation and neuronal density loss surrounding these 
devices.  Furthermore, cell cycle inhibitors may reduce these effects, and cause an 
improvement in recording quality and impedance data as a result.  We collected 
histology, impedance, and electrophysiology data over a 28 day time period in rats that 
were injected intracerebroventricularly (ICV) with either flavopiridol or vehicle alone at 
the time of probe insertion.  We report reduced impedance and reduced expression of cell 
cycle proteins in drug-treated animals.  There was no relationship between drug treatment 
and quantitative histology.  No effect on recording quality was observed; however, a 
general association between these data and the time course of the tissue response was 
noted.  Finally, significant correlations between histology, impedance, and recording 
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Methods 
Probe Implantation and Intracerebroventricular (ICV) Injection 
Sixteen channel chronic silicon probes with 1250 µm2 iridium recording sites and a 2.1 
mm long single shank were provided by the University of Michigan Center for Neural 
Communications Technology (CNCT) (See Appendix B for a diagram).  The design and 
fabrication of these probes has been described (Drake, Wise et al. 1988).  Sixteen male 
Sprague Dawley rats (300–350 g) were implanted with the devices using a surgical 
procedure similar to those previously reported (Ludwig, Uram et al. 2006). Anesthesia 
was achieved via a ketamine cocktail.  A 3x2 mm craniotomy was centered over the 
motor cortex, dura was resected and the probe was manually inserted into the brain (+3.0 
mm AP, 2.5 mm ML, -1.4 mm DV from Bregma).  The electrode connector was 
grounded to a bone-screw over parietal cortex using a stainless steel ground wire.  Prior 
to probe insertion, “flavopiridol”/“drug” and “control” rats were injected ICV with 5 µL 
of 250 µM flavopiridol (Sigma, St. Louis, MO) dissolved in artificial cerebrospinal fluid 
(ACSF) or ACSF alone respectively.  The solution was administered over the course of 
one minute through a cannula (Plastics One, Roanoke, VA) attached to a stereotaxic 
frame and inserted into the left lateral ventricle (-0.8 mm AP, 1.5 mm ML, -4.3 mm DV 
from Bregma).  The cannula was immediately withdrawn following the injection.  
Surgical closure was achieved with a combination of GelFoam (Henry Schein, Inc., 
Miami, FL), silicone (World Precision Instruments, Sarasota, FL), and dental acrylic (Co-
Oral-Ite, Dental Mfg. Co., Santa Monica, CA).  All procedures strictly complied with the 
United States Department of Agriculture guidelines for the care and use of laboratory 
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Neural recordings were taken from ten animals (five control, five flavopiridol) 
immediately following surgery, and every three to four days thereafter over a 28 day time 
course.  The remaining animals were processed for histology at the 3 day time point.    
Animals were placed in a Faraday cage and thirty second segments of high speed data 
were collected using a TDT multi-channel acquisition system (Tucker-Davis 
Technologies, Gainesville, FL) as previously described (Ludwig, Uram et al. 2006).  
Single and multi-unit recordings were sampled at 24414 Hz and bandpass filtered from 
450-5000 Hz.  Local field potentials (LFPs) were sampled at 1 Hz and bandpass filtered 
from 3 to 90 Hz.   
Offline analysis using custom automated MatLAB (Mathworks Inc., MA) software was 
performed as reported previously (Ludwig, Uram et al. 2006).    Briefly, candidate 
waveforms were identified when peaks exceeded an amplitude threshold window 3.5 
standard deviations above and below the mean of the sample distribution.  A 2.4 ms 
candidate waveform snippet centered on the absolute minimum of the waveform was then 
removed from the recorded segment and stored.  After all candidate waveforms had been 
removed, the peak-to-peak amplitude (rather than RMS) of the noise voltage was 
calculated as six times the standard deviation of the recording, thus including 
approximately 99.7 percent of the noise data (Ludwig, Miriani et al. 2008). Waveforms 
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with a cluster membership index of greater than 0.8 were used to determine a mean 
waveform for a cluster after initial principal component analysis and fuzzy C-means 
clustering.  The signal-to-noise ratio (SNR) for a given cluster was defined as the peak-
to-peak amplitude of the mean waveform for each cluster divided by the peak-to-peak 
amplitude of the noise floor.  Units were defined as clusters with a mean SNR of 1.1 or 
greater; the discrepancy between this and previous SNR values reported for units of 
moderate to high quality is accounted for by the difference between calculating SNR 
using the peak-to-peak amplitude of the noise floor instead of RMS (Ludwig, Miriani et 
al. 2008).  Common average referencing, in which the average of all the recordings on 
every functional electrode site is taken and used as a reference, was used to remove noise 
sources common to every electrode site (such as motion artifact, 60 Hz noise, 
instrumentation noise, thermal noise, and biological sources of noise) as previously 
described (Ludwig, Miriani et al. 2008).     
Impedance Spectroscopy 
Impedance spectroscopy measurements were taken for animals on the same days as 
neural recordings using an Autolab potentiostat PGSTAT12 (Eco Chemie, Utrecht, The 
Netherlands) and associated frequency response analyzer (Brinkmann, Westbury, NY).  
A 25 mV RMS sine wave was applied with frequencies varying logarithmically from 10 
Hz to 10 kHz using a stainless steel bone screw as the reference electrode.  
Immunohistochemistry and Analysis 
Animals were deeply anesthetized and transcardially perfused with 4% paraformaldehyde 
at the appropriate time point following probe implantation (3 days, n=3 animals per 
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group; 28 days, n=5 animals per group).  A single drug-treated rat brain in the 3 day 
histology group was not analyzed due to poor fixation and tissue processing.   Brain 
tissue was explanted, postfixed overnight in 4% paraformaldehyde, and cryoembedded 
following sucrose protection.  Probes were removed from the tissue prior to processing.  
Serial 12 micron thick sections along the tract of the probes were collected, and eight 
tissue sections spanning the shank of the probe were randomly selected and 
immunostained for NeuN (1:100, Millipore Corporation, Billerica, MA) and 
counterstained with Hoechst (1 µg/mL, Invitrogen Corporation, Carlsbad, CA) for 
quantitative analysis of tissue response.  Four of these sections were also stained with 
cyclin D1 (CD-1, 1:100, Abcam, Cambridge, MA) to investigate possible re-entry into 
the cell cycle.  An additional four sections were stained with Ox-42 (1:100, Serotec, 
Oxford, UK), CD-1 (1:100, Abcam, Cambridge, MA), and Hoechst (1 µg/mL).  A final 
four sections were stained for glial fibrillary acidic protein (GFAP, 1:100, Sigma, St. 
Louis, MO), CD-1 (1:100, Millipore Corporation, Billerica, MA), and Hoechst (1 
µg/mL).  These sections were used to qualitatively assess the role of cell cycle protein 
expression in glial activation and probe encapsulation. Sections were hydrated in buffer 
(PBS), blocked with 10% normal goat serum, and incubated overnight with primary 
antibodies at 4˚C.  Sections were then rinsed, incubated in the appropriate secondary 
antibodies (1:200 Alexa-488, and 568, Invitrogen), counterstained with Hoechst, and 
coverslipped with ProLong Gold (Invitrogen).  Antibody solutions included 0.3% triton 
X-100 and 5% normal goat serum.  Buffer was used in place of primary antibody for 
controls.  Confocal images were collected with an Olympus FV500 microscope with the 
20X objective.   
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Neuronal and non-neuronal densities were analyzed using a MatLAB graphical user 
interface as described previously (Seymour and Kipke 2007; Purcell, Seymour et al. 
2008). An outline of the exterior edge of the tract cross-section for each image was 
delineated using a differential interference contrast (DIC) and UV fluorescence image.  A 
blinded technician selected all nuclei as either neuronal (NeuN+, Hoechst+) or non-
neuronal (Hoechst+ only) within a software-defined 100 micron radius of the probe 
surface. The software algorithm used the coordinates of the user-selected nuclei to 
calculate the shortest distance to the tract edge, bin the counts by distance, and calculate 
the sampling area of each bin to result in neuronal and non-neuronal densities as a 
function of distance from the probe tract. 
 
Statistical Analysis 
A linear mixed model ANOVA was used to assess the effect of time and condition on 
impedance and recording metrics.  The random effect was the individual animal, and 
multiple electrode sites were included as a repeated measure.  Time and condition were 
included as fixed factors.  A linear mixed model was similarly used to assess the effects 
of distance and condition on neuronal and non-neuronal densities, although the data was 
averaged across multiple sections per animal and site-by-site analysis was not possible.   
 
Correlation between impedance and recording metrics over the course of the study were 
achieved by using a linear mixed model in which these values were standardized, and one 
variable was defined as a predictor (covariate).  The individual animal was included as a 
random effect to control for correlated observations within the same rat.  A Spearman's 
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ranked coefficient followed by a two-tailed t test for significance was calculated to assess 
the strength of correlation between endpoint tissue response, recording, and impedance 




The impedance of electrode recording sites at 1 kHz (the fundamental frequency of the 
neuronal action potential) and 10 Hz (in frequency range of LFPs) is shown in Figure 5.1.  
Impedance was decreased by flavopiridol administration at both frequencies (p<0.001, 
mixed model ANOVA).  Analysis of the time course of impedance changes for the 
combined group of animals revealed general trends which may be explained by the tissue 
response to the devices.  Impedance at 1 kHz increased from initially low values in the 0-
3 day time period at 7 days post-implantation (Figure 5.1a, p<0.001).  Values stabilized 
thereafter until a final significant increase at 28 days (p<0.05).  Similarly, a significant 
increase in impedance values at 10 Hz three days after the day of surgery was observed 
(Figure 5.1b, p<0.01).  Values stabilized until a significant increase at 28 days (p<0.001).  
Initially low impedance in the 3 day time period after device implantation, followed by 
increased, and more variable, values in the two weeks thereafter, has been previously 
reported (Ludwig, Uram et al. 2005).  Swelling and reduced cell density surrounding 
probes associated with initial insertion trauma is likely the reason for the initially low 
values.  The increased impedance beginning one week after insertion corresponds with 
the return of cells to the surface of the probe and progressive glial encapsulation 
(Szarowski, Andersen et al. 2003; Ludwig, Uram et al. 2005; Purcell, Seymour et al. 
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2008).  The final increase in impedance values at the 28 day time point was driven by 
control animals.    
         
 
 
Figure 5.1.  Administration of the cell-cycle inhibiting drug flavopiridol immediately 
prior to neural prosthetic device insertion reduced impedance at 1 kHz and 10 Hz (mixed 
model ANOVA, p<0.001).  Impedance increased following implantation in the 3 to 7 day 
timeframe, coinciding with a reported period of increased cellular density surrounding 
probes (Purcell, Seymour et al. 2008) (p<0.01).  Mean ± s.e.m. is shown.   
 
Neural Recording Data 
Flavopiridol had no effect on any of the recording metrics studied (mixed model 
ANOVA) (Figure 5.2a-e).  The time course of recording quality metrics generally 
followed the sequence of tissue response events reported in the literature: initial insertion 
injury, followed by swelling/edema, a subsequent return of neurons and glia near the 
probe surface, and, finally, a combination of neuronal density loss and the formation of a 
compact glial encapsulation layer around the device (Szarowski, Andersen et al. 2003; 
Biran, Martin et al. 2005; Purcell, Seymour et al. 2008).  The number of units, SNR, and 
LFP amplitude follow a similar time course in which peak values on the day of surgery 
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significantly dropped three days later (p<0.001), followed by an increase at the 10 day 
time point (p<0.05) (Figure 5a-c).  In the initial days following surgery, there is 
significant damage and swelling due to insertion trauma, and few neuronal soma are 
found within 100 microns of the implanted device (Purcell, Seymour et al. 2008), which 
may account for the reduction of recording quality at the 3 day time point (Figure 5a-c).  
These metrics are significantly increased one week later, during a period of dramatic 
tissue recovery, a return of neuronal sources, and maximal glial activation (Szarowski, 
Andersen et al. 2003; Ludwig, Uram et al. 2005; Purcell, Seymour et al. 2008).  During 
this time, signal and noise increase as cells return to the region surrounding the probes 
(p<0.05, Figure 5d-e).  After the 10-14 day time period, decreases in the number of units, 
SNR, signal amplitude, and noise occur corresponding to the formation of an 
encapsulating, compact glial sheath as reported in the literature (Figure 5.2, a-b, d-e) 
(Szarowski, Andersen et al. 2003; Purcell, Seymour et al. 2008).  LFPs, which are low 
frequency signals derived from aggregates of neurons rather than single cells, are likely 
less sensitive to the nuanced changes in the device-tissue interface after the period of 
insertion trauma and initial recovery, and do not decrease in amplitude in this timeframe 
(Schwartz, Cui et al. 2006).  Although neuronal density surrounding probes is known to 
be decreased in comparison to control tissue in this time period, decreasing density with 
time has not been shown and is unlikely to provide a simple explanation for the loss in 








       
 





























Days Following Surgery 
 
 
Figure 5.2.  Analysis of recording quality over the 28 day study period showed no effect 
of flavopiridol administration.  The progression of these values over the duration of the 
study may be explained by the tissue response to the probes.  Recording quality decreases 
in the 0-3 day time period, coinciding with initial insertion trauma (a-c).  Recovery of 
these metrics occurs approximately one week later, when signal and noise are increased 
as cells return to the device during healing (a-e).  Reductions in all metrics except LFP 
amplitude three to four weeks after surgery occurred during glial encapsulation. “Units” 
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Cell Cycle Protein Expression Surrounding Prostheses 
Histology at 3 days revealed expression of the cell cycle protein CD-1, primarily in Ox-
42 labeled microglia, surrounding probe tracts following implantation (Figure 5.3).  The 
microglia had an activated, amoeboid morphology surrounding probe tracts.  Di Giovanni 
et al. reported over 80% of Ox-42-labeled microglia and GFAP-positive astrocytes, as 
well as approximately 10% of NeuN-stained neurons, coexpressed CD1 surrounding the 
site of traumatic brain injury in rats at the same time point (Di Giovanni, Movsesyan et 
al. 2005).  Qualitatively, there appeared to be a lesser extent of CD-1 expression in drug 
treated animals (n=2 drug-treated and 3 controls).   
 
 
Figure 5.3.  Neuroprostheses are associated with an increase in the expression of a cell-
cycle protein (CD-1) in neighboring microglia three days after insertion, which appears 
reduced by flavopiridol administration at the time of surgery.  Analysis was qualitative on 
a sample size of 2-3 animals per group.  Images for each marker are from the same 
control and flavopiridol-treated animals.  Ox-42 (green), GFAP (red), and NeuN (green) 
are shown, and CD-1 is red, green, and red respectively.  Coexpressing cells are yellow.  
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Neuronal and Non-Neuronal Densities Surrounding Probes 
Drug treatment had no statistically significant effects on neuronal or non-neuronal cell 
densities surrounding the probes.  Significant effects of these measurements as a function 
of distance from the probe surface were noted which indicated improvements in the tissue 
response further away from the device.  ND and ND/NND generally increase and NND 
generally decreases when comparing these metrics measured from the area nearest the 
probe tract boundary (within 20 microns) to the region furthest from the boundary 
(greater than 70 microns away from the tract boundary) at the 28 day time point (p<0.05, 
mixed model ANOVA).   
 
Silicon probes necessitate removal prior to histology, disrupting the tissue-device 
interface.  In particular, the encapsulation layer immediately adjacent to the probe 
surface, which is predominantly composed of microglia, is likely to be damaged or 
removed with the prosthesis (Biran, Martin et al. 2005).  The microglial sheath was 
absent from images taken at the 28 day time point, although the distribution of neurons 
and astrocytes could be observed (Figure 5.5).  A steep decline of NND, and incline of 
ND, immediately near the probe surface is absent, which has been shown for in situ 
analysis of non-functional parylene probes (Figure 5.4) (Purcell, Seymour et al. 2008).  
This is a further indication that the glial sheath was disturbed upon probe explantation.  
Additionally, site-by-site analysis would not be accurate in the absence of the device, 
allowing only for average values for these metrics to be calculated along the probe tract 
as shown.  A larger sample size, or in situ probe histology, could reveal significant effects 
in future studies.   
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Figure 5.4.  Neuronal density (ND), non-neuronal density (NND), and the ratio 
(ND/NND) between them as a function of distance from the probe tract boundary three 
and 28 days after probe implantation. 
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Figure 5.5.  Representative images of the distribution of neuronal (NeuN, green) and non-
neuronal (Hoechst, blue) nuclei 28 days after implantation (right panels).  Glial 
encapsulation is shown by GFAP-labeled astrocytes (red), but the microglial sheath was 
absent at this time, likely due to remaining attached to explanted probes (left panels).  
Images are from the same control and flavopiridol-treated animals.  Scale = 100 microns. 
 
 
Correlations between Impedance, Recording Quality, and Quantitative Histology 
Correlations revealed several significant relationships between endpoint histology and 
electrophysiology metrics at the 28 day time point across all animals (Table 5.1, p≤0.05, 
Spearman’s rank coefficient test).  When interpreting the results, it is important to note 
that Spearman’s test assigns ranks for each data value, and assesses correlations between 
the ranks, so the variability of the original data is not necessarily reflected.  Neuronal and 
non-neuronal cell densities within 50 microns of the tract surface (the region known to 
yield reliably sorted units (Henze, Borhegyi et al. 2000)), as well as the ratio between the 
two, were tested for correlations with SNR, signal, noise, units, LFP amplitude and 
impedance at 10 Hz and 1 kHz.    Increasing 1 kHz impedance was positively correlated 
with NND and 10 Hz impedance (not shown), and negatively correlated with recording 
                                                                       142
quality (SNR and Units) and ND/NND.  NND was negatively correlated with SNR, 
signal amplitude (not shown), and units.  Thus, increased NND near the probe tract 
(which likely indicates astrocyte density, Figure 5.5) was related to increased impedance 
and reduced recording quality.  Increased ND/NND correlated positively with improved 
SNR.  Several correlations trended (p<0.1) toward significance (not shown), notably: a 
negative correlation between ND and NND, a positive correlation between impedance 
and noise, a negative correlation between ND and 1 kHz impedance, and a positive 
correlation between units and ND/NND.  The results corroborate the theory that glial 
encapsulation decreases recording quality and increases impedance, which has not been 
quantitatively shown previously. 
 
 
Table 5.1.  Correlation coefficients between histology and electrophysiology 
measurements at the 28 day time point reveal several significant relationships between 
these metrics.   “NND” is the density of non-neuronal cells within 50 microns of the 
probe tract boundary.  “ND/NND” is the ratio of neuronal to non-neuronal densities 
within the same region.  * = significant at the 0.05 level, ** = significant at the 0.01 level. 
 
Correlations between impedance and recording metrics across all days in the study period 
also indicated a significant inverse relationship between impedance and recording 
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quality.  Here, the data set was much larger, and could be analyzed on a site-by-site basis 
while controlling for correlated observations within the same rat using a linear mixed 
effects model.  The analysis demonstrated a significant, but small, inverse relationship 
between SNR and 1 kHz impedance (-0.24 correlation coefficient, p<0.001).  A similar 
effect between units and 1 kHz impedance was observed (-0.26 correlation coefficient, 
p<0.001).  There was a stronger, positive relationship between impedance and noise  
(0.51 correlation coefficient, p<0.001).   
 
Discussion 
Following implantation into the brain, neural prostheses incite characteristic changes in 
the surrounding tissue which are hypothesized to reduce recording quality over time.  
Neuronal density is dramatically reduced surrounding the probe immediately following 
insertion trauma; this improves over subsequent weeks, but remains at approximately 
60% of control levels four weeks later (Biran, Martin et al. 2005; Purcell, Seymour et al. 
2008).  One day after insertion, the probe is surrounded by activated microglia, which 
form a thin sheath encapsulating the device during the following week (Szarowski, 
Andersen et al. 2003; Purcell, Seymour et al. 2008).  Astrocytes are maximally activated 
one week after device implantation, and form a compact sheath approximately three 
weeks later (Szarowski, Andersen et al. 2003; Biran, Martin et al. 2005).  A prevailing 
hypothesis in the neural engineering field is that these phenomena result in recording 
instability over time.  In fact, numerous intervention strategies, including the use of 
protein-based coatings (Buchko, Kozloff et al. 2001; Cui, Lee et al. 2001; Cui, Wiler et 
al. 2003; He and Bellamkonda 2005; He, McConnell et al. 2006) , anti-inflammatory 
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drugs (Shain, Spataro et al. 2003; Spataro, Dilgen et al. 2005; Kim and Martin 2006; 
Zhong and Bellamkonda 2007), and hydrogels (Kim, Abidian et al. 2004), have been 
pursued to mitigate tissue response, and theoretically, improve chronic recording quality.  
However, the mechanisms underlying the tissue response are still largely unknown, and a 
direct relationship between in vivo recording quality and tissue response metrics has not 
been defined.      
 
Several studies have demonstrated the role of cell cycle re-entry in gliosis and neuronal 
death following CNS injury (Verdaguer, Jimenez et al. 2004; Cernak, Stoica et al. 2005; 
Di Giovanni, Movsesyan et al. 2005; Appert-Collin, Hugel et al. 2006; Alvira, Tajes et al. 
2007; Byrnes, Stoica et al. 2007).  Di Giovanni et al. demonstrated more than 80% of 
activated microglia and astrocytes, as well as over 10% of neurons, expressed cyclin D1 
(CD-1) around the site of traumatic brain injury in rats, indicating re-entry into the cell 
cycle (Di Giovanni, Movsesyan et al. 2005).  A single ICV injection of flavopiridol 
following injury reduced CD-1 expression in all cells by over 50% and reduced glial 
proliferation three days after injury.  After 28 days, flavopiridol-treated rats had reduced 
lesion volume and reactive gliosis, as well as improved functional recovery compared to 
control animals.   
 
We hypothesized that the upregulation of cell cycle proteins may be associated with the 
tissue response to probes, and that inhibiting cell cycle re-entry with flavopiridol may 
reduce surrounding glial activation, and, to a lesser extent, neuronal loss.  We 
administered the drug as a single ICV injection, which is easily implemented in research 
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settings.  Our results demonstrate a reduction in microglial activation surrounding probes 
three days after implantation, with lesser evidence of an effect on astrocyte activation.  
Additionally, a significant reduction in impedance occurred over the time course of the 
study, and the two results are likely related.  Increased 1 kHz impedance at recording 
sites associated with GFAP reactivity was demonstrated beginning four days after 
implantation (Williams, Hippensteel et al. 2007).  In the current study, the decreased 
impedance is more likely due to decreased microglial encapsulation, based on evidence 
that activation of these cells appears most strongly inhibited by the drug.  This sheath 
likely remains attached to the probe during explantation, which has been shown 
previously (Biran, Martin et al. 2005).  Non-neuronal densities likely reflect astrocyte 
counts at some distance from the actual probe surface.  These values were averaged along 
the probe tract, tended to be highly variable, and were not significantly affected by drug 
treatment.  Neuronal density, and the ratio between neuronal and non-neuronal density, 
tended to be higher for drug treated animals four weeks after implantation, but again, the 
data was too variable to demonstrate significance.  The data variability and loss of an 
intact device-tissue interface illustrate the need for in situ probe histology, which leaves 
the interface intact and allows site-by-site analysis, but requires advanced methods such 
as multi-photon microscopy for quantitative analysis (Bragin, Hetke et al. 2000; Holecko, 
Williams et al. 2005; Seymour, Purcell et al. 2008).         
 
A significant, but small, correlation between recording quality (SNR, Units) and 1 kHz 
impedance was demonstrated over the course of the study, but the relationship was not 
large enough for the impedance reduction by flavopiridol to result in improved recording 
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quality over time.  Endpoint data for these metrics at 28 days further reinforced the 
existence of a relationship between these quantities.  Suner et al. showed an overall lack 
of correlation between SNR and impedance in a study of two monkeys over a 1.5 year 
time course.  However, in one of the subjects, a significant, but small, correlation 
between the metrics was shown (r=0.2) (Suner, Fellows et al. 2005).  Signal quality was 
correlated with impedance for both monkeys (r=0.18).  The authors suggest a “loose” 
association between recording quality and impedance.  Theoretically, decreased 
impedance should improve recording quality through a reduction of noise and signal loss 
through shunt pathways (Shoham and Nagarajan 2003; Ludwig, Uram et al. 2005).  
Thermal noise is directly proportional to the square root of impedance, but the 
background activity of distant neurons is a noise source of typically equal importance in 
vivo (Shoham and Nagarajan 2003).  This biological noise may, therefore, offset 
improvements in recording quality derived from reductions in thermal noise.  Because the 
correlation between impedance and recording quality is weak, a large reduction in 
impedance may be required to result in improved recordings.   
 
There were several significant correlations between 28 day end-point histology and 
recording metrics at that time point which reinforce prevailing hypotheses in neural 
engineering, but have not previously been demonstrated quantitatively in the literature.  
Non-neuronal density within the first 50 microns of the probe tract was positively 
correlated with impedance, and negatively correlated with SNR, signal amplitude (not 
shown), and units. Again, NND appears to be predominated by astroglial cells in the 
current study.  Astrogliosis is known to be a diffusion barrier to ionic transmission 
through nervous tissue, which may result in increased impedance and a loss of signal 
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through shunt pathways (Roitbak and Sykova 1999).  A relationship between increased 
impedance and GFAP-positive astrocytes has been shown previously (Williams, 
Hippensteel et al. 2007).  Increased NND may also reduce the ability of units to be 
identified using common sorting methods, resulting in additional biological noise.  
Increased ND/NND correlated positively with improved SNR and negatively with 
impedance, and it is intuitive that increasing the signal source (neurons) in proportion to 
the signal barrier (glia) would have these effects.   
 
Neuronal density trended toward an inverse relationship with non-neuronal density and 
impedance, although these results were not statistically significant (p<0.1).  Notably, 
increased neuronal density alone was not sufficient to improve recording quality; the 
increase must be normalized for increases in non-neuronal density to have an effect.  The 
trend towards decreased impedance by increased neuronal density may be related simply 
to the tendency for ND to be inversely related to NND.  However, the possibility exists 
that there is a direct effect of ND on reducing electrode impedance.  Anecdotal evidence 
suggests that plating electrodes with neural cells in vitro decreases impedance, while 
fibroblasts and epithelial cells have the opposite effect (Sarah Richardson-Burns, 
personal communication).  Perhaps neural cells have unique effects on impedance due to 
their ionically conductive membranes and reduced surface contact with the electrode; 
these potential mechanisms warrant further investigation (Sarah Richardson-Burns, 
personal communication). In general, the correlation results indicate that glial 
encapsulation decreases recording quality and increases impedance, while increased 
neuronal density/non-neuronal density has the opposite effect.   
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Flavopiridol likely reduces glial (and particularly, microglial) encapsulation of the 
device, which resulted in reduced impedance across the study time course.  This was not 
demonstrated by the non-neuronal counts, as the interface was damaged upon 
explantation.  This illustrates the need for in situ probe histology, which will leave the 
interface intact and allow site-by-site analysis, but requires advanced methods (i.e. 
multiphoton imaging, see Conclusions and Future Directions).  A significant, but small, 
correlation between SNR/Units and 1 kHz impedance was demonstrated over the course 
of the study, but the relationship was not large enough for the impedance reduction by 
flavopiridol to result in improved recording quality over time.  This indicates that an 
intervention strategy which combines a glial activation inhibitor such as flavopiridol with 
a method aimed at protecting neurons, or improving their function/communication with 
the device, may be the optimal approach for improving recording quality over time.  
Additionally, prolonged administration of flavopiridol may further improve results.  The 
lack of correlation between neuronal density and recording metrics at the 28 day time 
point may indicate the importance of the neuronal function (not just density) surrounding 
the probe (see Conclusions and Future Directions).  Finally, endpoint histology and 
electrophysiology metrics significantly correlated at the 28 day time point, reinforcing the 
need for improvements in the device-tissue interface to enable long-term recording 
quality.         
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CHAPTER 6 




This dissertation describes the in vitro and in vivo evaluations of cell- and drug-based 
interventions on the chronic tissue response to implanted neural probes.  These studies 
used a wide variety of techniques in several fields of study, principally:  tissue 
engineering, material science, neuroscience, and neural engineering.  The data 
demonstrate significant effects of the intervention strategies on tissue response and 
electrophysiology measurements, characterize alginate stability and its use as a neural 
stem cell scaffold, and add insight into the relationship between the tissue-device 
interface and recording quality.   
 
Chapter 2 described the evaluation of the effects of alginate composition on the 
neurotrophic factor release, viability, and proliferation of encapsulated NSCs, as well as 
on the mechanical stability of the scaffold itself.  The results demonstrated that a high G, 
non-PLL coated alginate composition yielded superior support of neurotrophic factor 
release from encapsulated NSCs as well as resistance to an osmotic challenge.  This 
scaffold was shown to be potentially useful in the repair of damaged CNS tissue, as 
evidenced by the neuroprotective effects of medium conditioned by NSC-seeded alginate 
beads on the serum-withdrawal mediated death of PC-12 cells. 
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While Chapter 2 reported in vitro mechanical stability results, it was of interest to study 
the in vivo degradation behavior of alginate and its relationship to PLL coating.  Chapter 
3 reported a study in which uncoated and PLL-coated high G alginate disks were washed 
identically in saline, implanted subcutaneously in rats, and monitored over a three month 
time period for mechanical stability, weight changes related to swelling behavior, and 
biocompatibility.  All alginate samples experienced an 80% decrease in their complex 
moduli after 24 hours in vivo, followed by stabilization of this metric, progressive 
fragmentation, cellular infiltration and collagen encapsulation.  PLL-coating resulted in a 
slight but significant increase in the complex modulus seven days after implantation in 
comparison to non-coated gels; no other significant differences in stability between the 
two conditions were noted.  No differences in biocompatibility were seen.  PLL and non-
coated gels initially dropped in weight following implantation, followed by similar trends 
in increasing weight (interpreted as swelling) for a period of two weeks; weight increases 
were greater for uncoated than coated samples.  The data demonstrate little evidence for 
PLL enhancement of mechanical stability in vivo. Combined with the detrimental effect 
of PLL on neurotrophic factor detection from encapsulated cells and resistance to an 
osmotic challenge reported in the second chapter, a non-PLL coated scaffold was pursued 
for probe modification.      
 
Chapter 4 contains the results of an in vivo histological assessment of probes scaffolded 
with neural stem cell-seeded alginate in a hollow well.  This study reports a detailed, 
quantitative histological evaluation of a novel biohybrid device, and is the first such 
investigation of neural stem cell-seeding as a means to improve integration of a synthetic 
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neural prosthesis with surrounding brain tissue.  Additionally, the study assesses the 
degree of injury as a function of scaffold condition and distance from the probe surface 
over the course of four time points spanning three months, making it the most 
comprehensive quantitative data set evaluating tissue response to neural prostheses 
reported in the field of neural engineering to date.  The data are particularly compelling 
as they derive from analysis of intact tissue-probe surfaces instead of tissue where the 
interface has been disrupted by probe removal.  Neural stem cell seeding was shown to 
increase neuronal density surrounding the probe during the first week of implantation, 
along with reductions in non-neuronal density.  At later time points, these effects were 
reversed and cell-seeding exacerbated the tissue response metrics.  The results indicate 
that NSC-seeding may improve the early injury response through a bystander mechanism, 
and future studies may extend the effects to a chronic setting by improving alginate 
stability and graft cell viability.   
 
Chapter 5 describes the effects of a cell cycle inhibiting drug (flavopiridol) on the 
impedance, recording quality, and tissue response associated with neural prostheses.  The 
drug was administered as a single injection at the time of probe implantation, which 
could be easily implemented in a research setting, and could be translated into clinical 
studies.  The drug reduced impedance, likely due to a reduction in microglial 
encapsulation of the device.  Although recording quality and impedance were 
significantly inversely correlated, this effect was not large enough for the impedance 
reduction by flavopiridol to result in a significant improvement in SNR or the number of 
units detected.  Additionally, endpoint quantitative histology was too variable to 
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demonstrate an effect of the drug, and this result highlighted the importance of in situ 
probe histology.  Finally, endpoint non-neuronal density correlated positively with 
impedance and negatively with SNR and units, providing the first in vivo quantitative 
evidence supporting the hypothesis that recording quality and tissue response are related.  
Interestingly, neuronal density did not significantly correlate with recording quality 
unless normalized to non-neuronal density, which may indicate the importance of 
neuronal function and the glial barrier to signal transmission. 
 
Future Directions and Preliminary Results 
 
 
Establishing the Relationship Between Recording Quality and Tissue Response 
 
Despite numerous reports of instability in recordings over time, histological changes 
associated with the tissue response to neural prostheses, and a body of probe modification 
literature based on the working hypothesis that the two phenomena are related (see 
Chapter 1 for references and discussion), the relationship between electrophysiology, 
impedance, and histology metrics has not been explicitly defined.  Williams et al. 
reported increased impedance at 1 kHz at recording sites experiencing gliosis (Williams, 
Hippensteel et al. 2007). The authors also reported a shift to a more non-linear 
relationship between real and imaginary impedance components over time, indicating a 
capacitive contribution of increasing cellular density (Figure 6.1).  A similar trend was 
noted between sites having minimal (linear relationship) and extensive (non-linear 
relationship) glial reactivity.  Suner et al. reported a small correlation between signal and 
impedance, but no overall correlation between SNR and impedance (Suner, Fellows et al. 
2005).  The results reported in Chapter 5, which show significant correlations between 
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endpoint non-neuronal density, neuronal density normalized for non-neuronal density, 
impedance, SNR, and the number of units detected, are an important step in defining the 
relationship between electrophysiology and the tissue response to neural prostheses.  
However, refinement and further investigation into these results is required, particularly 
because explantation of probes prior to histology disrupts the tissue-device interface, 
resulting in the loss of important data. 
 
(a)  Immediately Post-Implant  (b)  7 Days Post-Implant 
   
Figure 6.1. Nyquist plots for 20 electrodes immediately after implantation (a) and after 7 
days (b), illustrating an increasingly non-linear relationship between real and imaginary 
components over time (Williams, Hippensteel et al. 2007). 
 
A deeper understanding of the cause-and-effect relationship between recording quality 
and the tissue response to devices will require improved quantitative histology 
techniques.  Silicon devices are prone to shatter and tear tissue when left in situ during 
conventional sectioning, and are therefore explanted prior to this step.  This process 
damages the probe-tissue interface, resulting in the loss of valuable data in what is 
potentially the most interesting region to analyze.  Additionally, it is extremely difficult, 
if not impossible, to accurately assess where the electrode sites were located when 
evaluating samples prepared in this way.  The result is a gross, and likely inaccurate, 
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understanding of the tissue-device interface.  Electrode site-specific data is far more 
desirable; it would allow the investigator to assess the relationship between recordings 
and tissue response metrics on a site-by-site basis, thus increasing sample size and 
accuracy.   
 
Recent work in our laboratory has used a combination of cryo-sectioning parallel to the 
face of the probe, immunohistochemistry of the resulting thick (100-200 microns) 
sections containing the intact probe, and multiphoton microscopy to enable quantitative 
site-by-site analysis of cellular density.  Previous studies have reported similar sectioning 
techniques (Bragin, Hetke et al. 2000; Holecko, Williams et al. 2005).  Holecko et al. 
further demonstrated the feasibility of GFAP immunohistochemistry on their samples 
using confocal microscopy for visualization.  No attempt at quantitative evaluation of the 
tissue was made in either of these studies.  Our work has demonstrated the ability to 
count individual cellular nuclei deep into tissue sections on an electrode site-by-site basis 
(Figure 6.2, preliminary counting data not shown) (Seymour, Purcell et al. 2008).  
Multiphoton imaging results in improved resolution at greater depths in the section and 
reduces photobleaching in comparison to confocal imaging.  However, there are 
limitations to this technique as well: algorithms may be required to resolve fluorescence 
signals when multiple stains are used, access to multiphoton microscopy is limited and 
expensive, and in situ sectioning and staining carries significant risks associated with 
having a single sample to process as opposed to numerous cross-sections.  Further 
improvements to our methods, as well as exploring new techniques (such as cross-
sectioning the probe in situ with a diamond knife, immunogold labeling and imaging with 
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Figure 6.2.  Comparison of multi-photon and confocal images of the same electrode sites 
implanted in guinea pig tissue.  Multi-photon imaging provides higher resolution at 
deeper focal planes (left panels), enabling cell counting near electrode sites not accessible 
with confocal imaging (right panels).  Neuronal and all cellular nuclei are counterstained 
with NeuN (green) and Hoechst (blue) respectively, and electrode sites are demarcated 
and labeled (Seymour, Purcell et al. 2008).  Also, note the site-by-site variability in 
cellular densities. 
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transmission electron microscopy) may enable a comprehensive recording/histology 
study in the future.  Alternatively, this may be possible by using functional polymer 
probes which may be left in place during conventional sectioning.  The development of 
these devices is on-going.  Importantly, a combined histology/recording study may 
identify the specific mechanisms which most severely impact recording stability and 
quality.  This, in turn, will result in more defined targets for probe modification and tissue 
response intervention strategies to improve recording stability.     
 
Neuronal Dysfunction and Plasticity after Probe Implantation 
 
Typically, neuronal density surrounding the probe is quantified as a measure of tissue 
response to the device, and the same is true in the studies reported in Chapters 4 and 5 
(Edell, Toi et al. 1992; Biran, Martin et al. 2005; Seymour and Kipke 2007).  The implicit 
assumption is that having more neurons nearer recording sites will result in improved 
signal.  However, this is not necessarily the case.  Anecdotal evidence from our lab 
suggests that neuronal soma may be located in close proximity to recording sites which 
do not detect units.  The lack of correlation between neuronal density and recording 
quality reported in Chapter 5 may indicate the importance of neuronal function.  
Additionally, Henze et al. have reported detecting approximately six units per tetrode, 
despite estimations that 60-100 neurons of the 1,000 within a recordable distance from 
device should have sufficient amplitude to be discernible above noise (Henze, Borhegyi 
et al. 2000).  The authors hypothesize that the majority of the cells may be silent during 
the recording period, or at least have an insufficient firing rate to be identified by 
clustering methods.  This raises interesting questions:  are the majority of cells near the 
probe functionally silent?  If so, is this an unavoidable characteristic of the brain tissue 
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itself, or in part due to the injury response to the probe?  If the latter is true, are there 
ways to “wake up” these cells? 
 
In recent years, several studies have explored the mechanisms underlying silent synapses.  
Christopherson et al. reported thrombospondin (TSP, an angiostatic extracellular matrix 
molecule) expression by immature astrocytes promoted synaptogenesis in development. 
The synapses were ultrastructurally normal but silent during patch clamp recording 
(Christopherson, Ullian et al. 2005).  The authors suggest that while TSP levels are low in 
the adult brain, their expression in reactive astrocytes may “explain the tendency of 
axotomized axons to…fail to regenerate when they contact reactive astrocytes,” and 
further state that “drugs that agonize or antagonize TSPs may help promote synaptic 
plasticity and repair in many CNS diseases.”  Alterations in AMPA and NMDA receptor 
expression offer an additional possible explanation for silent synapses (Isaac 2003).  
During early postnatal development, silent synapses have NMDA, but not AMPA, 
glutamate receptors; the latter are progressively acquired (Petralia, Esteban et al. 1999; 
Isaac 2003; Voigt, Opitz et al. 2005).  These synapses are functionally silent, although 
spontaneous synchronous network activity may convert silent synapses to active synapses 
by the incorporation of AMPA receptors (Voigt, Opitz et al. 2005).  Reductions in 
AMPA receptors have been demonstrated in the vicinity of spinal cord injury sites as 
early as twenty-four hours after trauma in rats (Grossman, Wolfe et al. 1999).  If a similar 
change in receptor profile or TSP expression were to occur respectively in neurons and 
astrocytes located near recording electrodes during injury remodeling, strategies to 
improve recording quality via receptor or TSP agonists/antagonists could be feasible. 
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The broader issue of neuronal function/dysfunction surrounding probes has not been 
addressed, and several areas of research may shed light on this issue.  The central 
question to be answered is whether or not the neurons located within a recordable 
distance from electrodes are functionally normal or not.  Neuronal dysfunction was 
evident on the border of small (~ 1mm diameter), focal lesions in the cat visual cortex in 
the days immediately following injury (Eysel and Schmidt-Kastner 1991).  Cells within 
the first 0.5 mm of the lesion displayed a depression in extracellular potentials.  Increased 
activity above control values was noted 1 mm away from the lesion border; this metric 
normalized with further distance from the injury site and may have been due to inhibitory 
interneuron damage.   Studying silent synapse formation around neural prostheses may 
also shed light on the neuronal dysfunction issue.  Additionally, what role does plasticity 
play in recording quality over time?  Brain injury has been shown to induce extensive 
rewiring of cortical connections, and whether this occurs following device implantation 
should also be researched (Dancause, Barbay et al. 2005).  Finally, what is the 
mechanism behind neuronal density reduction around probes:  are they merely physically 
displaced, or is cellular death the cause?  The data reported in Chapter 4 indicates the 
latter.  If neurons around these devices are dying, what is the mechanism (excitotoxicity, 
apoptosis, necrosis, etc.) and time course of these events?  Knowing the answers to these 
questions may result in new intervention strategies.                                   
 
 
Chronic Recordings with Functionalized Neural Stem Cell-Seeded Probes 
 
The development of a neural stem cell-seeded functional recording device will open the 
door for numerous future studies investigating the effects of these cells and their released 
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factors on surrounding neuronal activity.  Neurotrophins (specifically, NGF and BDNF) 
have been shown to enhance or depress neural activity in studies with varying methods 
and cell populations (Prakash, Cohen-Cory et al. 1996; Zhang, Chi et al. 2008).  The 
neural stem cells may secrete these and other factors in vivo which could potentially 
impact cell viability, plasticity, and electrophysiology metrics, and this device may 
enable studies to investigate the relationships between these effects.  These studies may 
also add insight into the mechanisms responsible for the in vivo results reported in 
Chapter 4.  This research will be enhanced further by the ability to conduct histology with 
the interface between the parylene probe, graft cells, and surrounding tissue intact.  
Improved in vivo detection of graft cells will strengthen results (see Appendix A).    
Fabrication of functional “open-channel” devices for cell-seeding was underway at the 





Neural prostheses have the potential to restore function to hundreds of thousands of 
patients who are immobilized by paralysis or neurodegenerative disease.  Additionally, 
these devices may have tremendous impact in neurophysiology research settings.  
However, stable, long-term recordings must be achieved in these applications.  
Understanding the reactive tissue response to these devices, and developing effective 
intervention strategies to improve upon it, may result in enhanced recording quality.  In 
this dissertation, two approaches to improving the tissue integration of synthetic probes 
were explored:  a biohybrid device with further research implications, and a drug-based 
approach which could be easily applied in a research or clinical setting.  Each study 
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resulted in a measurable improvement of the reactive tissue response and/or impedance 
associated with neural prostheses, and increased the current understanding of the device-
tissue interface.  Studying neural stem cell-seeded alginate additionally resulted in 
stability and scaffolding data which have impacts outside of the field of neural 
engineering.   
 
Numerous future studies are planned to expand upon these results further.  Specifically, it 
is of primary interest to characterize changes in neuronal function over time following 
device implantation.  If the amplitude and/or firing rate of neurons around devices is 
reduced due to injury remodeling, then methods of reducing tissue encapsulation and 
device impedance will be inadequate to improve recording stability.  This was illustrated 
in Chapter 5 data, which showed a drug-induced reduction in microglial activation and 
impedance, but no improvement in recording quality.  Further, the stabilization of 
neuronal density surrounding devices reported in Chapter 4, and the lack of correlation 
between neuronal density and recording quality reported in Chapter 5, support this 
contention.  When changes in neuronal function and their associated mechanisms are 
adequately characterized, then future studies will be conducted to intervene in this 
response, with the correct factors supplied via cell seeding, scaffolds, or direct drug 
administration.  Combining these strategies with impedance- or glial activation-reducing 
methods may ultimately be the optimal approach.  These research studies, which 
characterize the electrophysiology, cellular function, and tissue response to a source of 
brain injury, have the potential to impact not only the field of neural engineering, but also 
the understanding of, and development of therapies for, central nervous system damage.  
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APPENDIX A 
IDENTIFICATION OF GRAFTED NEURAL STEM CELLS IN VIVO 
 
In Chapter 4, mouse-derived neural stem cells were implanted into rats, and the murine-
specific marker M2 was used to identify the cells in vivo.  M2 “staining” was observed in 
NSC-seeded probes from several animals at multiple time points, but not in control 
probes.  However, control slides wherein the primary antibody was omitted revealed 
sufficient background to invalidate these results (Figure A.1) from all animals except for 
those from the 1 day time point.  The positive identification of the cells at this time was 
further validated by their location within a still intact alginate scaffold.  The source of the 
background problem is believed to be the use of the M2 antibody, which is raised in rat 
and necessitates the use of an anti-rat IgG secondary on rat tissue experiencing an 
immune response.  While this exact method has been used to detect murine NSCs in a rat 
model in published literature (Teng, Lavik et al. 2002; Deshpande, Kim et al. 2006), there 
was no accompanying discussion or evidence of background problems presented, and 
attempts to contact the authors regarding this issue received no response.  Alginate and 
parylene often brightly autofluoresced in green and blue respectively, which allowed 
visualization of these structures, but at times further obscured the M2 signal.  Several 
attempts using multiple batches of the M2 antibody were made, with secondary 
antibodies with different emission spectra, but background staining was an issue in each 
trial.    
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Figure A.1.  An example of M2 staining (green) in an animal at the 6 week time point (a), 
and a control image from a different section in the same animal where the primary 
antibody was omitted (b).  Note the similarity in staining patterns, and the location of 
staining at the graft site.  Images include the DIC channel to facilitate visualization of the 
probe.  Scale = 100 microns.  
 
A search for alternative mouse-specific antibodies did not reveal viable options.  The rat 
anti-mouse thy1.2 antibody, which is specific for most mouse neurons, was tested.  
Again, an anti-rat secondary was necessitated, and staining appeared similar to controls 
wherein the antibody was omitted (Figure A.2).   There may have been relatively few 
graft-derived differentiated neurons, which would make detection of these cells with this 
antibody unlikely. 
 
Figure A.2.  Thy1.2 staining reveals similar positive (brown) patterns in a probe in which 
the primary is included (a) and omitted in the place of buffer (b).  The cells being labeled 
are likely part of the immune response to the implant, and stain vascular elements 
throughout the brain tissue (c).  Scale = 100 microns. 
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Therefore, we cannot claim detection of graft cells at time points later than 1 day post-
implantation, and improved methods in the future may more accurately assess their 
existence and differentiation status in vivo.  Potential methods in the future (one of which 
will be used in an upcoming study with functionalized parylene probes seeded with 
neural stem cells) will pre-label the cells prior to implantation.  Genetic engineering with 
fluorescent proteins, the use of quantum dots, and magnetic resonance imaging of cells 
labeled with iron oxide nanoparticles are all options (Chapman, Oparka et al. 2005; 
Sykova and Jendelova 2007). 
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APPENDIX B 
NEURAL PROSTHESIS SCHEMATICS 
 





Figure B.1.  Chronic neural probe assembly. 
 
 
Figure B.2.  Probe schematic for devices used in Chapter 5 research.  Single shank, 
sixteen channel probes were used. 
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Figure B.3.  Illustration of probe insertion (a four shank model is shown) into the 
craniotomy.  The connector is attached to a stainless steel bone screw with dental acrylic, 
and the ground wire is wrapped around an additional screw.  Following GelFoam and 
silicone closure of the craniotomy, the entire region is encased in dental acrylic, leaving 
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APPENDIX C 
SELECTED CHAPTER 4 & 5 IMAGES AT HIGHER MAGNIFICATION 
 
Figure C.1.  Doublecortin staining, p. 116.  Doublecortin (red), NeuN (green), and 
Hoechst (blue).  Scale = 50 microns. 
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Figure C.2.  One week neuronal images, p. 113.  NeuN (green), neurofilament (red), and 
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Figure C.3.  Three month neuronal images, p. 113.  NeuN (green), neurofilament (red), 
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Figure C.4.  One week glial images, p. 109.  Ox-42 (green), GFAP (red), Hoechst (blue).  
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Figure C.5.  Three month glial images, p. 109.  Ox-42 (green), GFAP (red), Hoechst 
(blue).  Scale = 50 microns. 
 
NSC-seeded. 
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